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ABSTRACT 
The aim of this project was to study the identity of probiotic lactobacilli in fermented 
milk products from the United Kingdom/European markets during their survival 
during shelf-life. This in vitro study was also aimed at undertaking studies on some 
of the physiological probiotic criteria, such as resistance to stomach/intestine 
conditions and also possible functional properties of the isolates, such as 
antimicrobial activities, antibiotic resistance/susceptibility and antibiotic resistance 
genes, biofilm formation and production of conjugated linoleic acid (CLA). 
Primarily, a comparative study was carried out on selectivity of MRS-Clindamycin, 
MRS-Sorbitol and MRS-IM Maltose, to select the right medium for enumeration of 
probiotic Lactobacillus. Based on selectivity of medium for recovery of the targeted 
lactobacilli and also simplicity of preparation, MRS-Clindamycin was chosen as the 
best medium for enumeration of probiotic Lactobacillus in fermented milks. The 
results of enumeration of lactobacilli showed that 22 out of a total 36 tested 
products contained more than 106 colony forming units/g at the end of their shelf-
life, which comply with the recommended minimum therapeutic level for probiotics.  
Rep-PCR using primer GTG-5 was applied for initial discrimination of isolated 
strains, and isolates, which presented different band profile, were placed in different 
groups. The isolated Lactobacillus spp. were identified mainly as Lactobacillus 
acidophilus, Lactobacillus casei and Lactobacillus paracasei by analysis of partial 
sequences of the 16S ribosomal RNA and rpoA genes.  
In order to characterize the isolates for probiotic properties, this study was focused 
on six Lactobacillus isolates along with two commercial Lactobacillus cultures from 
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Chr. Hansen (Lactobacillus acidophilus La5 and Lactobacillus casei C431) and 
three Lactobacillus type strains (Lactobacillus casei subsp. casei, Lactobacillus 
paracasei subsp. paracasei and Lactobacillus acidophilus) which were purchased 
from NCIMB. 
The stomach and intestine conditions were mimiced using a batch culture 
fermentation system, and the combined effects of pH, enzymes and bile salts on 
survival of tested isolates was tested. The tested isolates were able to survive at 
low pH environment and also high concentrations of bile salts of the upper digestive 
tract.  
The potential of tested isolates for biofilm formation was determined in different 
conditions of nutritional and physiological stresses. The capability of tested isolates 
to produce biofilm in nutrient rich medium was recorded. However, the growth 
limitation, such as nutrient shortage in diluted media and also using inulin rather 
than glucose in synthetic medium, did not induce biofilm formation. 
Antimicrobial activities of tested bacteria against indicator bacteria namely 
Escherichia coli NCTC 12900, Salmonella enterica serovar Typhimurium DT124 
and Salmonella enterica serovar Enteritidis PT4 and Lactobacillus delbruckii subsp. 
bulgaricus were studied. The production of organic acids and bacteriocin was 
considered as key mechanisms for antimicrobial activity of tested strains.  
Screening the isolates competence for production of CLA demonstrated that this 
feature is species dependent and also entirely related to the level of initial linoleic 
acid in the medium. 
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Eleven tested isolates were also assessed for their antibiotic resistance profile by 
determination of minimum inhibitory concentration (MIC). The acquired resistance 
to cefoxitin, ceftriaxone, chloramphenicol, erythromycin, gentamycin, kanamycin, 
lincomycin, streptomycin, tylosin tartarate, tetracycline and vancomycin was 
observed in all tested isolates. Also their genetic background of antibiotic 
resistance genes was studied by PCR reactions and none of the tested isolates 
showed positive bands for investigated resistance genes. 
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1.1 Introduction 
During the past years, among different functional foods, the foods containing 
probiotic microorganisms have been given great attention (Granato et al. 2010a). 
Probiotic bacteria are "live microorganisms, which when administered in adequate 
amounts confer a health benefit to the host" (FAO/WHO 2002).  Apart from this 
widely used definition of probiotics, other reports have clarified this concept. In 
general terms, a probiotic food substance must contain a taxonomically defined 
microorganism and be shown in human studies to provide considerable benefits for 
the host. The FAO/WHO (2002) definition embraces utilization of all live microbes, 
not only those for intestinal benefits (Anukam and Reid 2007). In addition to the 
incorporation of the probiotics in food and dietary supplements, probiotic 
microorganisms may be used in pharmaceutical applications (tablet, capsule, 
sachet and powder forms) and microbial feed. A variety of food products, such as 
fermented milk, plant derived food and meat products, have been used as a food 
matrix for probiotics. The therapeutic effects of these microorganisms include 
balancing the intestinal flora, absorption of calcium, synthesis of vitamins, 
enhancing lactose tolerance, decreasing cholesterol level and modulating the 
immunological system (Margoles and Garcia 2003). 
Several endogenous and exogenous factors, such as age, stress, immunological 
status, diet and medical treatments, might affect the composition and activities of 
the intestinal microbiota (Isolauri et al. 2004). Most probiotics belong to the lactic 
acid-producing bacteria, including lactobacilli and bifidobacteria. There are also 
non-bacterial and non-lactic acid bacterial organisms, such as Saccharomyces 
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boulardii lyo and Escherichia coli (E. coli) strain Nissle, have been suggested as 
probiotic (Anukam and Reid 2007). Lactobacilli are among the bacteria mostly used 
as probiotics in animal feeds and human foods (Coeuret et al. 2004). 
Lactobacillus spp. which is one of the main genera found in the intestine, is most 
frequently chosen as a probiotic. The main commercial species used for the 
production of functional foods belong to this genus (Gibson et al. 2003; Vinderola 
et al. 2011).  
The most important species of Lactobacillus spp. used as probiotics include 
Lactobacillus acidophilus (Lb. acidophilus), Lactobacillus casei (Lb. casei), 
Lactobacillus paracasei (Lb. paracasei), Lactobacillus rhamnosus (Lb. rhamnosus), 
Lactobacillus plantarum (Lb. plantarum), Lactobacillus gasseri (Lb. gasseri), 
Lactobacillus johnsonii (Lb. johnsonii), Lactobacillus reuteri (Lb. reuteri), 
Lactobacillus crispatus (Lb. crispatus) and Lactobacillus fermentum (Lb. 
fermentum). The concentrates of probiotic lactobacilli used for functional foods are 
usually supplied in freeze-dried, spray dried or microencapsulated form. 
 
1.2 History of the probiotic 
The term probiotic means "for life" in Greek language, and is used to name bacteria 
associated with benefits for humans and animals (FAO/WHO 2002). Elie 
Metchnikoff in 1907 hypothesised that substituting the putrefactive bacteria in the 
gut with lactic acid bacteria (LAB) results in normalising the bowel health and 
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prolonging the life. He observed that the regular consumption of fermented dairy 
products is the main reason of health and longevity in Bulgarian people. 
Metchnikoff attributed the health effects of these bacteria and indicated how health-
promoting bacteria in yogurt might be helpful in digestion and also in better 
functionality of immune system. He stated that ‘the dependence of the intestinal 
microbes on the food makes it possible to adopt measures to modify the flora in 
our bodies and to replace the harmful microbes by useful microbes’ (Metchnikoff 
1907). Another investigation about the benefits of LAB was made by French 
paediatrician Henry Tissier who reported that some bacteria could be used for 
individuals with diarrhoea to restore their well gut flora (Tissier 1906). In 1935, a 
probiotic product, which was named Yakult, was produced by a Japanese scientist 
Minoru Shirota (Sako 2011). 
Lilly and Stillwell (1965) used the term “probiotics” and mentioned that there are 
some compounds produced by some organisms, which stimulate the growth of 
others. 
Parker (1974) stated that probiotics are the organisms that play an important role 
in intestinal microbial balance. In 1989, Fuller reported that probiotics are "live 
microbial supplements which have beneficial effects on the host by improving its 
microbial balance". According to another definition suggested by Havenaar and 
Huis in't Veld (1992), probiotics are "viable mono or mixed cultures of bacteria 
which, when applied to animal or human, beneficially affects the host by improving 
the properties of the indigenous flora". 
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The definition by FAO/WHO (2002), which defined probiotics as "live 
microorganisms, which when consumed in adequate amounts, confer a health 
effect on the host" is not acceptable to the European Food Safety Authority (EFSA), 
because it includes a health claim, which is not measurable (Rijkers et al. 2011).  
In recent years, scientific advances using molecular and genetic studies have been 
obtained in the selection and characterization of different probiotic microorganisms 
and health claims have been also substantiated regarding their use in life (Anukam 
and Reid 2007). 
 
1.3 Ecological considerations of the gastrointestinal tract  
More than 400 bacterial species have been identified in the GIT of human (Tannock 
1999).  The bacterial concentration in the stomach is <102 CFU /ml of gastric juice 
and in the colon is about 1012 CFU/g of colonic material (Table 1.1) (Mitsuoka 1992). 
Some preliminary studies on the environment of the human gut have indicated that 
consuming multiple probiotic strains presents more benefit than a single strain 
(Timmerman et al. 2004; Williams et al. 2008). Extensive 16S rRNA gene 
sequencing has indicated the high diversity of the intestinal microbiota (Ley et al. 
2006).  
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0Table 1.1 Numbers and species of the most common bacteria of the alimentary tract 
 
Source: Lonnermark (2010) 
 
 
Gut microbiota present extensive effect on the host physiology, biochemistry, 
immunology and resistance to intestinal infections (Berg 1996). Different 
compartments of the GIT have variable chemical and physical characteristics; 
therefore, only certain microbial communities are able to survive and grow in the 
stomach, small intestine, and large intestine (Tannock 1995). The human stomach 
and the first two-third of the small bowel contain relatively a small number of 
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microbes due to the pH of the stomach contents (pH 2, when empty). The toxicity 
of bile salts, and also the swift flow of the digesta might be the other reasons for 
low microbial population in the upper digestion systems (Tannock 1995).  
The microbial population of the proximal small intestine, ileum and colon are 103, 
108 and 1010-1012 CFU/ml, respectively. In addition to density, microbial diversity 
also increases from proximal small intestin to the colon (Finegold et al. 1983; 
Lonnermark 2010). Lactobacilli grow optimally between the temperatures of 30 and 
40 °C. Therefore, they have a diverse generation time, e.g. the generation time of 
Lb. acidophilus is in the range of 22 and 84 minutes in 40 and 30°C, respectively 
(Cho et al. 1996). Lactobacilli are commonly associated with the GIT of animals 
and humans, but some of them are originated from plant (Walter 2008). 
 
1.4 Lactobacilli 
Lactobacillus is a genus of Gram-positive facultative anaerobic or micro-
aerophilic, non-spore-forming and rod-shaped bacteria (Makarova et al. 2006). 
Usually lactobacilli are straight rods, but under certain conditions, they can be in 
spiral or coccobacillary forms. Lactobacilli are found in pairs or chains of different 
length. Almost all required energy for lactobacilli is obtained from the conversion of 
glucose to lactate during homolactic fermentation and, 85-90% (w/w) of the sugar 
utilised, is converted to lactic acid. Lactobacilli are a main part of the LAB due to 
the ability to convert lactose to lactic acid, and is traditionally identified on the basis 
of morphology, ability to use various carbohydrates, fermentation products and 
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associated enzyme activities. Testing for absence of catalase activity, and also the 
presence of lactic acid as the major acid produced from the fermentation of glucose, 
might be a confirmation result that the isolates belong to the genus Lactobacillus 
(Tannock 1999). 
Lactobacilli constitute a small part of the intestinal flora (Walter 2008). They are 
benign in GIT, but are associated with dental caries (Piwat et al. 2010). Generally, 
Lb. fermentum has been reported to be the most predominant species in dental 
caries of children (Piwat et al. 2010). Another study has revealed that Lb. gasseri 
and Lactobacillus ultunensis are prevalent species colonizing carious dentine 
(Byun et al. 2004). 
The genus Lactobacillus was identified by Martinus Beijerinck in 1901(Barinov et 
al. 2011). According to the type of metabolism, lactobacilli species can be classified 
into three groups including obligatory homofermentative (such as Lb. acidophilus, 
Lb. bulgaricus, Lactobacillus helveticus (Lb. helveticus)  and Lactobacillus 
salivarius), facultative heterofermentative (such as Lb. casei, Lactobacillus 
curvatus (Lb. curvatus), Lb. planetarum, Lactobacillus sakei (Lb. sakei)) and 
obligatory heterofermentative (such as Lb. brevis, Lactobacillus bunchneri (Lb. 
bunchneri), Lb. fermentum, Lb. reuteri) (Felis and Dellaglio 2005).  
Homofermentative lactobacilli in the fermentation process of glucose produce 
mainly lactic acid. Heterofermentative lactobacilli, in addition to lactic acid, produce 
acetate, ethanol and carbon dioxide (Karpinski and Szkaradkiewicz 2013). 
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1.5 Criteria for selection of probiotic bacteria 
1.5.1 Viability and effects of processing, food matrix and storage on probiotic 
lactobacilli 
Viability and functionality of probiotic lactobacilli should be maintained during 
processing, handling and storage of the product. Probiotic lactobacilli must be alive 
during the passage through the digestive tract and also they should be able to 
proliferate in the gut (Holzapfel et al. 2001). In vivo techniques to assess the 
survival of probiotics are performed using different methods such as faecal 
collection, intestinal intubation and identification of strain on mucosal biopsies 
(Marteau 2001).  
Animal and clinical studies are two forms of in vivo research. In vivo testing is often 
used over in vitro because it is more appropriate to monitor the overall impacts of 
an experiment on a living subject. 
It is necessary to note that extrapolation of results gained in animals to humans is 
dangerous, may be unrealistic and the results should be treated with caution, due 
to the variability of reactions among species and strains. 
Food matrix, physicochemical properties and functional ingredients of product 
affect the performance of lactobacilli (Ranadheera et al. 2010). Higher protective 
effect of bovine milk compared to soy milk on survival of Lb. casei in simulated 
gastric and intestinal juice has indicated the importance of the food matrix regarding 
the physiological properties of lactobacilli (Wang et al. 2009). Dairy products need 
refrigeration in the distribution channels but, in dried formulations, lactobacilli can 
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survive without refrigeration, if they are retained in proper vials kept in a cool and 
dry place with suitable desiccants (Anukam and Reid 2007). 
1.5.2 Adhesion of probiotic lactobacilli in gastrointestinal tract 
It has been hypothesized that Lactobacillus strains with a high value of cell surface 
hydrophobicity have a better adhesion to the epithelial cells of intestine 
(Kotzamanidis et al. 2010). Adherence of lactobacilli to epithelial cells can block 
adherence of pathogens. It has been reported that production of mucin by Lb. 
plantarum 299v or Lb. rhamnosus GG prevented the adhesion of entero-
pathogenic E. coli strain E2348/69 in cell culture assays (Mack et al. 2003). 
Lactobacillus rhamnosus GG can reduce adhesion of pathogenic Salmonella spp., 
Clostridium spp. and E. coli in pig intestinal mucus (Collado et al. 2007). 
In vitro studies have shown that Lb. casei DN-114001 (Ingrassia et al. 2005), Lb. 
plantarum 423 (Botes et al. 2008) and Lactobacillus kefir (Golowczyc et al. 2007) 
can interfere with invasion of host epithelial cells by Salmonella enterica serovar 
Typhimurium and Salmonella enterica serovar Enteritidis.  
1.5.3 Antimicrobial properties of probiotic lactobacilli  
Different antimicrobial substances, such as short chain fatty acids, hydrogen 
peroxide, lactic acid and bacteriocins are produced by lactobacilli. Lactic acid 
prevents the growth of microorganisms sensitive to acidic conditions by decreasing 
the local pH (De Keersmaecker et al. 2006). It also permeates the outer membrane 
of Gram-negative bacteria (Alakomi et al. 2000).  Lactobacilli can produce low and 
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high molecular weight bacteriocins including lantibiotics, heat stable non-
lantibiotics and cyclic antimicrobial peptides (Maqueda et al. 2008).  
Interactions among different lactobacilli have been reported during fermentation 
(Giraffa et al. 1996). Beneficial or unfavorable microbial interactions among 
different mixtures of probiotic and lactic starter cultures generate undesirable 
changes in the composition of the bacterial population throughout the fermentation 
and storage of dairy products (Bellengier et al. 1997). The inhibitory, stimulatory or 
neutral interactive effects among probiotics and starter cultures may be related to 
the production rate of lactic acid, other organic acids or secondary metabolites 
(Rattanachaikunsopon and Phumkhachorn, 2010). There is an associative growth 
between the yogurt starter cultures (Streptococcus thermophilus and Lb. 
delbrueckii subsp. bulgaricus) (Michaylova et al. 2007). However, in some co-
cultures the proportion of probiotic to starter culture becomes unbalanced, so 
neither functions properly (Goderska and Stanton 2010). To avoid the competition 
among the strains, it has been suggested to use starter cultures and probiotic 
strains from the same supplier (Cruz et al. 2009b). Apart from the difference 
between the starter and probiotic strains, it seems that this advice can be due to 
this fact that two types of strains undergo the similar environmental factors, which 
exist during preparation process, and subsequently impact the functional 
behaviours of the strains. In another study, it has been also reported that it can be 
solved by use of cultures from the same supplier (Granato et al. 2010b). 
It has been reported that interaction among species is an important factor affecting 
the viability of Lb. acidophilus (Kailasapathy and Rybka 1997). In some cases, 
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synergistic growth-promoting effects have been reported between Lb. acidophilus 
and Bifidobacterium bifidum strains (Kneifel et al. 1993). In other cases, growth 
inhibition has been found among probiotic species and it has been attributed to the 
production of bacteriocin (Yildirim and Johnson 1998). 
Lactobacillus acidophilus is a thermophilic starter which grows slowly in dairy 
products, and has a high acid tolerance (Tamime and Marshall 1997). As 
lactobacilli are the most acid tolerant of LAB, they can lower the pH of milk from 
initial values of (6.6-6.8) to below 4.0. Therefore, they are usually used in 
combination with S. thermophilus (Hassan and Frank 2001). H2O2, which is 
generated throughout the storage of yogurt, is considered as a main compound for 
reduction of the viability of Lb. acidophilus, and does not have catalase to hydrolyze 
H2O2. The presence of S. thermophilus helps decompose H2O2 into water and 
oxygen (Ng et al. 2011). 
It was demonstrated that the inhibitory effect of Lb. acidophilus CNRZ 1881 on Lb. 
delbrueckii subsp. bulgaricus Ab1 was attributed to the presence of a bacteriocin-
like compound, because antibacterial activity of Lb. acidophilus did not decrease 
after neutralization or heating at 121 °C for 15 min of the concentrated cell-free 
supernatant, while it entirely disappeared after treatment with proteinase K and 
pepsin (Vinderola et al. 2002b). 
In general, the interactions between species of probiotic bacteria and lactic acid 
starter include stimulation, delay or completely inhibition of growth, although in 
some cases no interactive effects between them. 
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Considering the interactions among the mentioned cultures, it is important to select 
the best combination in order to optimize their survival in the products and their 
performance during the fermentation process (Vinderola et al. 2002b). Hence, 
interaction among lactic acid starter and probiotic bacteria is needed to be well 
investigated, to provide an optimal combination of cultures for manufacturing 
probiotic dairy products (Timmerman et al. 2004; Kosin and Rakshit 2006). 
1.5.4 Safety 
Although some epidemiological surveillance have been conducted to assess the 
safety of  lactobacilli (Saxelin et al. 1996), potential probiotic lactobacilli should be 
periodically assessed for different characteristics, including antibiotic resistance 
gene transfer, enzymatic properties and metabolic activities, such as D-lactate 
production and bile salt deconjugation, toxicity and post-market incidents. Other 
side-effects of probiotics include systemic infections and excessive immune 
stimulation in susceptible people. Generally, safety evaluation of probiotics can be 
based on the intrinsic characteristics, their pharmacokinetics and interactions 
among different strains and the host (Marteau, 2001).  
1.5.4.1 Antimicrobial (antibiotic) resistance genes and their transferability 
potential 
Another main concern of the use of probiotic microorganisms in foods is the fact 
that they may contain specific antimicrobial resistance genes (FAO/WHO 2006) 
and, therefore, it is recommended that bacteria with transferable antibiotic 
resistance genes should not be used in foods. Unless, certain antibiotics may not 
be useful for treatment of infectious diseases.  
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The transferability of genetic elements to other intestinal and foodborne bacteria is 
one of the important criteria in investigation of probiotic safety (Saarela et al. 2000).  
Plasmids in isolated lactobacilli from the intestine may have genes which encode 
antibiotic resistance. In selection of probiotic strains, it is strongly advised that 
probiotic microorganisms should not contain transferable antibiotic resistance 
genes which encode resistance to clinical antibiotic, because resistance genes 
might be transferred by probiotics to the intestinal flora. Factors affecting the 
transferability of antibiotic resistance gene include nature of the genetic elements, 
their concentrations and exposure and the nature of the donor and recipient strains 
(Marteau 2001). Intrinsic resistance of lactobacilli is encoded by chromosome and 
is not transferable (Bernardeau et al. 2008). Thus, manufacturer has to prove that 
the strain used cannot acquire or transfer antibiotic resistance or be virulent and 
induce infection (FAO/WHO 2006). 
1.5.4.2 Infections and deleterious metabolites 
Although no pathogenic or virulence features of lactobacilli have been reported, 
some Lactobacillus spp. have been related to adverse effects, such as bacteremia 
under particular conditions (Saxelin et al. 1996). However, no increased 
incidence/frequency of bacteremia was reported with enhanced usage of 
lactobacilli (Salminen et al. 2001). Rare reports of local or systemic infections such 
as septicemia and endocarditis due to lactobacilli have been published (Husni et 
al. 1997).  
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1.5.4.3 Mortality 
In a randomised, double-blind, placebo-controlled trial in University Medical Center 
Utrecht, Netherlands, patients with diagnosed severe acute pancreatitis received a 
multispecies preparation of probiotics or placebo given twice daily via a jejunal 
catheter for 28 days.  
Multispecies preparation of probiotics (Ecologic® 641) consisted of 6 strains of 
viable and freeze-dried bacteria, including Lb. acidophilus, Lb. casei, Lb. salivarius, 
Lactococcus lactis subsp. lactis, B. bifidum and Bifidobacterium animalis subsp. 
lactis in a total daily dose of 1010 bacteria. Infections occurred in 30% and 28% of 
patients in the probiotics and placebo group, respectively. Also, the mortality rate 
was 16% and 6% in the probiotics and placebo group, respectively. In patients with 
predicted severe acute pancreatitis, the probiotic prophylaxis was associated with 
a more than two-fold increase in mortality (Besselink et al. 2008). There are 
concerns over recommending probiotic for sever conditions. Further in vivo studies 
are needed in order to characterize the safety and probiotic properties of different 
species. 
1.5.5 Functionality 
The viability of probiotic lactobacilli need to be controlled to monitor their 
functionality. Various concentrations of viable bacteria to guarantee the functional 
quality of the food have been viewed from different perspective (Saxelin, 2008; 
Degnan, 2008; Amagase, 2008). Vinderola et al. (2011) have stated that the control 
of cell viability is not sufficient to guarantee the probiotic functionality, because 
different conditions of production and storage have different effects on 
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susceptibility, adherence to the epithelial cells of the intestinal, without changes in 
viability of probiotic. In other words, there are some variations in the induced 
beneficial effect of a particular Lactobacillus species without changes in the viable 
cell counts.  
1.5.6 Health effects of lactobacilli 
Potential effects of probiotics include decreasing the risk of diseases of the 
gastrointestinal, urogential, respiratory, kidney and cardiovascular tract and allergic 
symptoms. Although many products with claim of probiotic on the label are 
available in the market, their efficacy has not been clinically proved. Thus, in some 
cases, the healthcare providers and consumers are not aware which to take and 
what to expect from the use of probiotic products (Anukam and Reid 2007). It is 
necessary to mention that molecular techniques are needed for identification of 
probiotics and selection of the most suitable strains for the prevention and 
treatment of an illness, and explanation of host-microbe interactions. 
1.5.6.1 Effect of lactobacilli on diarrhoea 
Some studies have reported the effect of probiotics on diarrhoeal diseases 
(Johnston et al. 2007; Szajewska and Mrukowicz 2005). Generally, the 
mechanisms of action of probiotic lactobacilli against intestinal pathogens include 
production of antimicrobial compounds, competition with them for nutrients and 
also exclusion of pathogen binding (Sullivan and Nord 2005; FAO/WHO 2006). The 
effectiveness of certain lactobacilli in diarrhoea is based on their ability to protect 
the host against toxins. 
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Oral administration of a fermented product containing Lb. gasseri CECT5714 and 
Lactobacillus coryniformis CECT5711 resulted in the production of short chain fatty 
acids. Also, it increased the volume, frequency and moisture of stool (Olivares et 
al. 2006). 
The influence of Lb. rhamnosus GG has been reported for prevention (Szajewska 
et al. 2001) and treatment (Guandalini et al. 2000) of acute diarrhoea. It has been 
reported that Lb. rhamnosus GG is capable of decreasing the duration of diarrhoea 
and reducing length of hospital stay in developed countries (Szajewska and 
Mrukowicz, 2005). It has also been shown that Lb. rhamnosus GG decreases the 
daily stool frequency and the duration of the diarrhoea in infants and toddlers 
(Canani et al. 2007; Henker et al. 2007). 
Lactobacillus GG is able to ameliorate ulcerative colitis (Zocco et al. 2006), but had 
no effect in extension of remission in Crohn’s disease patients (Schultz et al. 2004; 
Bousvaros et al. 2005). 
Effectiveness of Lb. reuteri 55730 in the treatment of rotavirus-associated 
diarrhoea has been proven (Weizman et al. 2005). In a double-blind and 
randomized controlled study, preventive effect of probiotics on antibiotic associated 
diarrhoea (Camras 2008; Wenus et al. 2008) and traveler's diarrhoea (MacFarland 
2007) has been reported.  
1.5.6.2 Effect of lactobacilli on inflammatory bowl disease 
There are also some studies regarding the efficacy of probiotics on inflammatory 
bowel disease, especially ulcerative colitis and pouchitis (Hart et al. 2003; Geier et 
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al. 2007), gastric ulcers, reduction of colorectal cancer risk (Geier et al. 2006) and 
irritable bowel syndrome (Verdu and Collins 2005; Aragon et al. 2010).  
Anti-inflammatory activity of Lb. plantarum has been attributed to the teichoic acid, 
which is a constituent of the Gram-positive cell wall (Grangette et al. 2005). The 
anti-inflammatory properties of Lb. fermentum has been attributed to a produced 
phospholipid, because it has been shown that inhibitory effect of Lb. fermentum is 
abolished during treatment of microorganism supernatants with phospholipase C 
(Frick et al. 2007).  
1.5.6.3 Effect of lactobacilli on lactose intolerance 
There are some investigations regarding correlation between oral supplementation 
with lactobacilli and lactose intolerance (Levri et al. 2005; Montalto et al. 2006). 
Lactobacilli with potential of high β-galactosidase activity might be a suitable 
treatment for the lactose intolerance. The effect of the probiotics administration on 
lactose intolerance is assessed via measurement of hydrogen levels (mg/kg) at the 
end of treatment. Lactose intolerance test is usually carried out using 50 g oral 
lactose, then breath hydrogen for three hours is analyzed. The 20 ppm hydrogen 
is considered as diagnosing level for lactose intolerance (Matthews et al. 2005). 
During lactose breath test, Lb. reuteri influences excretion of hydrogen in the breath 
and gastrointestinal symptoms in lactose intolerant patients (Ojetti et al. 2010). 
Another study has indicated that consumption of Lb. casei Shirota improve 
symptoms and diminish hydrogen breath level and these positive effects continued 
for three months after probiotic consumption (Almeida et al. 2012). In terms of 
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lactose intolerance, some studies have reported that although probiotic bacteria 
can alleviate lactose intolerance, they are not able to supply enough quantity of 
lactase for the consumers (Ouwehand et al. 2003). There is a high variability in the 
amount of lactase activity in different lactobacilli (Arola and Tamm 1994).  
1.5.6.4 Effects of probiotic lactobacilli on blood cholesterol level and 
cardiovascular disease 
A reduction of blood cholesterol level has been reported as a consequence of 
consumption of dairy foods containing different probiotic lactobacilli such as Lb. 
fermentum (Simons et al. 2006). Lactobacilli may reduce total plasma cholesterol 
and low-density-lipoprotein (LDL) cholesterol (Sanders 2000). Bile salt 
deconjugation ability by some lactobacilli is used to decrease serum cholesterol 
level in hypercholesterolemic patients and prevent hypercholesterolemia. 
Lactobacilli can excrete the bile salt hydrolase, which accelerate the hydrolysis of 
taurine and glycine conjugated bile salts, and generate amino acid residues and 
free bile salts (Liong and Shah 2005).  
 
1.6 Labelling of foods and supplements and declared counts of lactobacilli 
The microbial species and identity of the strain need to be declared on the food 
label. Also, it is necessary to accurately enumerate the probiotic cell count in the 
products, and state the viable count on their label. Labeling should be clear and 
comprise minimum dosage of probiotic count and health claims. Various differential 
and selective culture media has been proposed in the last decades for the 
microbiological analysis of probiotic lactobacilli (Vinderola et al. 2009). Selective 
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enumeration of lactobacilli at the level of species and strains is challenging, 
because they are phylogenetically related together and also show similar metabolic 
responses (Vinderola et al. 2011).  
As lactobacilli have a strain-specific response to some culture media, it is not 
possible to select one culture medium for all probiotic lactobacilli and for all the food 
matrices. Also, it is not easy to differentiate lactobacillus strains of the same species 
by the plate count method. Regardless of plate counts techniques which are used 
in routine quality control of laboratories at industrial level, more advanced methods 
may also be used, such as flow cytometry (Ben Amor et al. 2007) and real-time 
quantitative polymerase chain reaction (PCR) (Friedrich and Lenke 2006) to 
provide a better estimation of the number of bacteria in the products. 
 
1.7 Consumption dosage of probiotic lactobacilli and duration of use  
Probiotics should be adminstrated in adequate amounts to be able to exert the 
health effects on the host. Different studies have indicated that the concentration 
of probiotics should be at least 107 to 108 CFU/g with daily serving size around 100 
to 200 g (Rijkers et al. 2010). According to the other studies, the minimum daily 
quantity of probiotic for any beneficial effect on the host is considered to be 108–
109  CFU/day, which can be provided by intake of 100 g probiotic product containing 
106–107 CFU/g (Lourens-Hattingh and Viljoen 2001; Talwalkar and Kailasapathy 
2004). 
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Each probiotic product should state the minimum daily quantity required for it to 
confer specific health benefits. The minimum level of probiotic cells in 
commercialized probiotic products should be counted at the expiration date (Araujo 
et al. 2012).   
 
1.8 Non-Lactobacillus probiotic microorganisms  
Other probiotic microorganisms include different species of Bifidobacterium and 
Streptococcus. Other microorganisms, which are considered as probiotics, include 
Saccharomyces boulardii, Saccharomyces cerevisiae, Clostridium butyricum, 
Enterococcus faecalis and Enterococcus faecium (Heyman and Menard 2002).  
A few years ago, some medicinal supplements containing Bacillus species 
(Enterogermina®) were used as probiotic products in Italy (Cutting 2011). It has 
been reported that spore forming bacilli have higher capability of surviving the low 
pH of the gastric barrier and higher viability at room temperature compared to non-
spore formers such as lactobacilli (Barbosa et al. 2005).  
Some Bacillus species have shown probiotic effects as lactobacilli, including 
immune stimulation, antimicrobial activities and competitive exclusion (Cutting 
2011). Examples of such species include Bacillus clausii (Senesi et al. 2001), 
Bacillus coagulans (Mandel et al. 2010) and Bacillus subtilis (Hosoi and Kiuchi, 
2004). Bacillus clausii has been reported to have positive effects on respiratory 
infection (Ciprandi et al. 2004; Marseglia et al. 2007) and urinary tract infections 
(Fiorini et al. 1985). Bacillus coagulans produce a bacteriocin against enteric 
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microbes; it is named coagulin (Hyronimus et al. 1998). Bacillus coagulans also 
present some positive effects on rheumatoid arthritis (Mandel et al. 2010). 
 
1.9 The Market  
The market for foods, especially dairy products including fermented milks, yogurts, 
cheeses, and beverages containing probiotic cultures is on the rise (Viana et al. 
2008). The global market for probiotic ingredients, supplements and foods have 
been reported to be worth $14.9-16 billion in 2007-2008. The global probiotic 
products market was estimated at $26.12 billion in 2012 (Anon 2014). 
Products containing the genus Lactobacillus has approximately accounted for the 
62% of total sales of probiotic products in 2007. Although various products, such 
as probiotic cheese, ice cream, nutrition bars, infant formula and breakfast cereal 
and soy-based drinks have emerged, yogurt has accounted for the largest share of 
sales, representing 36.6% in 2008 (Anon 2009).  
Non-dairy probiotic products are also important in the global market, because there 
are some drawbacks related to the intake of dairy products including lactose 
intolerance, cholesterol content, and allergenic milk proteins (Granato et al. 2010b). 
Also, non-dairy probiotic products, such as fortified fruit and vegetables matrices 
with modified pH can be great substrates for probiotic cells, because they contain 
nutritional substances, such as antioxidants, minerals, dietary fibre and vitamins, 
without any dairy allergens (Betoret et al. 2003; Sheehan et al. 2007).  
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Consumer surveys are extremely important in the food industry. Increasing the 
general knowledge and awareness of probiotic products might be the key element 
contributing to the probiotic market growth. Probiotic products normally are 
purchased by people who pay attention to their health (FAO/WHO 2006). In some 
studies the level of knowledge of probiotic foods was related to educational level 
(Babajimopoulos et al. 2004), but in other investigations no relationship between 
consumption of probiotics and education level was established (Viana et al. 2008). 
Data on the perception and consumption of probiotic products and the type of action 
of these products need to be provided to enhance awareness of consumers. As 
previously mentioned, probiotic products are considered as one of the largest 
functional food markets in the world. The future success of probiotic foods 
containing lactobacilli in the market is related to various factors. One of the 
important elements in this regard is the fact that consumers should be convinced 
by health claims of probiotic foods through clear, truthful, and unambiguous 
messages (Granato et al. 2010b). Regardless of the use of probiotics in food 
additives, it is worth the efforts to introduce probiotics more frequently into 
medication (Oelschlaeger 2010). 
 
1.10 Rationale for this study 
Probiotic microorganisms should meet certain criteria based on physiological, 
safety and functional characteristics and to be present in high numbers in the 
product to be able to provide health benefits. One needs to bear in mind that, 
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probiotic functionalities and health benefits are strain dependent. Therefore, the 
strain needs to be noted on the product label (Saad et al. 2013; Rajasekaran and 
Kalaivani 2013). It has been reported that a large number of commercial products 
do not contain the specified strains nor they state the number of probiotic 
microorganism(s) present in the product (Hamilton-Miller and Shah 2002), or 
contain species other than what has been claimed on the label (Weese 2002). 
Hence, it was deemed necessary to review the status of the available probiotic 
products on UK and some other European markets and screen their quality in terms 
of the true strain and number of viable probiotic cells. In the absence of any 
international standard, the minimum therapeutic level of 106 to 107 CFU/ml probiotic 
cells is widely acceptable.   
Viability of the cells in the product aside, functionality of the probiotics also needs 
to be monitored (Vinderola et al. 2011). However, before that the organisms should 
prove fit for purpose from a physiological point of view and be able to survive the 
harsh condition of the upper digestive tract. Therefore, potential probiotic 
microorganisms are usually screened in vitro for acid and bile tolerance. Acid stress 
may occur in the stomach, but also during the fermentation, due to the production 
and accumulation of organic acids, such as lactic acid. Bile stress could also occur 
in the small intestine, due to the secretion of bile salts. Therefore, the effects of 
sequential treatment with acid, bile salts and gastric enzymes on the viability of 
probiotic bacteria are justified.  
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Some probiotic bacteria are able to form biofilms in the gut and produce 
antagonistic (antimicrobial) compounds to out-compete undesirable bacteria. This 
perhaps is one less studied area of probiotics.  
The probiotic organisms are expected to produce functional ingredients, such as 
conjugated linoleic acid (CLA). Again this is an area which is not well studied and 
deserves further investigation.  
Safety is also one of the most important selection criteria for probiotics (Gueimonde 
et al. 2013). Probiotic bacteria should be able to tolerate antibiotics in order to aid 
re-colonisation of the gut, during antibiotic therapy; however, they should not 
contain transferable antibiotic resistance genes to other bacteria. Thus, studying 
the antibiogram of selected lactobacilli was included in this project. The study is 
extended to include assessment of the antibiotic resistance gene transferability 
amongst the isolates. 
 
1.11 Purpose of this research 
The main aim of this project was to screen commercially available fermented dairy 
products in the UK/Europe for the presence and diversity of lactobacilli and 
evaluate their probiotic characteristics. Specific objectives included: 
 Monitoring survival of the lactobacilli in the carrier foods at the time of 
purchase and at the end of their shelf-life 
 Isolation and identification of presumptive lactobacilli with genotypic 
methods and differentiation of obtained isolates using of rep-PCR 
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 In vitro assessment of some of the requirements for probiotics as well as 
some of the functional properties of the isolates from fermented products 
particularly their resistance to the acidic condition of the stomach and the 
presence of bile salts in the small intestine  
 Antimicrobial activities and potential for bacteriocin production and other 
mechanisms involved  
 Biofilm formation in different environments 
 Production of secondary metabolite, such as CLA  
 In vitro assessment of their safety by screening the isolates for antibiotic 
resistance, presence of antibiotic resistance genes. 
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CHAPTER TWO: ENUMERATION AND 
IDENTIFICATION OF LACTOBACILLUS SPP. IN 
FERMENTED DAIRY PRODUCTS 
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2.1 INTRODUCTION 
Certain dairy products are vehicles by which consumers receive adequate counts 
of probiotic lactobacilli (Vinderola and Reinheimer 2000). Probiotic effects are 
dependent on the number of viable microbial cells that reach the human gut (Leahy 
et al. 2005). Therefore, their viability in the product is considered as an important 
prerequisite for achieving health effects.  
There are various reports regarding the adequate number of probiotic 
microorganisms in different products in order to ensure the probiotic effects. Some 
of the suggested minimum levels of viable cells in dairy products are 105 CFU/g 
(Shah et al. 1995), 106 CFU/g (Talwalkar and Kailasapathy 2004) and 107 CFU/g 
(Korbekandi et al. 2011). It should be noted that it is not simple to keep a high 
number of viable probiotic bacteria in fermented milk throughout the shelf life, 
because the viability of probiotic bacteria in the product matrix is influenced by 
numerous factors. These parameters include temperature of storage condition, 
hydrogen peroxide (H2O2) which might be produced by other existing bacteria, 
dissolved oxygen content due to process conditions, pH of final product and finally, 
strain variation that is considered the most important factor for survivability of 
probiotic cultures in final product (Shah and Lankaputhra 1997; Vinderola et al. 
2002).  
Probiotic lactobacilli may be incorporated alone or in combination with commercial 
cultures into specific dairy products. Interactions between microorganisms in co-
cultured products cause difficulties in enumeration. Lactobacillus acidophilus, Lb. 
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casei and B. animalis subsp. lactis are the most frequently used strains in 
commercial probiotic products (Tabasco et al. 2007).  
Reliable determination of viable probiotic bacteria in food is important and 
selective/differential media are necessary to count the probiotic population. 
Different parameters such as medium, time, temperature and also incubation 
conditions influence the effective isolation of probiotic bacteria (Lima et al. 2009). 
Generally, de Man, Rogosa and Sharpe (MRS) agar is used for enumeration of 
LAB; however, MRS is a general medium and is not suitable for selective 
enumeration of probiotic lactobacilli in the presence of other starter or probiotic 
cultures.  
Numerous selective media have been developed for accurate enumeration of 
Lactobacillus spp. in fermented milks. However, due to presence of closely related 
species of Lactobacillus in probiotic products, the differential enumeration seems 
challenging and relies directly on differences in colonial morphology (Van de 
Casteelea et al. 2006). 
Variable results have been reported for enumeration of probiotic lactobacilli in the 
presence of bifidobacteria, S. thermophilus and Lb. delbrueckii subsp. bulgaricus, 
e.g. Lb. acidophilus (Van de Casteele et al. 2006; Tabasco et al. 2007; Lima et al. 
2009), Lb. casei (Tharmaraj and Shah 2003; Talwalkar and Kailasapathy 2004; 
Lima et al. 2009), Lb. paracasei (Van de Casteele et al. 2006; Tabasco et al. 2007) 
Lb. plantarum and Lb. rhamnosus (Tharmaraj and Shah 2003; Van de Casteele et 
al. 2006). 
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Selectivity and/or differentiation ability of the culture media depends on the type 
and concentration of inhibitory compounds added.  
Elective media promote the growth of certain microorganisms, while selective 
media inhibit the growth of certain microorganisms. The additives including bile 
(Bergamini et al. 2005), gentamycin (Lima et al. 2009), clindamycin (Van de 
Casteele et al. 2000) penicillin (Bielecka et al. 2000) and salicin (Bielecka et al. 
2000) are added to the media because they have suppressive effects against some 
species, but other compounds, such as lithium chloride and sodium propionate 
(Tharmaraj and Shah 2003; Lima et al. 2009), sorbitol (Tharmaraj and Shah 2003), 
maltose (de Souza et al. 2008; Lima et al. 2009) trehalose (Lima et al. 2009), 
fructose (Tabasco et al. 2007), ribose (Ravula and Shah 1998) are added to the 
media because of inability of some species to metabolise them. 
There are various instructions regarding the probiotic enumeration, but few are 
official protocols for enumeration of lactobacilli (ISO 2006). Enumeration in co-
cultured products is more complicated than in products made with single culture. 
In mixed cultures, inhibitory agents are needed to suppress the interfering species 
in order to recover the target lactobacilli.  
Anaerobically-incubated MRS with vancomycin and bromocresol green (LAMVAB) 
is another selective medium suggested for enumeration of lactobacilli. Two 
selective agents in LAMVAB agar are vancomycin and low pH. Bromocresol green 
was considered as a differentiative agent, Lactobacilli colonies appear in blue or 
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green colour, but other genera produce yellow or white colonies (Hartemink et al. 
1997). 
One real concern is that some culture media that contain antibiotics might also 
restrict the growth of target lactobacilli and the counts may not be representative of 
the real number of viable cells present in the product (Ashraf and Shah 2011). In 
addition, some antibiotics cannot inhibit the growth of all non-target bacteria (Novik 
et al. 2007). The variation among the minimum inhibitory concentration (MIC) 
ranges of antibiotics for lactobacilli can be exploited in selective enumerative media 
to allow discrimination between different probiotic lactobacilli species used in the 
same product (D'Aimmo et al. 2007). 
2.1.1 Enumeration of lactobacilli using plate count techniques 
As Lb. acidophilus and Lb. casei were found to be the most commonly used 
probiotic species in probiotic products, it is essential that they are properly 
enumerated and isolated from those products, hence an appropriate selective 
medium is always needed.  
2.1.1.1 Enumeration of Lactobacillus acidophilus 
MRS-bile agar has been originally proposed for detection and enumeration of Lb. 
acidophilus (IDF 1945). For enumeration of Lb. acidophilus in the presence of the 
dairy cultures or bifidobacteria, MRS-bile agar, incubated aerobically at 37 °C or at 
42 °C can be used (Lima et al. 2009). Gentamycin in MRS agar has been shown 
to inhibit Lb. casei Lc1 incubated at 42 °C without affecting Lb. acidophilus La5. It 
is necessary to mention that gentamycin presented no inhibitory effect at an 
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incubation temperature of 37 °C, in neither aerobic nor anaerobic conditions (Lima 
et al. 2009).  
In the study of Gomes and Malcata (1999) TGV agar (tryptone, glucose, and meat 
extract) containing 2% (w/v) NaCl was used to enumerate Lb. acidophilus Ki. Van 
de Casteele et al. (2006) used Nutrient agar and MRS supplemented by salicin and 
clindamycin, respectively, for enumerating Lb. acidophilus. Acidified MRS agar with 
pH 5.4 and anaerobic incubation at 37 °C for 3 days can be useful for counting Lb. 
acidophilus (Kasımoglu et al. 2004).  Darukaradhya et al. (2006) have stated that 
Reinforced Clostridium Agar (RCA) with bromocresol green and clindamycin 
(RCABC) with pH 6.2 is the best culture medium for selective counting of Lb. 
acidophilus in Cheddar cheese. 
Replacement of glucose in MRS agar by maltose or trehalose negatively affects 
the growth of the yogurt bacteria, indicating that glucose is essential for their growth 
(Lima et al. 2009). Glucose in MRS agar might be substituted by maltose in order 
to modify the MRS for Lb. acidophilus recovery (Buriti et al. 2005). The same 
procedure has been used by Cardarelli et al. (2008) for counting Lb. acidophilus 
after 72 h anaerobic incubation at 37 °C in petit-suisse cheese. 
MRS-D-sorbitol agar is one of the suitable media which need to undergo membrane 
sterilization because D-sorbitol is structurally deformed by heat treatment (Ozer et 
al. 2008).  
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2.1.1.2 Enumeration of Lactobacillus casei 
Vinderola and Reinheimer (2000) have used MRS agar with lithium chloride and 
sodium propionate (MRS-LP) and MRS-bile for selective and differential 
enumeration of Lb. casei from Lb. acidophilus, bifidobacteria and LAB starters in 
fermented milk and yogurt. This medium has been reported as inhibitory for S. 
thermophilus and Lb. delbrueckii subsp. bulgaricus. They used catalase testing and 
cell morphology recording to confirm the identity of the colonies. In their study, the 
colonies of Lb. casei were round, creamy- white and measured 1.7-2.4 mm and 
0.9-1.3 mm on MRS-LP and MRS-bile, respectively. Also, the colonies of Lb. 
acidophilus were irregular, light brown on MRS-bile with a diameter of 0.9-1.5 mm. 
According to their results, both MRS-LP and MRS-bile can be utilized for the 
enumeration of Lb. casei, but in presence of other probiotics, MRS-LP and MRS-
bile allow the growth of bifidobacteria and Lb. acidophilus, respectively. 
Bile has been shown to be inhibitory to Lb. casei Lc1 when anaerobically incubated 
at 42 °C, but not under aerobic condition (Lima et al. 2009). However, it has been 
recently indicated that bile, like lithium chloride and sodium propionate, is not a 
selective agent for differentiation of Lb. casei and Lb. acidophilus colonies 
(Colombo et al. 2014). 
Another proposed medium for the selective counting of Lb. casei in yogurts and 
fermented milk drinks is MRS-Lactobacillus casei (MRS-LC) medium (Ravula and 
Shah 1998; Shah and Ravula 2000). MRS-LC agar inhibits the growth of yogurt 
bacteria and bifidobacteria, due to the adjusted pH of the medium (pH 5.1) and 
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inability to ferment ribose, but Lb. acidophilus also can grow on this medium 
(Talwalkar and Kailasapathy 2004). 
It has been observed that nalidixic acid in nalidixic paromomycin neomycin lithium 
MRS agar (MRS-NPNL) allows the growth of Lb. casei at the incubation 
temperatures of 30 and 37 °C. Furthermore, nalidixic acid in that medium inhibits 
Lb. delbrueckii subsp. bulgaricus, S. thermophilus, Lb. acidophilus, Bifidobacterium 
and Propionibacterium freudenreichii subsp. Shermanii strains (Tharmaraj and 
Shah 2003). 
Colombo et al. (2014) reported that MRS with nalidixic acid is not able to inhibit 
LAB, except S. thermophilus TH-4® and ST 066. They concluded that nalidixic acid 
is not a selective agent for Lb. casei, Lb. paracasei and Lb. rhamnosus.  
2.1.2 Molecular methods for identification of lactobacilli 
In addition to the plate count enumeration, lactobacilli need to be identified and 
characterized (Dalezios and Siebert 2001). Different characteristics including 
phenotype, physiological and biochemical features and sequence comparisons of 
16S rRNA gene have been suggested to make the identification and 
characterization of Lactobacillus spp. more reliable (Kwon et al. 2004). It should be 
noted that there is taxonomic dispute and ambiguity among some lactobacilli due 
to the differences at nucleotide level in the 16S rRNA gene (Singh et al. 2009). It is 
hard to differentiate between some species and strains of lactobacilli (Song et al. 
1999), and some closely related groups of lactobacilli species are indistinguishable 
on the basis of phenotype. 
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Several reports have revealed the misidentification of a number of strains belonging 
to some groups of lactobacilli (Yeung et al. 2002). As probiotic ability is often strain 
dependent, accurate detection, characterization and identification of probiotic 
lactobacilli is required.  
Advanced methods like DNA-based molecular techniques are needed for proper 
identification and characterization of lactobacilli added in functional products.  
Also, to assure quality management, it is necessary to unambiguously identify 
probiotic lactobacilli at genus, species and strain levels using genotyping methods 
(Herbel et al. 2013). Molecular identification methods are consistent, rapid, reliable 
and reproducible, compared to phenotypic methods.  
There are some studies in which species-specific oligonucleotide probes have 
been employed to identify various Lactobacillus spp. (Ampe 2000; Chagnaud et al. 
2001; Park and Itoh 2005). Most genetic probes have been designed based on 16S 
rRNA or 23S rRNA (Briengel et al. 1996; Sghir et al. 1998).  
Some of the most utilized molecular techniques for identification of Lactobacillus 
spp. are as follows: 
a) Non-PCR-based methods 
DNA dot blot techniques (Rachman et al. 2003), ribotyping (Kitahara et al. 2005) 
and pulsed field gel electrophoresis (Bouton et al. 2002) are common non-PCR-
based methods. 
b) PCR-based methods 
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PCR-based techniques including simple PCR, randomly amplified polymorphic 
DNA (RAPD) and multiplex PCR have been employed to identify lactobacilli. 
In general, there is an ambiguity in differentiation of specific lactobacilli. According 
to the study of the Singh et al. (2009) there are simillarity at nucleotide level in the 
16S rRNA gene in some lactobacilli, such as Lb. acidophilus, Lb. casei, Lb. 
plantarum and Lb. bulgaricus, making them hard to distinguish. It has been 
reported that sometimes Lb. gasseri and Lb. johnsonii are difficult to differentiate 
from each other even by molecular methods (Walter et al. 2000). Lactobacillus 
plantarum and Lactobacillus pentosus have greater than 99% similarity with only 
0.3% difference in their 16S rRNA sequences (Quere et al. 1997). However, some 
alternative molecular markers have been used for discrimination among these 
species (Torriani et al. 2001). 
The aim of the work described in this chapter was to isolate, enumerate and identify 
Lactobacillus spp. in commercial probiotic dairy products in UK and European 
markets. 
The specific objectives were: 
a) Evaluation of 36 commercial probiotic dairy products for the number of probiotic 
Lactobacillus spp. by enumerating at the time of purchase and at the end of shelf-
life. 
b) Isolation and preservation of probiotic Lactobacillus spp. from these commercial 
probiotic products. 
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c)  Identification of the isolates using genotypic tests and in particular sequencing 
the 16S rRNA gene and discrimination by rep-PCR. 
In addition, accuracy of the label descriptions for fermented milk products was 
assessed. 
 
2.2 MATERIALS AND METHODS 
2.2.1 Media  
2.2.1.1 General media 
MRS agar (CM0361, Oxoid, Basingstoke, UK) was prepared according to the 
manufacturer’s instructions and autoclaved at 121 °C for 25 min, cooled in water 
bath to 55 °C and poured into petri dishes. 
Also, Maximum Recovery Diluent (MRD) (CM0733, Oxoid, Basingstoke, UK) was 
used as diluent for serial dilutions. 
2.2.1.2 Selective/elective media 
Three selective/elective media were used for comparative enumeration of 
lactobacilli: 
a) MRS-clindamycin: 
MRS supplemented with clindamycin hydrochloride for selective, isolation and 
enumeration of Lb. acidophilus and Lb. casei was developed by ISO (2006). MRS 
medium supplemented with clindamycin (C5269-10mg, Sigma, UK) was evaluated 
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herein as a medium for enumeration of Lb. acidophilus, Lb. rhamnosus, Lb. casei 
and Lb. paracasei. 
The medium was prepared as follows: 
Two mg of clindamycin hydrochloride was dissolved in 10 ml distilled water and 
sterilized through a 0.2 µm syringe filter (Nalgene, Fisher Scientific, Loghborough, 
UK), and kept as a stock solution at -20 °C. MRS agar was prepared according to 
the manufacturer's instructions, autoclaved at 121 °C for 25 min and cooled to 44 
°C and 47 °C. Aliquots of 250 µl of the clindamycin stock solution (0.02% w/v) were 
added to 500 ml of MRS agar and mixed carefully to avoid bubbles and poured into 
petri dishes.  
b) MRS-Sorbitol  
In this medium sorbitol was added to the MRS agar instead of dextrose. A 100 
mg/ml concentration of sorbitol solution was prepared and added at the rate of 10 
ml to 90 ml molten MRS (Ozer et al. 2008; Ong and Shah 2009). 
Only Lb. acidophilus grows on MRS-D-sorbitol agar. It forms small, rough, 
brownish, dull colonies of 0.1 to 0.5 mm in MRS-Sorbitol agar. 
c) MRS-IM agar with Maltose 
Based on sugar fermentation patterns, maltose was used instead of glucose 
(dextrose) was used. MRS-IM agar with added Maltose  (Ref: 610067,Liofilchem, 
Italy) was  prepared according to the manufacturer’s instructions, autoclaved at 121 
°C for 25 min, cooled to 55 °C and poured into petri dishes. 
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In this medium, Lb. acidophilus and Lb. casei display growth. Lactobacillus 
acidophilus gives star formed, irregular small colonies while Lb. casei gives larger 
regular colonies in this medium. 
2.2.2 Reference microorganisms 
Reference microorganisms used in the study included three commercial cultures 
(Lb. acidophilus La5, Lb. delbrueckii subsp. bulgaricus Lb12 and Lb. casei C431) 
which were kindly provided by Chr. Hansen and four type strains of Lactobacillus 
from National Collections of Industrial, Marine and Food Bacteria (NCIMB). These 
were Lb. delbrueckii subsp. bulgaricus 11778, Lb. acidophilus 701748, Lb. casei 
subsp. casei 11970 and Lb. paracasei subsp. paracasei 700151. 
2.2.3 Probiotic products 
Thirty six commercial fermented milks claiming to contain Lactobacillus strains/spp. 
were purchased from different supermarkets and retailers in the UK and Europe, 
transported to laboratory and stored at 4 °C. Samples from countries outside of the 
UK were purchased and sent to the UK in a cool box; they were received in very 
good condition. Table 2.1 shows details of the tested products. 
2.2.4 Measurement of pH value  
The pH was measured with a pH meter (Whatman PHA 2000), which was 
calibrated using pH buffer at pH 4.0 and 7.0 according to the operating manual. 
 
 
 
64 
 
  1Table 2.1 Details of tested probiotic products 
Sample 
Code 
Commercial 
Name 
Product 
Description 
Manufacture/Supplier Days To 
Expiry 
Claimed Culture Initial pH* Final pH** 
P1 Waitrose Stirred yogurt Waitrose 10 Bifidobacterium, 
Lactobacillus acdophilus, 
Streptococcus thermophilus 
4.16 3.99 
P2 Yeo vally Organic natural 
yogurt 
OMSCO 12 Lactobacillus acidophilus, 
Bifidobacterium 
4.10 4.00 
P3 Onken Natural fresh 
and mild yogurt 
Dr. Oetker 17 Lactobacillus acidophilus, 
Bifidobacterium longum, 
Streptococcus thermophilus 
4.12 4.01 
P4 Rachel’s Fruit yogurt Rachel’s 13 Lactobacillus acidophilus, 
Bifidobacteria 
4.05 3.92 
P5 Waitrose Thick and 
creamy yogurt 
Waitrose 11 Bifidobacterium, 
Lactobacillus acidophilus, 
Streptococcus thermophilus 
4.08 4.01 
P6 Morrison Fruit yogurt Morrison 13 Bifidobacterium animalis 
subsp.lactis  
Lactobacillus acidophilus 
4.22 4.10 
P7 Delamere Natural goat 
yogurt 
Delamere 25 Bifidobacterium longum, 
Lactobacillus acidophilus 
3.95 3.66 
P8 Delamere Goat fruit yogurt Delamere 26 Streptococcus thermophilus, 
Lactobacillus casei *** 
3.80 3.80 
P9 Sheep milk  
yogurt 
Natural greek 
style 
Woodland Dairy 15 Lactobacillus acidophilus, 
Lactobacillus bulgaricus,**** 
Streptococcus thermophilus 
4.28 4.20 
P10 Low fat fruit 
yogurt 
Fruit yogurt Stapleton 11 Lactobacillus bulgaricus,**** 
Lactobacillus acidophilus, 
Streptococcus thermophilus, 
Bifidobacterium 
4.70 4.61 
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Table 2.1continued 
Sample 
Code 
Commercial Name Product 
Description 
Manufacture/Supplier Days 
To 
Expiry 
Claimed Culture Initial 
pH* 
Final 
pH** 
P11 Actimel Fat free yogurt 
drink 
Danone 19 Lactobacillus casei*** 4.06 4.01 
P12 Count Lodge Bio pouring 
yogurt 
OMSCO 11 Probiotic 3.94 3.96 
P13 Multi fruit yogurt drink Fruit yogurt drink Morrison 4 Lactobacillus casei*** 4.24 4.02 
P14 Yakult Fermented milk 
drink 
yakult 23 Lactobacillus casei Shirota 3.62 3.76 
P15 Diet Fat free probiotic 
yogurt 
Fruit yogurt Irish yogurt 19 probiotic 3.95 3.95 
P16 Natural probiotic  
goats  milk yogurt 
Gout milk yogurt St. Helen’s farm 17 Lactobacillus acidophilus, 
Lactobacillus bulgaricus,**** 
Streptococcus thermophilus, 
Bifidobacterium 
4.16 3.99 
P17 Waitrose 
Deliciously fruity low 
fat yogurt 
Fruit  yogurt Waitrose 14 Lactobacillus acidophilus, 
Bifidobacterium, 
Streptococcus thermophilus 
3.95 3.86 
P18 Lassi Fruit Yogurt 
smoothie 
 Tesco 20 Yogurt culture, 
Lactobacillus acidophilus, 
Bifidobacterium 
3.85 3.61 
P19 Tesco 
Fat free natural 
defences 
Yagurt drink Tesco 11 Lactobacillus casei*** 4.06 3.97 
P20 Apple  + spice 
gourmet probiotic 
yogurt 
Fruit yogurt The collective great 
dairy 
11 Streptococcus thermophilus, 
Lactobacillus acidophilus, 
Bifidobacterium, 
Lactobacillus casei*** 
3.97 3.55 
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 Table 2.1continued 
Sample 
Code 
Commercial Name Product 
Description 
Manufacture/Supplier Days To 
Expiry 
Claimed Culture Initial pH* Final 
pH** 
P21 Little swallow Bi 
grade plus with 
casei cultures 
Live natural 
yogurt 
House of westphalia 
(Germany) 
23 Lactobacillus acidophilus, 
Lactobacillus casei,*** 
Bifidobacterium 
3.94 4.21 
P22 Organic natural 
fromage frais 
Fromage 
frais blanc 
Vrai 27 Bifidobacterium, 
Lactobacillus acidophilus 
4.21 4.24 
P23 Sainsbury’s 
Crunch tip &mix 
chocolate 
probioticyogurt 
yogurt Sainsbury’s 12 Sainsbury’s probiotic bacteria 3.79 3.8 
P24 Tesco (value) 
Probiotic yogurt 
drink 
Yogurt drink Tesco 26 Lactobacillus acidophilus La5 3.98 4.05 
P25 Sainsbury’s active 
health 
Yogurt drink Sainsbury’s 19 Sainsbury’s probiotic bacteria, 
Lactobacillus casei*** 
3.76 3.46 
P26 Taste the diffrence 
(Sainsbury’s) West 
country yogurt 
 
Probiotic 
yogurt 
selection 
Sainsbury’s 11 probiotic  3.92 3.81 
P27 Sojade 
Bio organic Fresh 
soya specialty 
Fermented 
soya drink 
Sojade. 
(France) 
11 Bifidus, 
Lactobacillus acidophilus 
4.07 3.78 
P28 Biona fresh 
Demeter 
Organic kefir Windmill organics 
Ltd. 
17 Probiotic 3.99 3.85 
P29 Nourish kefir Natural 
probitic drink 
Nourish kefir 19 Rich in probitic 4.29 4.45 
P30 
 
Optifit active 
Full of natural 
ingredients 
Fruit layer 
Yogurt 
Aldi 20 Lactobacillus acidophilus La5 
Bifidobacterium animalis 
subsp.lactis BB12 
3.9 3.82 
 
 
 
 
67 
 
Table 2.1continued 
Sample 
Code 
Commercial Name Product 
Description 
Manufacture/Supplie
r 
Days 
To 
Expiry 
Claimed Culture Initial 
pH* 
Final pH** 
P31 Minus L 
(Lactosefrei) 
Joghurt mild 
himbeere 
Probiotic yogurt OMIRA MILCH 
(Germany) 
15 probiotic 3.99 3.77 
P32 Probiotic joghurt Stirred yogurt Hergestellt Fur 
(Germany) 
10 Bifidobacterium animalis 
subsp. lactis BB12 
Lactobacillus acidophilus  
3.97 3.95 
P33 LC1 Stirred yogurt Nestle. 
 (Germany) 
8 Lactobacillus lc1 ***** 4.11 4.16 
P34 BIAC probiotic 
kulturen 
fruit yogurt BIAC 
(Germany) 
4 Lactobacillus casei*** 3.92 3.85 
P35 Be light 
(Leichte Linie) 
Probitic yogurt 
drink 
Be light 
(Leichte Linie) 
(Germany) 
3 Bifidobacterium animalis 
subsp. lactis BB12 
Lactobacillus acidophilus La5 
Lactobacillus casei*** 
4.04 3.94 
P36 Proviact Fruit yogurt Lidl 
(Germany) 
7 Lactobacillus casei*** 4.05 3.88 
 
*Initial pH was measured upon their arriving date to the lab 
**Final pH was measured at their expiry date 
*** Lactobacillus casei subsp. casei 
**** Lactobacillus delbrueckii subsp. bulgaricus 
***** Lactobacillus johnsonii La1 
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2.2.5 Determination of viable cell count of Lactobacillus spp. in the fermented 
milks 
 
All products were analysed on the day of purchase and again on their expiry date 
using unopened product each time. Four pots of each product were purchased. 
Two of them were tested for presumptive Lactobacillus spp. sampled on the day of 
receipt in laboratory and two on the expiry date. One gram of homogenised sample 
was mixed with 9 ml of MRD and vortexed (homogenised using Whirlimixer). 
Several dilutions were made using MRD up to 10-8. Agar plates were divided into 4 
sections using a marker and 25 µl of each dilution was spread on to each quarter 
of MRS, MRS-Maltose, MRS-Sorbitol and MRS-Clindamycin in duplicate. The 
plates were then incubated at 37 °C in anaerobic cabinet (Don Whitley, Skipton, 
UK) containing 80% nitrogen, 10% hydrogen and 10% carbon dioxide for three 
days. 
2.2.6 Isolation and storage of the isolates 
 
Two to four typical colonies grown on MRS-Clindamycin were harvested per each 
product and cultured on MRS agar. Following overnight anaerobic incubation at 37 
°C, the colonies were streaked on MRS agar and incubated in the same conditions. 
A pure isolate was picked up and inserted aseptically into a cryovial (Micro Bank, 
Pro-Lab Diagnostics, Neston, UK) and stored at - 20 °C.  
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2.2.7 Identification of the isolates by genotyping methods 
Initially, six selected Lactobacillus spp. isolates, which were provided by 
microbiology research unit (MRU) culture collection were identified using 
phenotypic methods (API 50 CHL), and results were compared with genotypic 
identification. The results did not match together. Tested isolates were not part of 
this study, and they were used only for validation of phenotypic test and accuracy 
of identification. Therefore, the rest of experiments were based on the genotypic 
techniques. 
2.2.7.1 DNA Extraction 
The presumptive Lactobacillus spp. isolates, which have been kept on the beads 
at -20 °C, were grown on MRS agar anaerobically at 37 °C for 24 h, restreaked and 
incubated under the same conditions. A fresh colony was picked and resuspended 
in 1 ml of sterile water in a sterile Eppendorf tube and centrifuged for 1 min at 6700 
× g, then the supernatant was discarded and, after addition of 100 µl of Instagene 
matrix (BioRad, Hemel Hempstead, UK), the mixture was incubated at 56 °C on a 
heating block (TECHNE, Stone, UK) for 30 min. After mixing the tube content for 
10 seconds, incubation was continued at 100 °C for 10 min. The tubes were then 
vortexed for 10 seconds, centrifuged at 9700 × g for 3 min and the supernatant was 
collected in a sterile Eppendorf tube, which was stored at -20 °C and used as DNA 
template for future use. 
2.2.7.2 Differentiation of isolates using rep-PCR 
This method was used for initial screening and grouping of the isolates by 
comparing their DNA profiles with commercial and type strains. Rep-PCR was 
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applied for differentiation of all isolates by the method of Ouoba et al. (2008a). Rep-
PCR was undertaken in 25 µl of reaction mixture containing 2 µl of DNA template, 
2.5 µl of PCR buffer (10 X; N808-0161, Applied Biosystems), 4 µl of dNTP (1.25 
mmol/l; U1511, Promega, Southampton, UK), 2 µl of MgCl2 (25 mmol/l; AM9530G, 
Applied Biosystems), 4 µl of primer GTG5 (5’-GTG GTG GTG GTG GTG-3’) (5 
pmol/µl), 0.25 µl of Taq polymerase (5 U; N808-0161, Applied Biosystems) and 
10.25 µl of autoclaved high purity water (Sigma, Gillingham, UK). Amplification 
consisted of 30 PCR cycles in a thermocycler (GeneAmp PCR 2700 system, 
Applied Biosystems, Singapore). The cycling was programmed as follows: initial 
denaturation at 94 °C for 4 min followed by 30 cycles of denaturation at 94 °C for 
30 s, annealing at 45 °C for 1 min and elongation at 65 °C for 8 min. Also, final 
extension at 65 °C for 16 min ended the rep-PCR and the amplified product cooled 
at 4 °C. The DNA fragments were separated by applying 10 µl of each PCR product 
with 2 µl of loading buffer (AM8556, Applied Biosystems) to 1.5% agarose gel (Bio-
rad, Hemel Hempstead, UK).  
2.2.7.3 Agarose gel electrophoresis 
The products of rep-PCR were analysed using agarose gel electrophoresis, 
followed by staining with ethidium bromide and visualisation of the gel under UV 
irradiation of the gel. A volume of 10 µl of PCR products was mixed with 2 µl loading 
dye (Sigma, UK) and loaded in to a 1.5% (w/v) agarose gel. A DNA molecular 
marker (D7058, Sigma, UK) was also run to give an indication of the size of the 
bands. The gel was run in 1X TBE (Tris Borate-EDTA) buffer (Sigma, UK) for 2 h 
at 120 V. The gel was stained by placing in a solution of ethidium bromide 0.5 µl/ml 
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(Sigma, UK) for 20 min and excess stain was rinsed off with distilled water. PCR 
products were viewed under a UV light at 260 nm. 
The DNA profiles were observed and all bacteria showing the same profile were 
clustered in the same group. Profiles were analyzed using the Bionumerics system 
(Bio-Numerics 4.50, Applied Maths, Sint-Martens-Latem, Belgium). 
2.2.7.4 Identification of the isolates by sequence analysis of 16S ribosomal 
RNA gene 
2.2.7.4.1 First PCR cycle sequencing 
Following the rep-PCR screening and arranging the isolates into different groups, 
further identification was carried out using 16S rRNA gene sequencing. The 
amplification of 16S rRNA gene was undertaken using the primers pA (5`-AGA-
GTT-TGA-TCC-TGG-CTC-AG-3`) and pE (5`CCG TCA ATT CCT TTG AGT TT 3`; 
Sigma, UK). The polymerase chain reaction (PCR) was carried out using a reaction 
mixture consisting of: 
Water (autoclaved high purity)                           37.75    µl 
10 X PCR Buffer (with MgCl2)                      5           µl 
dNTP (1.25 mM)                                                5           µl 
Primer pA (100 µM)                                           0.5        µl 
Primer pE (100  µM)                                          0.5        µl 
Taq DNA Polymerase (5U)                                0.25      µl 
Chromosomal DNA                                            1           µl 
Amplification of DNA was performed using a thermo cycler (GeneAmp PCR 2700 
system)  
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under the following conditions, 5 min at 95 °C, 35 cycles of 1 min at 94 °C, 1 min 
at 55 °C and 1 min at 72 °C and finally 5 min at 72 °C. 
2.2.7.4.2 Purification of PCR products 
The PCR products were then purified using a QIA quick PCR purification kit (Qiagen 
Ltd, Neston, UK) according to the manufacturer’s instructions (described in 
appendix). 
2.2.7.4.3 Second PCR Cycle Sequencing 
The second PCR was undertaken to generate 550 base pair (bp) of nucleotides, 
using the primer pD (5` GTA TTA CCG CGG CTG CTG 3`, Sigma, UK). This was 
done with a reaction mixture which consisted of: 
PCR product       4 µl 
Primer pD (20 ng/µl)                                                  2 µl  
ABI Big Dye Terminator Reaction                                  4        µl 
Amplification was performed under the following conditions: an initial denaturation 
at 95 °C for 2 min, 35 cycles consisting of 96 °C for 15 s, 40 °C for 1 s and 60 °C 
for 4 min. 
2.2.7.4.4 Precipitation 
Second PCR products were precipitated with 1 µl of 3 M sodium acetate (pH 4.6) 
and 50 µl of absolute ethanol and centrifuged at 9700 × g for 20 min. Pellets were 
rinsed with 250 µl of 70% v/v ethanol and centrifuged for 10 min at 9700 × g. 
Supernatants were discarded and pellets were air dried and sent for sequencing 
(Gene servicing, Cambridge, UK). 
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Sequences of each isolate were compared to the GenBank database (National 
Centre for Biotechnology Information, USA) using the online Basic Local Alignment 
Search Tool (BLAST) program. 
2.2.7.5 Identification of bacteria by rpoA gene sequencing 
Primarily, all randomly selected isolates were identified by 16S rRNA gene 
sequencing, where it was not possible to distinguish between closely related 
species (i.e. Lb. casei and Lb. paracasei), amplification and sequencing of rpoA 
gene was carried out.  
The amplification of rpoA gene was carried out using the forward primer rpoA- 21-
F (5`ATG ATTC GAGA TTT GAA AAA CC 3`) and reverse primer rpoA-23-R 
(5`ACACT GTGA TTGA ATD CCGAT GCGA CG 3`) (Anyogu et al. 2014). 
 The reaction mixture consisted of: 
 
Water (autoclaved high purity)                           36.8     µl 
10 X PCR Buffer (with MgCl2)                      5          µl 
dNTP (1.25 mM)                                                5          µl 
Primer rpoA-21-F (21 µM/L)                              0.5       µl 
Primer rpoA-23-R (21 µM/L)                             0.5        µl 
AmpliTaq DNA Polymerase (5U)                        0.25     µl 
Chromosomal DNA                                             2          µl 
 
Amplification of DNA was performed under the following thermal programme,  
(I) 5 min at 95 °C. 
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(II) 3 cycles of 1 min at 95 °C + 2 min 15 s at 46 °C + 1 min 15 s at 72 °C. 
(III) 30 cycles of 35 s at 95 °C + 1 min 15 s at 46 °C + 1 min 15 s at 72 °C. 
(IV) A final 7 min at 72 °C. 
 All PCR products were checked by gel electrophoresis and products of positive 
reactions purified as described in section 2.2.7.4.1, and the samples were sent for 
sequencing using 3.2 pmol/µl of the same primers. 
2.2.8 Statistical analysis 
Results are the mean±standard deviation. Data were analysed using the 
independent-samples t-test was performed using SPSS 21 software (Chicago, IL: 
SPSS Inc.) to determine the statistical significance of differences. Data were 
considered significantly different when p<0.05. 
 
2.3 RESULTS 
In the present study MRS, MRS-Maltose, MRS-Sorbitol and MRS-Clindamycin 
were used for enumeration of probiotic lactobacilli in 36 probiotic dairy products 
(Figure 2.1 a, b, c, d, e and f). MRS was used as a non-selective culture medium 
and a reference medium to assess the growth of probiotic lactobacilli. MRS-Maltose 
did not give a good recovery of the target strain even when compared with that 
obtained on the control medium (MRS). Comparison of the viable counts indicated 
that in eight products (P8, P9, P11, P13, P14, P31, P32 and P35)  the viable counts 
on MRS-Sorbitol were higher than viable counts on MRS-Clindamycin, while in six 
products (P15, P17, P26, P29, P34 and P36) viable counts on MRS-Clindamycin 
were higher than viable counts on MRS-Sorbitol.  
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2.3.1 Enumeration of Lactobacillus spp. in commercial fermented milk 
Thirty one out of 36 fermented milks contained more than 6 log10 CFU/g on at least 
one medium at the time of purchase (Figures 2.1 a, b, c and d, e and f). According 
to the results of the present study and those suggested by Van de Casteele et al. 
(2006), MRS-Clindamycin seems to be a valuable selective culture medium for 
enumeration of probiotic lactobacilli. The following figures (2.2 a, b, c, d) show 
numbers recovered on MRS-Clindamycin at the end of expiry dates compared to 
the numbers at initial sampling. 
Depending on the tested product, the number of Lactobacillus spp. declined 
between 0.00 and 2.62 log10 on the expiry date (Figure 2.2 a, b, c, d). However, at 
the end of the shelf life, 22 (61.1%) of tested samples contained greater than 6 
log10 CFU/g viable Lactobacillus spp. Products P3, P4, P15, P18, P21, P22 and 
P23 contained an initial Lactobacillus spp. population of more than 6 log10 CFU/g, 
which had significantly decreased to less than 6 log10 CFU/g by the expiry date (p 
< 0.05). However, products P8, P11, P14, P27 and P32 contained less than 6 log10 
CFU/g viable Lactobacillus spp. at the time of purchase.  
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 Data are means ± SD (n=4) 
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1Figure 2.1 a The average viable counts of presumptive Lactobacillus spp. (log10 CFU/g) on four different media (MRS, MRS 
Maltose, MRS-Sorbitol, MRS-Clindamaycin) 
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Data are means ± SD (n=4) 
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2Figure 2.1 b The average viable counts of presumptive Lactobacillus spp. (log10 CFU/g) on four different media (MRS, MRS-
Maltose, MRS-Sorbitol, MRS-Clindamaycin) 
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Data are means ± SD (n=4) 
2
3
4
5
6
7
8
9
P13 P14 P15 P16 P17 P18
M
e
a
n
 l
o
g
1
0
C
F
U
/g
Products
MRS MALTOSE SORBITOL CLINDAMAYCIN
3Figure 2.1 c The average viable counts of presumptive Lactobacillus spp. (log10 CFU/g) on four different media (MRS, MRS- 
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Data are means ± SD (n=4) 
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Data are means ± SD (n=4) 
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Maltose, MRS-Sorbitol, MRS-Clindamaycin)  
Data are means ± SD (n=4) 
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Data are means ± SD (n=4) 
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7Figure 2.2 a The average viable counts of presumptive Lactobacillus spp. (log10 CFU/g) on MRS-Clindamycin agar in tested  
products at the time of purchase and at the end of expiry date 
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Data are means ± SD (n=4) 
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Data are means ± SD (n=4) 
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Data are means ± SD (n=4)
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2.3.2 Changes in pH value during storage of samples 
The pH of all samples declined during the shelf life (Table 2.1). The initial pH on 
the day of purchase ranged between 3.62 and 4.7 and at the end of shelf life 
ranged from 3.46 to 4.61. 
2.3.3 Differentiation of isolates by rep-PCR 
At the end of the enumeration procedure, with regard to shape and size of visible 
colonies on MRS-Clindamycin in section 2.2.1.2, a total of 85 isolates were 
isolated and purified. All selected isolates were categorized along with 
commercial and type strains of Lactobacillus by using rep-PCR. All tested 
isolates were categorized in 8 different groups A, B, C, D, E, F, G and H (Figure 
2.3). Group A, as the major group, contained 51 isolates presenting the same 
DNA band profile. Others included 22 isolates in group B, six isolates in group 
C, five isolates in group D, four isolates in group E, two isolates in group H and 
one isolate in each group of  F and G.  
Sequencing of 16S rRNA and rpoA genes was applied for further identification 
of isolates. In total, 20 isolates were randomly selected from the above groups, 
and identified by partial sequencing of 16S rRNA and rpoA genes. 
2.3.4 Identification of lactobacilli isolates recovered from fermented milk 
products by partial sequencing of 16S rRNA and rpoA genes 
Random representatives of each group {A (6), B (3), C (4), D (2), E (2), F (1)} 
were analysed using the 16S rRNA gene and where needed examined further 
with rpoA gene sequencing. Table 2.2 presents the results of identification using 
16S rRNA and rpoA genes sequencing of isolates. 
 
 
 
87 
 
 
 
11Figure 2.3 Dendrogram obtained by cluster analysis of rep-PCR fingerprints from  
      isolated strains. 
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The six isolates selected as being representative of the 51 isolates in group A 
were identified as Lb. acidophilus (100% similarity to GenBank sequences) by 
16S rRNA sequencing. 
The identity of the isolates in group B was revealed as Lb. casei/paracasei 
(98%) by 16S rRNA gene sequences. As the 16S rRNA gene sequencing could 
not differentiate between Lb. casei and Lb. paracasei, sequencing of rpoA gene 
was used to discriminate the two species.  
Similarly, isolates in group C were identified as Lb. casei/paracasei (99% 
similarity) by both, 16S rRNA and rpoA gene sequencing. 
Isolates of group D, were identified as Lb. Johnsonii (100% similarity) by 16S 
rRNA gene sequencing. The isolates in group E were identified as Lactobacillus 
helveticus, gallinarum, suntoryeus (99% similarity) by both 16S rRNA and rpoA 
gene sequencing. Group F included one isolate and was identified as S. 
thermophilus (96% similarity) by 16S rRNA gene sequencing. Groups G and H 
were identified as Lb. helveticus, gallinarum, suntoryeus (99% similarity) by both 
16S rRNA and rpoA gene sequencing. 
Sequencing of rpoA genes in addition to sequencing of 16S rRNA did not 
discriminate between isolates in groups B, C, E, G and H (Table 2.2).  
Due to failure of the 16s rRNA and rpoA genes sequencing to differentiate 
closely related species, the DNA banding profiles of unconfirmed isolates was 
compared with those of type strains and their identy confirmed according to their 
similarities to the type strains.  
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Isolate 
code 
and 
group 
Identification 16S rRNA 
sequencing 
Similarity Identification rpoA 
sequencing 
Similarity 
A-1 Lactobacillus acidophilus 100% _____ _____ 
A-2 Lactobacillus acidophilus 100% _____ _____ 
A-3 Lactobacillus acidophilus 97% _____ _____ 
A-4 Lactobacillus acidophilus 100% _____ _____ 
A-5 Lactobacillus acidophilus 99% _____ _____ 
A-6 Lactobacillus acidophilus 99% _____ _____ 
B-1 Lactobacillus casei 
Lactobacillus paracasei 
95% 
95% 
Lactobacillus casei 
Lactobacillus paracasei 
99% 
99% 
B-2 Lactobacillus casei 
Lactobacillus paracasei 
100% 
100% 
Lactobacillus casei 
Lactobacillus paracasei 
99% 
99% 
B-3 Lactobacillus casei 
Lactobacillus paracasei 
98% 
98% 
Lactobacillus casei 
Lactobacillus paracasei 
100% 
100% 
C-1 Lactobacillus casei 
Lactobacillus paracasei 
99% 
99% 
_____ _____ 
C-2 Lactobacillus casei 
Lactobacillus paracasei 
99% 
99% 
Lactobacillus casei 
Lactobacillus paracasei 
100% 
100% 
C-3 Lactobacillus casei 
Lactobacillus paracasei 
100% 
100% 
Lactobacillus casei 
Lactobacillus paracasei 
100% 
100% 
C-4 Lactobacillus casei 
Lactobacillus paracasei 
99% 
99% 
Lactobacillus casei 
Lactobacillus paracasei 
99% 
99% 
D-1 Lactobacillus johnsonii 100% _____ _____ 
D-2 Lactobacillus johnsonii 100% _____ _____ 
E-1 Lactobacillus helveticus 
Lactobacillus gallinarum 
Lactobacillus suntoryeus 
99% 
99% 
100% 
Lactobacillus helveticus 
Lactobacillus gallinarum 
Lactobacillus suntoryeus 
99% 
99% 
100% 
E-2 Lactobacillus helveticus 
Lactobacillus gallinarum 
Lactobacillus suntoryeus 
98% 
97% 
98% 
Lactobacillus helveticus 
Lactobacillus gallinarum 
Lactobacillus suntoryeus 
98% 
97% 
98% 
F-1 Streptococcus thermophilus 95% 
 
_____ _____ 
 
 2Table 2.2 Identification of probiotic lactobacilli isolated from commercial fermented 
milks by sequence analysis of 16S rRNA 
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Table 2.2 Continued 
 
Isolate 
code 
and 
group 
Identification 16S 
rRNA sequencing 
Similarity Identification rpoA 
sequencing 
Similarit
y 
G-1 Lactobacillus helveticus 
Lactobacillus gallinarum 
Lactobacillus suntoryeus 
95% 
95% 
95% 
Lactobacillus helveticus 
Lactobacillus gallinarum 
Lactobacillus suntoryeus 
99% 
98% 
99% 
H-1 Lactobacillus helveticus 
Lactobacillus gallinarum 
Lactobacillus suntoryeus 
95% 
95% 
95% 
Lactobacillus helveticus 
Lactobacillus gallinarum 
Lactobacillus suntoryeus 
99% 
98% 
99% 
 
 
 
2.4 DISCUSSION 
The use of food as a carrier probiotic organism has attracted considerable 
attention among food manufacturers because of the claimed health-associated 
benefits. However, maintaining a large amount of viable probiotics in fermented 
milks is not easy, and a large quantity of probiotic culture should be added to 
the carrier food to compensate for the likely losses of probiotics during the 
shelflife (Wang et al. 2009). The recommended quantity of probiotic lactobacilli 
that needs to be consumed for a health benefit varies in different studies 
(Guarner et al. 2008). Information concerning the expected viable concentration 
of each probiotic present at the end of shelflife should be available to the 
consumer (Reid et al. 2001). 
In order to ensure that the consumers benefit from commercial probiotic 
products, it is necessary to confirm the identity of the claimed organisms at 
species/strain level and that they are present in the product in appropriate 
numbers before consumption.  
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Although there are no universally established standards for microbial content 
and label claims on the labels of probiotic products, the manufacturers should 
at least clearly express the genus, species and strain of the probiotic 
microorganism and also the minimum viable count of each probiotic strain at the 
end of shelf-life (Guarner et al. 2008). 
To have any health benefits and functional properties, it is suggested that at 
least 106-7 CFU/g of live probiotic should be present in the product at the end of 
expiry date (Samona and Robinson 1994; Gueimonde et al. 2004; Wang et al. 
2010). Current research findings show that at the time of purchase 86% of 
tested samples contained the minimum recommended quantity, but on the 
expiry date only 61% of tested products met the minimum therapeutic 
requirement.   
Other researchers have also reported commercially probiotic dairy products with 
inadequate amounts of viable probiotic (Iwana et al. 1993; Schillinger 1999; 
Gilliland et al. 2002). The difference between actual included and counted 
number of probiotic lactobacilli may also be attributable to disruption of the cold 
chain (Nayra et al. 2002; Godward and Kailasapathy 2003), or inadequate 
proliferation of lactobacilli throughout processing due to shortage of probiotic 
culture enhancer (Perko et al. 2002). In this study during cold storage, the 
number of Lactobacillus spp. in eight samples decreased considerably more 
than in others. The most important contributing factors for loss of cell viability 
are decreasing pH during product storage, presence of dissolved oxygen and 
also presence of preservatives in final products (Vinderola et al. 2002a). In this 
study, the pH decline between the purchase and expiry date was in some cases 
 
 
 
92 
 
considerable. It could be due to continued fermentation process by LAB even in 
low temperatures known as post acidification. 
The presence of dissolved oxygen might be the other important reason for drop 
in viability of cell count in fermented milk (Dave and Shah 1997; Shah 2000). 
The majority of tested products in this study were stirred yogurts, in which air 
could have been incorporated when the yogurt was mixed with the fruit compote. 
Also, some of the commercial fruit products contain preservative agents to 
control contamination and this might affect the viability of the probiotic cells 
(Kailasapathy et al. 2008).  
Based on these results, which are in line with those of Jayamanne and Adams 
(2006), higher numbers of probiotic would be ingested if probiotic fermented 
products are consumed earlier than their expiry date. The viability of the 
bifidobacteria in bio-yoghurts available in the UK market was decreased during 
storage at 4°C. On expiry (3 weeks) only five products retained viability >106 
CFU/g.  
It was found that MRS-Maltose is not a good choice for selective enumeration 
of lactobacilli; but, MRS-Clindamycin and MRS-Sorbitol media are both reliable 
in their ability to recover accurately numbers of Lb. acidophilus and Lb. casei in 
fermented dairy products. This study reports that MRS-Sorbitol exhibits higher 
viable count than MRS-Clindamycin, suggesting that MRS-Sorbitol might allow 
the growth of additional LAB. In other words, MRS-Sorbitol agar could not be 
used for selective enumeration of Lb. casei and Lb. acidophilus in products 
containing both these bacteria (Shah 2000). MRS-Clindamycin has been 
proposed to enumerate lactobacilli in different studies (Van de Casteele et al. 
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2006). Furthermore, the International Organization for Standardization (ISO 
2006) has recommended MRS-Clindamycin agar for the enumeration of Lb. 
acidophilus in dairy products where Lb. acidophilus strains are present along 
with other LAB and bifidobacteria. Additionally, another study reportes that 
MRS-Clindamycin could be used for the selective enumeration of Lb. 
acidophilus in yogurt-related milk products containing a mixed microflora of 
lactobacilli, streptococci and bifidobacteria (Ashraf and Shah 2011). MRS-
Clindamycin has the advantage of being simple (only one composite antibiotic 
supplement) and easier to prepare. However, it has proved not to be a perfect 
selective medium as other LAB, such as S. thermophilus (difficult to different 
from lactobacilli based on colony morphology) are able to grow on the medium. 
Oberg et al. (2011) reported that although MRS-Sorbitol is a medium designed 
for Lb. acidophilus in which sorbitol is the sole sugar constituent and, Lb. casei 
can grow on the medium only at elevated incubation temperature (42 °C). At 
this temperature, the MRS-Sorbitol medium gave higher bacterial counts 
compared to the Lb. casei specific medium (LC agar), indicating that it could be 
used to obtain the total LAB count at different temperature. However, in this 
study colonies of both Lb. acidophilus and Lb. casei were recovered on MRS-
Sorbitol agar. 
Some of the tested products in this study presented inadequate information on 
their labels. Microbial investigations of probiotic products have indicated that the 
number and identity of recovered species do not always correspond to those 
stated on the labels of products (Hamilton-Miller and Shah 2002; Temmerman 
et al. 2003).  
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Identification of probiotic species used in carrier products is considered an 
important issue, which should be verified in support of health benefits claimed 
for the products. To obtain accurate and reliable identification of the probiotic 
species, molecular techniques should be applied. DNA profiling by PCR based 
methods are the best applicable means for identification of probiotic bacteria to 
strain level (Gueimonde et al. 2004; Tabasco et al. 2007). Many mis-
identifications of probiotic microorganisms maybe due to the use of only 
phenotypic methods for taxonomic characterization (Ouwehand et al. 2006).  
The rep-PCR fingerprinting profile revealed relative genetic differences between 
the tested isolates. Rep-PCR genomic fingerprinting is able to differentiate 
bacteria at species, subspecies and even strain level. In addition, many 
repetitive sequence primers are available, and a different primer could generate 
different band patterns, which would assist identification (Rademaker et al. 
2005). 
In this study, 85 isolates from fermented milks were grouped based on their 
DNA patterns by rep-PCR, and 20 isolates out of 85 were selected for 
identification by sequence analysis of 16S rRNA. Amplification of the 16S rRNA 
gene often provides a rapid and reliable tool for bacterial identification without 
the need for phenotypic characterization. However, 16S rRNA sequencing 
cannot discriminate closely related species. Thus, sequencing of alternative 
genes such as rpoA with more reliability has been proposed (Koo et al. 2003; 
Santos and Ochman 2004; Naser et al. 2007).  
However, in this research, amplification and sequencing of the rpoA gene could 
not provide enhanced discriminatory information for identifying tested isolates 
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compared to use of 16S rRNA gene sequences. Sequencing of other genes 
such as rpoB and pheS with more discriminatory potential to differentiate strains 
with close genetic profiles could be more interesting. Anyogu et al. (2014) stated 
that sequencing of the pheS, rpoA and rpoB genes along with 16S rRNA gene 
sequencing provide a better identification of LAB and Bacillus isolates. 
The results of identification revealed that Lb. acidophilus and Lb. casei were the 
most frequently recovered species from the fermented milks.  
 
2.5 CONCLUSION 
Out of 20 identified isolates of probiotic Lactobacillus, six were selected for 
screening for functional properties. These isolates were carefully chosen to 
include all major brands of probiotic products. These isolates along with two 
commercial cultures of Lactobacillus from Chr. Hansen (La5 and C431) and also 
three different type strains from National Collection of Industrial Food and 
Marine Bacteria (NCIMB) (Lb. casei subsp. casei, Lb. paracasei subsp. 
paracasei and Lb. acidophilus) were used throughout this study.   
The potential of MRS-Maltose, MRS-Sorbitol and MRS-Clindamycin as 
selective medium for isolation of Lactobacillus spp. from commercial fermented 
milks was examined. It was concluded that MRS-Maltose was not a good choice 
for selective enumeration of lactobaciili, MRS-Sorbitol might allow the growth of 
additional LAB regardless of the intended lactobacilli and at last MRS-
Clindamycin not to be perfect selective medium as S. thermophilus was able to 
grow on it and it is relatively difficult to differentiate from colonies of lactobacilli. 
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However, MRS-Clindamycin has the advantage of being simple (only one 
composite antibiotic supplement) and easier to prepare. 
The total viable count of Lactobacillus spp. in most tested products remained 
over 106 CFU/g at the end of shelflife. This could mainly be due to technical 
processing and strain selection improvement. Also, most Lactobacillus spp. 
were isolated from commercial fermented milks were identified as Lb. 
acidophilus, Lb. casei and Lb. paracasei by analysis of partial sequences of the 
16S rRNA and rpoA genes and discrimination by rep-PCR. 
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CHAPTER THREE: IN VITRO ASSESSMENT OF 
LACTOBACILLUS SPP. FOR PHYSIOLOGICAL 
PROPERTIES: TOLERANCE TO ACID, BILE 
SALT AND ENZYMES  
 
(Criteria for selection: Resistance to upper 
digestive tract conditions)  
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3.1 INTRODUCTION 
In order to sustain certain organisms, such as probiotics, some requirements 
need to be fulfilled; viability and survival of probiotic bacteria are the most 
important parameters to provide therapeutic functions. Probiotic lactobacilli 
need to survive during the manufacturing process of food and then in the upper 
GIT.  
A number of factors have been claimed to affect the viability of probiotic bacteria 
in dairy foods, such as yogurt and fermented milks, including low pH and 
refrigerated storage (Dave and Shah 1998; Shah 2000). Moreover, the 
resistance to human gastric transit constitutes an important selection criterion 
for probiotic bacteria (Goldin and Gorbach 1989). Microorganisms ingested with 
food begin their journey to the lower intestinal tract via the mouth and are 
exposed to stress factors that influence their survival.  
Resistance to gastric acid and physiological concentrations of bile is one of the 
invitro tests that have been frequently suggested for the evaluation of the 
probiotic potential of Lactobacillus spp. (Vijendra and Prasad 2005; Mathara et 
al. 2008).  
3.1.1 Effect of pH on viability of lactobacilli 
Lactic acid production is an important index of adaptation of LAB, which secrete 
lactic acid as end-product of lactose fermentation. The viability of Lactobacillus 
spp. depends on a number of factors (Marteau et al. 1997). Acidity is believed 
to be the most detrimental factor affecting the viability of lactobacilli, because 
their growth is reduced considerably below pH 4.5 (Lankaputra and Shah 1995). 
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The time reported from entrance to release of food from the stomach is about 
2-4 h (Berrada et al. 1991), but dwell time in the stomach depends on the nature 
of food, e.g. fatty food may lead to longer residence times. Cellular stress begins 
in the stomach. Depending on whether the subject is in a fasting or fed state, 
the pH of gastric juice is about 0.9, but the presence of food in the stomach 
raises the pH value to the level of pH 3 (Vandamme et al. 2002). 
So, food matrix would buffer probiotic Lactobacillus spp. to facilitate survival at 
the pH of the stomach (Prasad et al. 1998). Among different foods, milk and 
dairy products play a critical role in the survival of probiotic lactobacilli through 
the GIT and in the colonization of intestine (Ritter et al. 2009).  
It has been demonstrated that milk proteins are able to neutralize the harmful 
effects of different substances on bacterial growth (Boyaval et al. 1995; Kim and 
Liu 2002). Rodriguez et al. (2012) found that selected lactobacilli isolates in their 
work had good viability during the simulated GIT digestion, with reductions of 
0.87– 2.89 log10 units. They concluded that Lb. paracasei INIA P272 and Lb. 
rhamnosus INIA P344 were the most resistant to simulated gastric digestion 
and best adhesive bacteria during the in vitro test. Corsetti et al. (2008) 
evaluated the resistance of the Lb. casei strains isolated from Pecorino cheese 
to gastric acidity (pH 2.0) and bile salts (0.5% w/v bovine bile) in simulated 
gastric and intestinal fluid, respectively. Lactobacillus casei strains were highly 
susceptible to low pH and their viability decreased after the exposure to 
simulated gastric fluid with an average reduction of 4.42 log10 CFU/ml. In other 
reported study, Lb. acidophilus La5 reduced only 1 og10 cycle after 2 h of 
exposure to pH 2, but were entirely destroyed after 1 h at pH 1 (Favaro and 
Grosso 2002). Pan et al. (2009) observed that with an increased incubation 
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time, the count of viable lactobacilli was decreased. They evaluated the 
resistance of Lb. acidophilus NIT to pH 2–4 and 1–3% bile. In their study, at the 
lowest pH of 2, the counts of lactobacilli were reduced to an undetectable level 
after 2 h. The lactobacilli survival at pH 3 was higher than pH 2, and after 3 h 
interaction, 10% viable count of Lb. acidophilus NIT was achieved. A higher 
survival of these bacteria (70%) was seen after 3h exposure at pH 4.   
3.1.2 Effect of bile on viability of lactobacilli 
In accordance with guidelines for the evaluation of probiotics described by WHO 
experts (FAO/WHO 2006), bile salt hydrolase activity is a property to be 
considered in the screening of potential probiotic organisms. The expression of 
bile salt hydrolase has been proposed as a protective system to allow the 
potential probiotic bacteria to survive and colonize the intestine after oral 
consumption (Parvez et al. 2006). 
Cholesterol is the main component of primary bile salts, which are formed in the 
liver and are accumulated as conjugated bile salts in the gall bladder (Corzo 
and Gilliland 1999). Conjugated bile salts are released into the duodenum after 
ingestion of fatty meals and improve the emulsification of lipids as well as the 
absorption of lipid nutrients. They are in the form of N-acyl compounds 
conjugated with glycine or taurine (Hofmann and Mysels 1992). 
Bile secretion is one of the important pathways of eliminating serum cholesterol 
(Turley and Dietschy 1988). About 97% of conjugated bile salts are reabsorbed 
to the liver from the duodenum (MacDonald et al. 1983). 
Bile secreted in the small intestine reduces the survival of bacteria by destroying 
their cell membranes. Bile is able to affect the phospholipids and proteins of cell 
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membranes and disrupt cellular homeostasis, as well as disturbing 
macromolecule stability (Begley et al. 2005). 
It has been shown that some lactobacilli could lower total plasma cholesterol 
and low-density lipoprotein (LDL) cholesterol (De Smet et al. 1994; Ahn et al. 
2000).  
The study by Ahn et al. (2000) revealed that serum cholesterol levels of the 
volunteers decreased significantly after the intake of acidophilus milk, 
containing Lb. acidophilus SNUL01 for 4 weeks. This hypocholesterolaemic 
effect of acidophilus milk has been attributed to the deconjugation of bile salts 
by Lb. acidophilus SNUL01.  
Some probiotics secrete bile salt hydrolase (BSH) (cholylglycine hydrolase; EC 
3.5.1.24), the enzyme that catalyzes the hydrolysis of glycine and taurine 
conjugated bile salts into amino acid residues and free bile salts (bile acids) 
(Liong and Shah 2005). Free bile salts are less soluble than conjugated bile 
salts, resulting in lower absorption in the GIT, and therefore are lost in faeces 
(Center 1993). Bile salt hydrolysis was reported in Lactobacillus spp., 
Bifidobacterium longum, Clostridium perfringens and Bacteroides fragilis subsp. 
fragilis (Corzo and Gilliland 1999).  
The solubility and emulsifying capacity of conjugated bile salts decrease when 
they are deconjugated in the intestine (Hofmann and Mysels 1992; Tannock 
1995). 
Gilliland et al. (1984) considered 0.3% bile salts as a critical concentration to 
screen for resistant strains. Goldin and Gorbach (1992) stated that the same 
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level should be critical when selecting human probiotics.  
Moreover, different bile salt hydrolase activities have been reported for different 
strains of the same bacterial species under similar pH values (Lunden and 
Savage 1990). 
3.1.3 Bile salt deconjugation properties of lactobacilli 
It is necessary to examine the bile salt deconjugation properties and bile salt 
hydrolase activities of Lactobacillus strains, before further usage in in vivo 
studies. Unconjugated bile salts are considered more toxic than conjugated 
forms (Vinderola and Reinheimer 2003), and glycoconjugates are more toxic 
towards probiotic bacteria than their tauroconjugates counterparts (Noriega et 
al. 2006) and the toxicity may be attributed to the different dissociation constants 
(De Smet et al. 1995). Differences in sensitivity among strains could be related 
to the presence of bile salt hydrolases with preference to glycoconjugated bile 
acids, which are a common trait in intestinal isolates (Begley et al. 2006).  
However, acid resistance and bile tolerance of Lactobacillus spp. are 
considered as the main criteria for selection as probiotics and these 
characteristics should be examined by in vitro and in vivo methods. 
One useful tool in the selection of a probiotic strain would be in vitro tests to 
determine the survivability of bacteria in the upper gastrointestinal conditions. 
The aim of this experiment was to determinate the survival of Lactobacillus 
isolates in simulated gastric juice and intestinal conditions. The specific 
objectives included: 
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a) In vitro assessment of the resistance of the isolates to various pH level 
(i.e. 2.0, 3.0 and 4.0). 
b) In vitro assessment of the resistance of the isolates to the different 
concentration of bile salts. 
c) In vitro assessment of protective role of gastric enzymes for the isolates. 
d) Comparing the isolates to type strains and commercial cultures for the 
above. 
 
3.2 MATERIALS AND METHODS  
3.2.1 Acid resistance 
An acid resistance study of 11 Lactobacillus strains was carried out in normal 
Phosphate Buffered Saline (PBS) (pH 7.4) (as control) and PBS with the pH 
adjusted to 4, 3 and 2 using 2M hydrochloric acid. 
Strains tested for this experiment were as follows (Table 3.1): 
a) Two commercial cultures of Lactobacillus spp. kindly provided by starter 
culture supplier, Chr. Hansen (Lb1 and Lb2). 
b) Three different lactobacili type strains purchased from NCIMB (National 
Collection of Industrial Food and Marine Bacteria, Aberdeen, UK) (Lb3, Lb4 
and Lb5). 
c) Six Lactobacillus spp. which were isolated from yogurt and other 
fermented milk products (Lb6-Lb11). 
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Acid tolerance was determined with and without addition of 3 g/l of pepsin 
(P7000, Sigma, UK) to the PBS to evaluate any protective or damaging effect 
of pepsin at low pH. 
Acid resistance test was performed according to the method of Prasad et al. 
(1998). After two consecutive streaking of cultures, individual colonies from 
MRS (De Man, Rogosa and Sharp agar) (CM0361, Oxoid Ltd., UK) were 
inoculated into 1 ml of MRD ( Maximum Recovery Diluent) (CM0733, Oxoid Ltd., 
UK) until a heavy microbial suspension was obtained and this suspension was 
diluted in 5 ml of sterile PBS. The final concentration of cells was adjusted to 
0.5 MacFarland solutions using a calibrated sensititrenephelometer (Trek, 
diagnostic systems Ltd., East Grinstead, UK). This microbial suspension was 
used as an inoculum for the further experiments. An aliquot of each culture (1 
ml) was inserted into control and experimental tubes (9 ml) and were incubated 
at 37 oC for 0, 0.5, 1, 1.5, 2 and 3 h under anaerobic conditions. The resistance 
to acid was measured by viable cells counts on MRS agar and expressed as 
log10 CFU/ml. 
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3Table 3.1 Organisms and their origin used for the acid and bile tolerance  
Code Bacteria Origin 
Lb1 Lactobacillus acidophilus (La5) Pure culture from Chr. Hansen 
Lb2 Lactobacillus casei (C431) Pure culture from Chr. Hansen 
Lb3 Lactobacillus acidophilus 
701748 
NCIMB 
Lb4 Lactobacillus casei 11970 NCIMB 
Lb5 Lactobacillus paracasei 
700151 
NCIMB 
Lb6 Lactobacillus johnsonii Isolated from goat yogurt 
Lb7 Lactobacillus acidophilus Isolated from cereal yogurt 
Lb8 Lactobacillus casei Isolated from  drinking yogurt 
Lb9 Lactobacillus casei Isolated from drinking yogurt 
Lb10 Lactobacillus helveticus Isolated from kefir 
Lb11 Lactobacillus helveticus Isolated from fruit yogurt 
 
3.2.2 In vitro assessment of bile tolerance 
Bile salt tolerance of the isolates was studied in PBS (control) and PBS 
containing 0.5, 1, 1.5 and 2% w/v bile salt (B3883, Ox-bile, Sigma UK), which 
represented the physiological condition of small intestine (Collado and Sanz 
2007). The tubes were incubated at 37 oC for 0, 0.5, 1 and 2 h to mimic the 
transit time in the small intestine as described by Prasad et al. (1998). All 
bacterial inocula were prepared as described in section 3.2.1 and inoculated 
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into control tube (free of bile) (PBS) and experimental tubes (with addition of 
bile salts). Viable cells were enumerated on MRS agar after 48 h incubation at 
37 oC in an anaerobic cabinet and expressed as log10 CFU/ml. 
3.2.3 Deconjugation of bile salts 
Deconjugation of bile salt by tested strains was examined through the plate 
assay of Ahn et al. (2003). TCA–MRS agar and GCA-MRS plates were prepared 
by adding 1 mmol sodium salts of TCA (taurochenodeoxycholic acid) and GCA 
(glycochenodeoxycholic acid) (Sigma, UK) to MRS agar, respectively. All plates 
were streaked using an overnight culture, and were incubated in the anaerobic 
cabinet at 37 oC for 48 h. Subsequently, precipitate halos around colonies were 
considered to be deconjugation products of bile salts. 
3.2.4 Effects of sequential treatment with acid, pepsin, pancreatin and bile 
salts on the viability of the tested bacteria 
In order to study the resistance of the isolates in a condition similar to the upper 
GIT conditions, the tolerance of all strains was studied in a sequential model, 
involving exposure first to gastric conditions, followed by exposure to conditions 
in the different parts of the intestine. 
In this experiment, a batch fermentation system (Figures 3.1 and 3.2) was used. 
The system consisted of sterile, magnetically stirred, water jacketed batch 
fermentation vessels (300ml, Soham Scientific, Ely, UK). The temperature was 
maintained at 37 °C by means of a circulating water bath (type GD 120, Grant, 
Shepreth, UK), and pH was screened in each vessel using a pH meter (FerMac 
260, Electrolab, Tewkesbury, UK). The system was set to maintain the required 
pH level in each fermentation vessel. 
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The fermentation vessels were filled with 150 ml PBS and autoclaved at 121 °C 
for 15 min.  
 The vessels were continuously sparged with O2-free N2 throughout. 
Fermentations were run over a period of 9.25 h and samples were obtained at 
the start of the experiment and then at the end of the transit/incubation time 
through each section (Table 3.2).   
The conditions in the vessels were set according to the method described by 
Gbassi et al.  (2011). Four regions of the upper GIT with their specific pH and 
transit (incubation) time were studied. The conditions of GIT were simulated as 
shown in Table 3.2.  
 
 
 
 
12Figure 3.1 A single batch fermentation system used 
for studying the resistance to bile and acid 
 
 
 
108 
 
 
 
 
 
4Table 3.2 In vitro experimental condition in the GIT model 
 Stomach Duodenum Jejunum Ileum 
Incubation/ transit time 2 h 0.25 h 3 h 4 h 
pH 3.0 6.0 7.0 8.0 
        Source: Gbassi et al.  (2011) 
 
As mentioned earlier, PBS as a substitute for gastric and intestinal secretions 
was introduced in all vessels (150 ml each). Apart from the control vessel, the 
pH was adjusted to the stomach pH values (3.0) using 2 M hydrochloric acid in 
all other vessels. The inoculum suspension (%1 v/v) and pepsin (3 g/l) were 
added to the gastric fluid at the beginning of the stomach transit/incubation time. 
After 2 h, the pH was slowly increased to the values of duodenum (6.0) with 2 
M sodium hydroxide (Fisher Scientific, Loughborough, UK). Pancreatin (10 g/l) 
13Figure 3.2 The series of batch fermentation system used for studying 
the resistance to bile and acid 
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(P7545, Sigma, UK) and bile salts (3 g/l) were also added at the beginning of 
the duodenum incubation. To evaluate any protective effect of pancreatin in the 
duodenum, these experiments were carried out with and without addition of 10 
g/l of pancreatin to simulated gastric juice. 
After 15 min duodenum incubation, pH values were changed to 7.0 to simulate 
the jejunum compartment and held for 3 h. These conditions were followed by 
those of the ileum (pH = 8.0) and the incubation continued for 4 h. 
Sampling of gastric and intestinal fluids was carried out at the end of the average 
transit (incubation) time in each region of the artificial duodenum. One ml of 
each sample was suspended in 9 ml of MRD, the uniform suspension was 
decimally diluted. Twenty five µl of each dilution was spread on to quartered 
MRS plates in duplicate. The plates were incubated at 37 °C for 48 h 
anaerobically. The colony forming units (CFU) of the sample were calculated 
and log10 CFU/ml was reported. 
3.2.5 Statistical analysis 
Results are the mean±standard deviation. Data were analysed using the 
independent-samples t-test was performed using SPSS 21 software (Chicago, 
IL: SPSS Inc) to determine the statistical significance of differences. Data were 
considered significantly different when p < 0.05. 
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3.3 RESULTS 
3.3.1 Resistance to acid 
Different pH values in this study were selected to represent the pH range of the 
empty and full human stomach. The strains studied showed very poor survival 
at pH 2 with or without pepsin. At pH 2 (the lowest), the number of cells dropped 
from the inoculated level of 6-7 log10 CFU/ml to an undetectable level (<2.6 log10 
CFU/g) after only 0.5 h for Lb5, Lb8, Lb9 and Lb10, 1 h for Lb3, Lb6 and Lb11 
and 1.5 h for Lb1 and Lb4. Only isolate Lb7 showed good survival up to 1.5 h 
(Figure 3.3). Eight out of eleven tested strains lost their viability during the first 
hour of acid exposure and some degree of protective effects was seen in the 
presence of pepsin at pH 2 (Figure 3.4).  
At pH 3, the survival of the isolates was generally greater than at pH 2 at all 
tested sampling intervals, with the exception of Lb5, Lb6 and Lb8 which were 
undetectable (<2.6 log10 CFU/g) after 1.5 h at this pH. Other tested strains 
showed some degree of resistance even after 3 h (Figure 3.5). The best 
resistance was observed with Lb1, Lb9 and Lb10 where the reduction was 
slightly more than one log10. An interesting observation was that the presence 
of 0.3% pepsin had a considerable effect on the survival at pH 3 (Figure 3.6), 
where all tested strains showed a steady population, very similar to their initial 
counts.   
When the pH was increased to 4, a high survival rate was observed even in the 
absence of pepsin. As Figure 3.7 shows, the viability of strains Lb6, Lb7, Lb8, 
Lb9 and Lb10 were maintained the highest throughout 3 h of exposure to pH 4. 
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As expected in the presence of 0.3% pepsin, the survival rate was higher than 
the effect of pH alone (Figure 3.8).  
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14Figure 3.3 Survival of Lactobacillus species in PBS adjusted to pH 2 after 0, 0.5, 1, 1.5, 2 and 3 h incubation at 37 oC under 
anaerobic condition (no added pepsin) 
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15Figure 3.4 Survival of Lactobacillus species in PBS adjusted to pH 2 after 0, 0.5, 1, 1.5, 2 and 3 h incubation at 37 oC under anaerobic 
condition (with added pepsin)
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16Figure 3.5 Survival of Lactobacillus species in PBS adjusted to pH 3 after 0, 0.5, 1, 1.5, 2 and 3 h incubation at 37 oC under anaerobic 
condition (no added pepsin) 
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17Figure 3.6 Survival of Lactobacillus species in PBS adjusted to pH 3 after 0, 0.5, 1, 1.5, 2 and 3 h incubation at 37 oC under anaerobic 
condition (with added pepsin)
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18Figure 3.7 Survival of Lactobacillus species in PBS adjusted to pH 4 after 0, 0.5, 1, 1.5, 2 and 3 h incubation at 37 oC under anaerobic 
condition (no added pepsin) 
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19Figure 3.8 Survival of Lactobacillus species in PBS adjusted to pH 4 after 0, 0.5, 1, 1.5, 2 and 3 h incubation at 37 oCX under anaerobic 
condition (with added pepsin)
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3.3.2 Resistance to bile 
The bile resistance of Lactobacillus spp. was evaluated by supplementing the 
PBS with bile. Figures 3.9, 3.10, 3.11 and 3.12 illustrate the tolerance of the 
tested Lactobacillus strains in the presence of 0.5, 1, 1.5, and 2% of bile salts. 
The survival rate of all tested Lactobacillus strains at four different 
concentrations of bile salts for a period of 2 h exposure, were very similar to the 
survival at the beginning of the experiment (t=0) with the exception of Lb3, Lb4 
and Lb7 (Figures 3.9 – 3.12). 
Tolerance to bile salts, allows bacteria to survive in the small intestine. At the 
beginning of the experiment, the initial cell population was in the range of 6-7 
log10 CFU/ml, however, all tested isolates showed a very good resistance to bile 
salt even at 2% concentration and their viability was maintained  with no or very 
little loss.  
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20Figure 3.9 Survival of Lactobacillus species in PBS containing 0.5% of bile salt after 0, 0.5, 1 and 2 h incubation at 37 oC under anaerobic 
condition
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21Figure 3.10 Survival of Lactobacillus species in PBS containing 1% of bile salt after 0, 0.5, 1 and 2 h incubation at 37 oC under 
anaerobic condition
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22Figure 3.11 Survival of Lactobacillus species in PBS containing 1.5% of bile salt after 0, 0.5, 1 and 2 h incubation at 37 oC under anaerobic 
condition
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23Figure 3.12 Survival of Lactobacillus species in PBS containing 2% of bile salt after 0, 0.5, 1 and 2 h incubation at 37 oC under anaerobic 
condition
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3.3.3 Deconjugation of bile salts 
All lactobacilli streaked on TCA and GCA–MRS agar plates were able to grow 
well and formed fine precipitate halos around the colonies, with appearance of 
a clear zone around the colonies (Figure 3.13 and 3.14). It was difficult to 
measure the diameter of the precipitated halo zone, but certainly, no inhibitory 
effects of TCA and GCA were seen on the growth of the tested isolates. All 
strains could deconjugate bile salts. 
 
 
24Figure 3.13 Representative of deconjugation of bile salt by Lb 1,2,3,4 and 5 on  
bile salt–MRS agar plates containing TCA. 
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25Figure 3.14 Representative of deconjugation of bile salt by Lb 1,2,3,4,5 and 6 on  
bile salt–MRS agar plates containing GCA. 
 
3.3.4 Sequential effects of acid, pepsin, pancreatin and bile salts on 
viability of tested isolates 
After initial screening of the isolates for their resistance to pH and bile salt and, 
due to complexity of the contents of the GIT, their behaviour was studied using 
an in vitro GIT model. 
In this model the sequentially combined effects of pH, pepsin and bile salts and 
also pH, pepsin, bile salts and pancreatin on survival of testedstrains were 
studied.  
As Figures 3.15 to 3.25 show apart from isolates Lb4, 7 and 9, a detrimental 
effect of bile salts was seen in all tested strains; as numbers were reduced by 
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more than 1 log10 CFU/ml. In the initial studies where the sole effect of acid 
and/or bile was examined, all strains showed tolerance to bile salts; but, after 
acid stress their tolerance to bile salts, was reduced. 
The protective effect of enzyme pancreatin was observed for all tested strains. 
The number of recovered bacteria at the stage at which conditions mimiced 
leaving the stomach, duodenum, jejunum and ileum were more or less similar 
to the control except for isolates Lb 8 and 10. Numbers of these two isolates 
were drastically reduced after exposure to bile salts. No protective effect of 
pancreatin was noticed (p < 0.05). 
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26Figure 3.15 Survival of Lb1 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence  of 
acid (pH), bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l) + pancreatin (10g/l)
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27Figure 3.16 Survival of Lb2 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence of acid (pH), 
bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l) + pancreatin (10g/l) 
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28Figure 3.17 Survival of Lb3 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence of acid  (pH), 
bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l) + pancreatin (10g/l) 
  
0
1
2
3
4
5
6
t=2 t=2.15 t=5.15 t=9.15
B
ac
te
ri
al
 c
o
u
n
ts
 (
LO
G
1
0
 C
FU
/m
l)
Time (h)
control Treatment 1 Treatment 2
stomach
pH 3
Pepsin
Duodenum
pH 6
Pepsin
Jejunum
pH 7
Pepsin
Ileum
pH 8
Pepsin
 
 
 
129 
 
 
 
29Figure 3.18 Survival of Lb4 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence  of acid (pH), 
bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l) + pancreatin(10g/l)
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30Figure 3.19 Survival of Lb5 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence of acid (pH), 
bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l) + pancreatin(10g/l) 
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31Figure 3.20 Survival of Lb6 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence  of acid (pH), 
bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l) +pancreatin (10g/l)
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32Figure 3.21 Survival of Lb7 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence  of acid (pH), 
bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l) +pancreatin (10g/l) 
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33Figure 3.22 Survival of Lb8 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence  of acid (pH), 
bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l) + pancreatin (10g/l)
0
1
2
3
4
5
6
7
8
t=2 t=2.15 t=5.15 t=9.15
B
ac
te
ri
al
 c
o
u
n
ts
 (
LO
G
1
0
 
C
FU
/m
l)
Time (h)
control Treatment 1 Treatment 2
stomach
pH 3
Pepsin
Duodenum
pH 6
Pepsin
Jejunum
pH 7
Pepsin
Ileum
pH 8
Pepsin
134 
34Figure 3.23 Survival of Lb9 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence  of acid (pH), 
bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l) + pancreatin (10g/l) 
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35Figure 3.24 Survival of Lb10 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence of acid 
(pH), bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l) + pancreatin(10g/l) 
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36Figure 3.25 Survival of Lb11 (log10 CFU/ml) under different conditions of stomach and small intestine influenced by the presence of acid 
(pH), bile salt, pepsin, pancreatin and transit time (h)  
Control: PBS (pH= 7) 
Treatment 1: bile salt (3g/l) 
Treatment 2: bile salt (3g/l)+pancreatin(10g/l) 
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3.4 DISCUSSION 
The in vitro survival experiments of Lactobacillus spp. Mimicking transit from 
stomach to intestinal conditions are valuable for estimating the survival rate of 
strains. It is clear that strain behaviour in GIT would be different when the 
probiotic bacteria are protected by the food matrix or presented in 
microencapsulated forms. 
However, the survival of strains in the harsh conditions of GIT needs to be 
assessed properly to determine changes in the total number of consumed 
probiotic bacteria. It would be useful to estimate the minimum requirement for 
oral administrations of probiotic. 
Schillinger et al. (2005) reported that six Lb. acidophilus strains isolated from 
probiotic yogurts were able to survive for 90 min in a simulated gastric juice 
containing pepsin (3 mg/ml) at pH 2. The reduction of Lb. acidophilus strains 
varied from 0.1 to 2.5 log10 cycles during that period. They also reported that 
these Lb. acidophilus strains were more tolerant to low pH, compared to Lb. 
paracasei subsp. Paracasei and Lb. rhamnosus, which demonstrated complete 
loss of viability within 30 min of starting the experiment. 
In the study of Madureira et al. (2005) no changes were seen in the viability of 
the Lb. acidophilus LAC-1 and Lb. acidophilus Ki strains in Requeijão cheese. 
These lactobacilli retained numbers above 7 and 8 log10 CFU/ml of simulated 
gastric content, respectively, when exposed at pH 2.5 and 3 with pepsin (1000 
unit/ml) over 2 h. 
The present study confirmed that all tested strains were able to survive in the 
neutral pH of PBS solution for 3 h. At pH values of 4 and 3, no considerable 
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reduction in the viable counts was observed except for a few strains. However, 
after one h, viable cells were undetectable at pH 2 for many of the tested 
isolates. Nevertheless, all tested strains are able to meet the requirements for 
probiotic properties in terms of acid tolerance in the stomach.  
In addition, the fact that probiotic bacteria are carried in milk products and milk 
proteins support the survival of probiotic bacteria in the acidic condition of the 
stomach (Maragkoudakis et al. 2006). Lo Curto et al. (2011) investigated the 
survival of Lb. casei Shirota, Lb. casei Immunitas and Lb. acidophilus johnsonii 
in a gastric model of digestion followed by incubation under duodenal 
conditions. They incorporated those lactobacilli in water and milk as food 
matrices. According to their findings the survival in milk was higher than water. 
This can be related to the lower buffering capacity of the water in comparison to 
milk (Holzapfel et al. 2001).  
Investigating the sensitivity of microorganisms to gastric juices, such as pepsin, 
is an important step for selection of potential probiotic lactobacilli. The combined 
influence of a pepsin-pH solution in simulated gastric juice is not clear. Pepsin 
introduces restrictive conditions for growth of lactobacilli (Radulovic et al. 2010).  
Maragkoudakis et al. (2006) stated that actual gastric juice compared with low 
pH buffer, provides some degree of protection for bacteria. This study showed 
that survival of the tested strains during incubation at low pH in medium fortified 
with pepsin was higher than incubation without pepsin. These bacteria 
presented extreme sensitivity to acidic condition at pH 2 and the protective effect 
of pepsin at pH 2 was not as noticeable as at pH 3 and 4. The findings herein 
reported for protective effects of pepsin on tested isolates at low pH are in 
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agreement with the existing literature (Maragkoudakis et al. 2006). They 
indicated that all 29 strains of lactobacilli in their study maintained their viability 
after 3 h of exposure to pH 3. Among strains subjected to the pepsin solution at 
pH 2 for 1 h, highest survival was seen with Lb. casei Shirota ACA-DC 6002, 
Lb. casei Immunitas ACA-DC 6003 with lower than 1.0 log10 cycle reduction. 
After 3 h of exposure to pepsin, the best survival was observed with strains Lb. 
rhamnosus ACA-DC 112 and Lb. paracasei subsp. paracasei ACA-DC 130 with 
2.0 log10 cycles reduction. All strains retained their viability after 4 h of exposure 
to pancreatin at pH 8.0 with below 1 log cycle reduction. 
Ahn et al. (2003) have indicated that deconjugation of bile salt does not 
necessarily represent bile tolerance of Lb. acidophilus. Other researchers have 
reported similar results (Usman and Hosono 1999; Moser and Savage 2001). 
Contradictory reports, however, indicate that deconjugation of bile salt promoted 
bile tolerance of LAB (De Smet et al. 1995). 
This study reported that no considerable retardation occurred of growth of the 
tested isolates in the presence of TCA and GCA, and all colonies appeared on 
the agar plates. Therefore, the precipitated halo around the colonies on the bile 
salt–MRS agar plates were believed to be free bile salts, produced by the 
deconjugation of the added bile salts. 
All tested isolates in the current research showed good resistance to different 
levels of bile salts even after 2 h and were able to retain their viability, as well 
as deconjugating TCA and GCA into cholate. This might be due to presence of 
BSH activities in those isolates which deconjugate bile salts; therefore, the toxic 
effects of bile salts on bacteria were decreased. The deconjugation of bile salts 
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in human intestinal tract starts at the end of the ileum and is completed in the 
large intestine (Tanaka et al. 2000a). Noriega et al. (2006) reported that 
lactobacilli provide a protective system with BSH, which enables them to 
deconjugate the bile salts, and the results in this study are in line with them. 
In spite of good tolerance of the tested strains to bile salts, most of them died in 
the sequential model experiment in which they were exposed to gastric 
conditions followed by bile salts. However, viable numbers were maintained 
when duodenal juice was complemented by pancreatin. It seems that all tested 
strains not only are intrinsically resistant to pancreatin, but also pancreatin helps 
them to recover strains from harsh conditions in the duodenum. 
Frece et al. (2005) investigated the functional role of surface layer proteins in 
Lb. acidophilus M92. It was demonstrated that surface layer proteins of Lb. 
acidophilus M92 were resistant to pepsin and pancreatin and they have a 
protective role for this strain, but they were sensitive to enzymatic treatments 
with proteinase K. 
In the study of Maragkoudakis et al. (2006), all tested Lactobacillus strains were 
resistant to pancreatin, and even after 4 h of exposure retained their viability 
with less than 1 log10 cycle reduction. 
As mentioned earlier, probiotic bacteria are mostly delivered by fermented milk 
products. Lactobacilli grown in fermented milks are protected by protein and fat 
matrices. Due to this encapsulation, they might survive the critical passage 
through the GIT, much better than unprotected bacteria. Also, the proteins of 
milk contain some peptide segments, which may be released during digestion 
(Maubois and Leonil 1989). Their degradation products can be involved in the 
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physiological regulation of digestion (Yvon et al. 1994). Caseinomacropeptide 
is one of these bioregulators, which is produced by initial pepsin hydrolysis of κ-
casein during milk digestion (Robitaille et al. 2012). It has a protective effect and 
improves the resistance of Lb. rhamnosus to acid stress. 
Tolerance of intestinal lactobacilli to acid and bile has been described as strain 
dependent (Vinderola and Reinheimer 2003). The intrinsic characteristics of the 
Lactobacillus strains can be improved by the protective action of carrier foods 
and by the presence of nutrients (Charalampopoulos et al. 2003). Different food 
ingredients such as inulin-type fructans (Donkor et al. 2007), whey protein 
concentrate (Kos et al. 2000; Akalin et al. 2007), malt, wheat, and barley extracts 
(Patel et al. 2004) and pectin (Nazzaro et al. 2012) could exert a protective effect 
against the pH changes and the enzymes secreted during the passage through 
the GIT.  
There are techniques to improve the survival of the lactobacilli, for example, 
when a microorganism is exposed to a stress such as cold, heat or acid 
beforehand, the surviving cells can better tolerate a subsequent unfavourable 
environment and adverse conditions of the GIT. This type of protection from one 
stress gained from prior exposure to another stress is named the cross-
protective stress response (Saarela et al. 2004; Cruz et al. 2009a). 
3.5 CONCLUSION 
All tested strains were able to meet the requirements for probiotic properties in 
terms of acid tolerance in the stomach and also showed high resistance to bile 
salts at strength corresponding to the concentrations in the small intestine. 
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During this study, the protective effect of pepsin, enhancing acid tolerance of 
Lactobacillus species was confirmed. 
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CHAPTER FOUR: IN VITRO ASSESSMENT OF 
LACTOBACILLUS SPP. FOR FUNCTIONAL 
PROPERTIES: BIOFILM FORMATION
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4.1 INTRODUCTION 
Adhesion and colonization ability of probiotic bacteria are important factors for 
enhancement of the epithelial barrier, immune modulation and pathogen 
exclusion (Perdigon et al. 2002; Kelly et al. 2005; Boekhorst et al. 2006). An 
intricate symbiotic interaction occurs between human intestinal flora and 
epithelial and immune cells of the GIT (Alander et al. 1999). The important role 
of the gut microbiota is to provide a primary defence line against pathogenic 
organisms and regulate the immune responses. The host supplies a secure and 
stable environment for the microbiota, including uniform temperature, pH, 
osmolarity and nutrient compounds. Part of the helpful activities of the gut 
microbiota is their capability to grow into microcolonies and biofilms (Perea et 
al. 2010). 
Biofilms are defined as surface-associated microbial populations embedded in 
self-produced extracellular polymeric matrixes, which reduce their vulnerability 
to the host immunity systems and antimicrobial compounds (Donlan 2002).  
It has been demonstrated that biofilms are involved in creating of an intimate 
relationship between the human GIT and its inhabitant microorganisms 
(Macfarlane and Dillon 2007).  
Tuomola et al. (1999) stated that attachment to epithelial cells, potential 
colonisation power and better contact with the mucosa are regarded as reasons 
for some beneficial effects of probiotics including modulation of the immune 
system and combating the pathogens. 
Two different growth modes are defined for bacteria. One is the single, free-
floating cell form known as planktonic cells, and the second is a structured, 
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multi-cellular consortium described as a biofilm. Compared to planktonic cells, 
bacteria growing in biofilms present new behaviours, such as more resistance 
to stress, biocides, and host immunological defences (Branda   et al. 2005; Kim 
et al. 2009). 
Teitzel et al. (2003) stated that Pseudomonas aeruginosa biofilms were 2 to 600 
times more resistant to heavy metal stress than the planktonic cells. 
It has also been stated that biofilm of Listeria monocytogenes improved its 
resistance to heat treatment and also surfactant sanitisers (Simoes et al. 2010). 
With regard to LAB, Kubota et al. (2008) demonstrated that the biofilms 
produced by Lb. plantarum, Lb. brevis and Lactobacillus fructivorans, could 
present greater protection to acetic acid and ethanol. They observed badly 
damaged surfaces of the treated planktonic cells with acetic acid and ethanol, 
but the surface of biofilm cells was only slightly damaged.  
The potential for some LAB to form biofilm has been reported, and also genes 
associated with adhesion or biofilm formation have been described. For 
example, Lebeer et al. (2007) studied the role of luxS in biofilm development of 
Lb. rhamnosus GG, and, the luxS gene has been detected in streptococci 
(Stroeher et al. 2003), Campylobacter spp. (Plummer, 2012) and also 
Staphylococcus spp. (Xu et al. 2006). The luxS is involved for the synthesis of 
the autoinducer type 2 (AI-2), which is needed in quorum sensing (Cvitkovitch 
et al. 2003). 
It is believed that biofilm formation in a synthetic medium comprises several 
stages (Figure 4.1) including: 
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 Movement of planktonic cells from the media toward the solid surface.
 Adsorption of cells at the surface (attachment is easier to coated and
hydrophobic surfaces).
 Production of cell–cell signalling molecules.
 Transfer of substrates to and within the biofilm and also enhance
substrate metabolism by the cells and transport of products out of the
biofilm. During this stage, cell growth, replication, and extra-cellular
polysaccharide (EPS) production take place.
 Biofilm disintegration by detachment of attached cells.
37Figure 4.1 Processes governing biofilm formation (Source: Breyers and Ratner 
(2004) cited in Simoes et al. 2010) 
4.1.1 Role of surface properties of the cell on adhesion  
Microbial attachments depend on cell surface hydrophobicity and the presence 
of extracellular filamentous appendages (Donlan 2002).  
Many types of bacteria have flagella, which are responsible for the motility 
of bacteria. A flagellum may create an adhesive bond with the adhesion 
surface. 
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Pili or fimbriae are fine, filamentous appendages, which are found on many 
Gram-negative bacteria. They are not involved in motility, but they also are able 
to make cells more adhesive to other bacterial cells and inorganic particles 
(Donlan 2002; Simoes et al. 2010).  
4.1.2 Extracellular polymeric substances (ECPS)  
Settled cells bind together (cohesion) and to a solid surface (adhesion) by 
ECPS. The main compositions of ECPS are polysaccharides and proteins, 
which account for 75–89%; however, nucleic acids, lipids, phospholipids, and 
humic substances are also involved in ECPS composition (Sutherland 2001; 
Tsuneda et al. 2003). 
4.1.3 Cell–cell communication 
The role of cell–cell signalling is important in bacterial attachment or detachment 
from biofilms (Donlan 2002; Daniels et al. 2004), and also where bacteria 
develop complex systems of interactions and communications to adapt to a new 
environment. For adaptation to a new situation, bacteria should sense and react 
to external changes and consequently modulate gene expression (Daniels et al. 
2004). The process of quorum sensing is considered as auto-induction, which 
provides an environmental sensing system and enables bacteria to respond to 
their population densities (Beck von Bodman and Farrand 1995). A diffusible 
organic signal is generated by cells known as the auto-inducer (AI) molecules 
and it accumulates in the environment during growth. As a result of 
accumulation of such molecules, cell densities increase and expression of 
certain genes is induced (Simoes et al. 2010). The physiological response of 
the cell to a chemical signal depends on concentration of the signal molecule. 
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The most important AI molecules, which are involved in communication of 
Gram-positive and Gram-negative bacteria, are oligopeptides and N-
acylhomoserine lactones (AHL), respectively. Also, boronated diester (AI-2) is 
the major molecule involved in communication among both Gram-positive and 
Gram-negative bacteria (Parsek and Greenberg 2005; Simoes et al. 2010). 
Quorum sensing systems are involved in some important microbial activities 
such as extracellular enzyme biosynthesis, biofilm development, antibiotic 
biosynthesis, biosurfactant production and ECPS synthesis (Beck von Bodman 
and Farrand 1995; Daniels et al. 2004; Fux et al. 2005). 
The composition of extracellular matrices in biofilms and the time for their 
formation are variable and the biofilm produced by different species are easily 
distinguishable (Simoes et al. 2010).  
The microbial communities in biofilms might be single or multiple species which 
are able to form biofilms on biotic and abiotic surfaces. Single species biofilms 
are formed in many infections, however, multiple species biofilms are found in 
most environments (O’Toole et al. 2000). 
Nutrient shortage might act as a particular environmental signal to initiate biofilm 
formation; however, environmental cues are different for bacteria. In most Gram 
negative bacteria, transition from planktonic cells to attached cells occurs when 
they are in nutrient rich medium. In the opposite case of nutrient shortage and 
in response to starvation, sessile cells turn to planktonic cells by detaching from 
the surface and searching for new sources of nutrients (Kolter et al. 1993). 
Biofilm of Pseudomonas aeruginosa and Pseudomonas fluorescens develop 
under good growth conditions. Escherichia coli O157:H7 is able to produce 
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biofilm in low nutrient conditions. However, Escherichia coli K-12 and Vibrio 
cholera cannot produce biofilm in minimal nutrient conditions unless amino 
acids are added to the medium (Dewanti and Wong 1995). 
The signal complexity for forming or not forming biofilm might be due to the 
presence of multiple genetics pathways in the microorganisms, which control 
those behaviours. 
Apart from nutritional signals, other environmental factors which might trigger 
biofilm development are pH, oxygen, temperature, osmolarity and iron (Lebeer 
et al. 2007).  
Applications of probiotic microorganisms, as a remedial approach to target 
pathogens on the mucosal surface, are quite popular. Therefore, it would be 
valuable to understand the mechanisms, which might influence biofilm formation 
by probiotic bacteria. It would also give an insight into how gut microflora is 
sustained.   
When grown under planktonic conditions many bacteria are sensitive to 
antimicrobials; however, biofilms are extremely hard to treat with antimicrobials. 
The mechanisms are not clear, but it is suggested that they may inactivate or 
prevent penetration of antimicrobials. Such capacity could lead to resistance of 
probiotics to antibiotics which, controversially, is considered encouraging when 
probiotics are given along with antibiotics for treatments of GIT infections. On 
the other hand, biofilms could increase the opportunity for gene transfer 
between/among bacteria. Hence, from this point of view, production of biofilm 
by probiotics would not be welcomed. The concern is that the illnesses caused 
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by the pathogens may become untreatable if the bacteria become antibiotic 
resistant (NIH 2002). 
The effects of gastrointestinal stresses (e.g. acid and bile), nutritional stress and 
also source of energy on the potential probiotic lactobacilli may be carried out 
for assessing biofilm formation. Therefore, this chapter was aimed at examining 
the potential of the isolates for in vitro biofilm formation.  
Invitro assessment of the isolates for biofilm formation on the different nutritional 
and environmental conditions, including: 
a) Different media (MRS, NA and TSB).
b) Different media concentration (1, 1/2 and 1/20).
c) Different bile salt concentration (0.3% and 1.5%).
d) pH = 4.0.
e) Presence of inulin.
4.2 MATERIALS AND METHODS 
4.2.1 Microorganisms 
The name bacteria detailed in Table 3.1 were used in biofilm assay. 
4.2.2 Media 
The basic medium used in this study was de Man, Rogosa and Sharpe broth 
(MRS) (CM0359, Oxoid, Basingstoke, UK). Four modified versions of MRS 
broth were prepared as described below: 
A) Acidified MRS: The final pH of MRS was adjusted to 4 by using 2 M HCl.
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B) MRS with added bile salt: MRS broth was supplemented with 0.3 and 
1.5% bile salt (B3883, Ox-bile, Sigma, Gillingham, UK). Bile salt was 
solubilized in water, and filter sterilized. Stock was added to autoclaved 
MRS broth.  
C) MRS with added inulin: MRS broth was made by mixing of its basal 
ingredients but inulin (20g/ml) (Orafti GR, Beneo, Tienen, Belgium) was 
added instead of dextrose, and modified medium was autoclaved.  
Tryptone Soya Broth (TSB) (CM0129, Oxoid, UK), Nutrient broth (NB) (CM0001, 
Oxoid, UK) and MRS broth, as well as, a diluted form of these media (1/2 and 
1/20 strength) was examined. Hence, nine variants of the three media (MRS 
broth, TSB, NB and their 1/2 and 1/20 dilutions) were prepared and autoclaved 
at 121°C for 25 min. Anaerobic incubation was carried out using an anaerobic 
incubator (80% N2, 10% CO2, and 10% H2; Don Whitley, Skipton, UK). 
4.2.3 Quantitative biofilm assay 
Quantification of biofilm formation was performed according to the method of 
Stepanovic et al. (2007).  
After two consecutive subcultures, a selection of single colonies on MRS plates 
were suspended in 1 ml of sterile MRD (this was used as a stock solution for 
preparing the final inocula). The working inoculum suspension was prepared by 
diluting the stock inoculum in 5 ml MRD in glass boiling tube and using a 
calibrated Sensititre nephelometer (Trek, Diagnostic Systems Ltd., East 
Grinstead, UK) to measure the turbidity. The final concentration of cells per tube 
was adjusted to 0.5 MacFarland standard (107-108 CFU/ml). Each medium (180 
μl) was dispensed into the wells of a sterile 96 well flat bottomed polystyrene 
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micro plate (Sero-Well, Birmingham, UK). The inoculum (20 μl) was added to 
each well containing 180 μl of the medium (a ratio of 1:10). The negative control 
wells contained just 200 μΙ broth. The micro plates were incubated anaerobically 
for 24, 48 and 72 h at 37 °C. At this stage the optical density (OD) was read as 
indicator of planktonic growth at 595 nm. Then the contents of the micro plates 
were poured out. Each well was washed three times with 200 μΙ of sterile 
phosphate buffered saline (PBS) at pH 7.2. After washing, the remaining 
attached bacteria were fixed by keeping the plates for an hour at 60 °C. The 
adherent biofilm layer in micro plates were stained with 200 μΙ per well of 0.1% 
v/v crystal violet solution (Sigma-Aldrich, Gillingham, UK) for 15-30 min at room 
temperature. Excess stain was rinsed off by placing the micro plate under 
running tap water. The micro plates were then air dried and the dye bound to 
the adherent cells was re-solubilised with 200 μΙ of bleaching solution 
(ethanol/acetone 80/20). The optical density of each well containing the 
bleaching solution was measured at 595 nm. Based on the OD obtained, the 
following categories were recognised: (a) non-biofilm producer, (b) weak biofilm 
producer, (c) medium biofilm producer and (d) strong biofilm producer. The cut-
off OD (ODc) was defined as three standard deviations above the mean OD of 
the negative control (un-inoculated medium).  
ODc: (Mean negative control OD595 + 3 SD) 
OD: Mean sample OD595 
Strains were therefore classified as follows:  
 OD ≤ ODc = non-biofilm producer 
 ODc < OD ≤ (2 x ODc) = weak biofilm producer 
 (2 x ODc) < OD ≤ (4 x ODc) = moderate biofilm producer and  
153 
 (4 x ODc) < OD = strong biofilm producer
All tests were carried out in triplicate and the results were averaged. 
4.3 RESULTS 
In this study the potential for 11 strains of Lactobacillus spp. to form biofilm was 
assessed by microtiter plate assay. Different media with normal and altered 
compositions were used and the potential for tested strains to grow in these 
media either in planktonic form or biofilm, were determined. 
4.3.1 Influence of normal growth medium on biofilm formation  
The general medium, MRS, was chosen as a nutritious laboratory medium that 
is frequently used for cultivation and enumeration of anaerobes. In this 
experiment, all tested strains were able to grow well (planktonic growth) in MRS 
broth after the incubation (Figure 4.2). 
According to Figure 4.3 and Table 4.1, apart from three isolates (Lb5, Lb8 and 
Lb9) no considerable biofilm formation was formed within 24 to 72 h incubation 
(p < 0.05). 
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OD: optical density  
Data are means ± SD of three replications (n=9) 
 
 
OD: optical density  
Data are means ± SD of three replications (n=9) 
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38Figure 4.2 Planktonic growth of Lactobacillus isolates (expressed as OD) in original 
MRS broth after 24, 48 and 72 h incubation at 37°C 
39Figure 4.3 Biofilm formation by Lactobacillus isolates (expressed as OD) in original 
MRS broth after 24, 48 and 72 h incubation at 37°C 
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4.3.2 Influence of growth medium adjusted to some gastrointestinal 
conditions on planktonic growth and biofilm formation. 
Some gastrointestinal conditions, such as low pH and presence of bile, were 
able to affect the suspension growth yield of the tested strains and accordingly, 
the biofilm formation was influenced as a consequence of these conditions.  
4.3.2.1 Low pH  
Changing pH in gastrointestinal environment is considered as one of the most 
important stressful conditions, which might endanger the viability of intestinal 
bacteria. To test the pH impact on biofilm formation, conditions that probiotic 
bacteria might face in transition through the GIT.  
In the MRS medium adjusted to pH 4, only few strains (Lb2, 4, 5, 8 and 11) were 
able to grow after 24, 48 and 72 h of incubation (Figure 4.4). However, the 
biofilm quantities formed by Lb5 and Lb9 were greater than moderate level 
(Figure 4.5 and Table 4.1). Other tested strains presented no or weak biofilm 
within 24 to 72 h of incubation. Table 4.1 summarises the extent of biofilm 
production by all isolates after 24, 48 and 72 h incubation. 
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OD: optical density  
Data are means ± SD of three replications (n=9) 
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Data are means ± SD of three replications (n=9) 
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40Figure 4.4 Planktonic growth of Lactobacillus isolates (expressed as OD) in 
reduced pH MRS (pH=4) broth after 24, 48 and 72 h incubation at 37°C 
41Figure 4.5 Biofilm formation by Lactobacillus isolates (expressed as OD) in 
reduced pH MRS (pH=4) broth after 24, 48 and 72 h incubation at 37°C 
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4.3.2.2 Presence of bile 
Bile acids are surface-active molecules, which show antimicrobial activities 
against enteric bacteria; however, several probiotic bacteria develop 
mechanisms to resist to bile. In the presence of 0.3% bile, apart from five strains 
(Lb1, Lb6, Lb7,Lb8, Lb9),  the planktonic growth of other strains was limited, but 
the majority of the tested isolates presented extensive biofilm formation during 
incubation shown in Figure 4.6 and 4.7 and Table 4.1. 
A higher concentration of bile salts (1.5% bile) reduced planktonic growth of 
some tested strains, but isolates Lb1, Lb3, Lb5, Lb6, Lb7 and Lb11 showed 
substantial biofilm formation, more than moderate levels, during different stages 
of incubation (Figure 4.8 and 4.9, Table 4.1).   
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OD: optical density  
Data are means ± SD of three replications (n=9) 
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42Figure 4.6 Planktonic growth of Lactobacillus isolates (expressed as OD) in MRS 
broth plus 0.3% bile after 24, 48 and 72 h incubation at 37°C 
43Figure 4.7 Biofilm formation by Lactobacillus isolates (expressed as OD) in MRS 
broth supplemented with 0.3% bile after 24, 48 and 72 h incubation at 37°C 
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44Figure 4.8 Planktonic growth of Lactobacillus isolates (expressed as OD) in MRS 
broth plus 1.5% bile after 24, 48 and 72 h incubation at 37°C 
45Figure 4.9 Biofilm formation by Lactobacillus isolates (expressed as OD) in MRS 
broth supplemented with 1.5% bile after 24, 48 and 72 h incubation at 37°C 
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4.3.2.3 Presence of inulin 
Prebiotics usually carry out their functions in the lower gastrointestinal 
environment. In the current experiment, the influence of inulin, a non-digestible 
complex carbohydrate, on potential formation biofilm was also studied. Glucose, 
the main carbon source for LAB was omitted from MRS medium and was 
replaced by inulin. The results showed that the planktonic growth of four strains 
was limited (Figure 4.10) and higher amounts of biofilm were observed only for 
Lb5 and Lb9 (Figure 4.11 and Table 4.1).   
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46Figure 4.10 Planktonic growth of Lactobacillus isolates (expressed as OD) in 
replaced sugar MRS broth (with inulin) after 24, 48 and 72 h incubation at 37°C 
47Figure 4.11 Biofilm formation by Lactobacillus isolates (expressed as OD) in 
replaced sugar MRS broth (with inulin) after 24, 48 and 72 h incubation at 37°C 
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5Table 4.1 Classification of the tested Lactobacillus for biofilm formation in different conditions 
- = No biofilm,    + = Weak biofilm,    ++ = Moderate biofilm,   +++ = Strong biofilm
Time MRS pH=4 0.3% Bile 1.5% Bile Inulin 
Lb1 24h - - - - - 
48h - ++ + +++ + 
72h - - - +++ - 
Lb2 24h - + - - + 
48h - + + + +++ 
72h + - - + ++ 
Lb3 24h ++ +++ +++ ++ ++ 
48h + + + - - 
72h + - ++ ++ + 
Lb4 24h + + - - - 
48h + ++ + + + 
72h ++ + - + + 
Lb5 24h ++ ++ ++ ++ ++ 
48h ++ +++ ++ + ++ 
72h +++ ++ ++ ++ ++ 
Lb6 24h ++ - ++ - - 
48h - - + +++ - 
72h + ++ + ++ + 
Lb7 24h ++ + ++ ++ ++ 
48h + - + +++ - 
72h + - + +++ + 
Lb8 24h ++ + + - + 
48h ++ + + + + 
72h ++ + + + + 
Lb9 24h - +++ ++ + ++ 
48h ++ +++ ++ +++ ++ 
72h ++ ++ ++ +++ ++ 
Lb10 24h + ++ + + + 
48h - - - - - 
72h - +++ - + - 
Lb11 24h ++ +++ +++ + ++ 
48h - - - - - 
72h - - ++ +++ +++ 
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4.3.3 Influence of growth media and dilutions on biofilm formation 
The results of Lactobacillus spp. growth in three different media (MRS broth, NB 
and TSB) and their dilutions revealed that all tested strains were able to grow 
well in MRS broth, but growth in NB and TSB was less than in MRS broth. 
Diluting the medium reduced the available nutrients, which significantly 
influenced the cell growth of tested microorganisms (result not shown). 
The results of biofilm formation on plastic surfaces by Lactobacillus spp. 
cultivated in different media and dilutions, thereof, revealed that almost all tested 
cultures produced biofilm in the original TSB medium. However, the quantities 
of biofilm produced by the different species varied. The nutrient content of the 
diluted medium influenced the quantity of biofilm produced by the tested isolates. 
Overall, TSB was the most effective medium in promoting biofilm production as 
three out of 11 tested strains were considered moderate biofilm producers in 
this medium (Table 4.2), followed by NB, in which eight out of 11 tested strains 
were considered biofilm producers. However, MRS was the least effective 
medium, in which as five of the tested isolates were not able to produce biofilm 
after 48 h. The results also illustrated that diluting MRS broth to 1/2 and 1/20 
strength resulted in no biofilm formation.  
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6Table 4.2 Classification of the tested Lactobacillus for biofilm formation in different nutritional conditions after 48 h 
Isolates MRS MRS(1/2) MRS(1/20) NB NB (1/2) NB (1/20) TSB TSB (1/2) TSB (1/20) 
Lb1 - - - + - + + + + 
Lb2 - - - ++ ++ + + ++ ++ 
Lb3 + - - + - + + - - 
Lb4 + - - - - + ++ ++ - 
Lb5 ++ - - + + + + ++ ++ 
Lb6 - - - - + - + + + 
LB7 + - - - + - + + + 
Lb8 ++ + - + + - ++ + + 
Lb9 ++ - - ++ + - + ++ ++ 
Lb10 - + - + - - ++ ++ + 
Lb11 - - - + + + + + + 
- = No biofilm  += Weak biofilm  ++= Moderate biofilm  +++ =Strong biofilm
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4.4 DISCUSSION 
Earlier research has indicated that biofilms are not just stacks of 
microorganisms with a slime matrix that bonds and safeguards them, instead 
they are a highly programmed and distinguished population with a greater 
capability to defy environmental stresses. However, there are very few studies, 
which elaborate on influences of different stresses on biofilm formation by 
probiotic cultures. This research focused on biofilm formation by Lactobacillus 
strains under different environmental and nutritional stresses for different 
incubation times. 
The GIT is an important target for probiotics and its environment could influence 
the probiotic characteristics. Consequently, the effects of some parameters 
related to the GIT and also the influence of nutritional stresses on biofilm 
formation capabilities of Lactobacillus probiotic strains, were studied, in vitro.  
The tested conditions including low pH (4.0), two concentrations of bile (0.3 and 
1.5%) and also presence of inulin modulated biofilm formation of tested 
Lactobacillus strains and it can be concluded that the effect of each factor 
depends on the strain.  
Numerous studies demonstrated that bile acids are able to increase adhesion 
and biofilm formation of enteric pathogens (Hung et al. 2006; Pumbwe et al. 
2007). The physiological concentrations of bile ranges from 0.1 to 2.0% in the 
human intestine (Hung et al. 2006). Therefore, it seems reasonable to assume 
that the observed biofilm formation of some tested Lactobacillus strains in the 
presence of bile is due to stimulation of aggregation of cells, or bile may greatly 
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affect the cell surface of the tested strains and thereby influence biofilm 
development. 
It has been stated that the presence of bile might be a signal for bacteria to form 
biofilms in the small intestine (Begley et al. 2005). However, the effect of bile 
does not appear to be dependent on its concentration, since the effect was 
similar when two different concentrations of bile (0.3 and 1.5%) were added to 
the medium. This might be due to good tolerance of bile by the tested isolates. 
The results obtained in this research are in line with those of Lebeer et al. (2007) 
who studied the influences of environmental stresses such as osmolarity, pH, 
oxygen and bile salts on biofilm production. They demonstrated that tested 
lactobacilli were able to form biofilms on abiotic surfaces. 
This study also demonstrated that depending on the enviromental conditions, 
some isolates are more readily to form biofilm on plastic surfaces than others. 
Biofilm formation by these bacteria was considerably affected by the growth 
medium composition. Media, such as NB and TSB, are not suitable for 
Lactobacillus spp. and they cannot grow well in these media. However, it was 
decided to include these media in order to study biofilm formation under 
suboptimal nutritional composition. Biofilm formation in TSB was greater than 
NB and MRS, and this might be related to the nutritional composition of the 
media. However, the potential for biofilm formation by most isolates was 
reduced as the medium became nutrient limited by dilution. 
Hood and Zottola (1997), who investigated biofilm formation by five different 
bacterial species, found that the medium, which induced the production of the 
highest quantities of biofilm, was different for each tested microorganism. They 
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showed that Listeria monocytogenes, in general, produced more biofilm in 
nutrient rich media than Salmonella enterica serovar Typhimurium which 
produced more biofilm in nutrient limited medium. However, the composition of 
the medium did not have the same extent of influence on all tested strains. 
Lebeer et al. (2007) stated that composition of media could influence biofilm 
formation. They assessed the role of Tween 80, as surfactant active detergent 
present in MRS broth, on inhibition of biofilm formation. They stated that the 
effect of Tween 80 was medium specific. 
This research found that the potential for tested strains to form biofilm in different 
media is strain dependent, as not all tested strains were able to produce 
considerable biofilm in different media. It is not possible to conclude which strain 
is the highest biofilm producer, as variations were observed according the tested 
isolate, the media used and the incubation time. 
In general, the tested strains produced more biofilm in nutrient rich medium. It 
seems that there is not a direct relationship between biofilm formation and 
growth of planktonic cells in the media. Nutrient shortages and low availability 
of fermentable carbon sources (in diluted media) or the substituting glucose with 
inulin, led to limited or no growth. However, nutrient limitation alone is not 
enough to induce biofilm formation. Nevertheless, such a reaction might be 
different among several strains of the same microorganism. Stepanovic et al. 
(2004) investigated biofilm formation by Salmonella spp. and L.monocytogenes 
strains on a plastic surface. They found that composition of the medium did not 
have the same extent of influence on all tested Salmonella spp. and L. 
monocytogenes strains. 
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Biofilm formation is a complex process regulated by diverse factors, including 
the growth medium (Donlan 2002), but is still poorly understood. One possible 
explanation for different responses of microorganisms to environmental 
conditions could be the results of mutations in genes that control biofilm 
formation (Romling et al. 1998). 
Planktonic growth rates did not correlate with biofilm formation after 24, 48 and 
72 h of incubation at 37°C, indicating that differences in biofilm formation were 
due to factors other than the ability to grow in MRS/modified MRS broth. 
Initiation, maturation, maintenance and dissolution are sequential steps in 
formation of biofilm matrix. In this study, biofilm formation was measured after 
24, 48, and 72 h of incubation. Within such large time intervals (24 h), numerous 
changes may occur, and the cells may encounter some stressful conditions. 
This might explain irregularities in some of the recorded values and lack of any 
recognisable trend. 
Therefore, further in vivo studies need to be carried out to examine the 
capabilities of Lactobacillus strains for biofilm formation in conditions mimicking 
different segments of the GIT, such as the small intestine and colon. 
4.5 CONCLUSION 
Tested isolates were able to produce biofilm in different media according to their 
nutritional/environmental stress.  The data show some differences among the 
tested isolates, which in turn could be interpreted as being different strains or 
more likely be a result of going through different processing conditions and 
exposed to various stress condition. This, however, needs further investigations. 
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CHAPTER FIVE: IN VITRO ASSESSMENT OF 
LACTOBACILLUS SPP. FOR FUNCTIONAL 
PROPERTIES: ANTIMICROBIAL ACTIVITIES 
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5.1 INTRODUCTION 
Extensive prescriptions of antibiotics not only have led to an increase in 
antibiotic-resistant bacteria, but are also associated with the disruption of the 
protective flora, resulting in the tendency to infections. Hence, the control of 
infections through a non-antibiotic approach is always needed. Bacterial 
replacement therapy using non-pathogenic bacteria from the natural flora may 
introduce a promising alternative (Forestier et al. 2001). The most widely studied 
probiotics are Lactobacillus strains, which contribute to counteracting the 
influence of different infections, such as antibiotic-associated diarrhoea, 
Helicobacter pylori gastroenteritis and urovaginal infections (Reid et al. 2003; 
Canani et al. 2007). Lactobacilli can act as microbial barriers against 
gastrointestinal pathogens through competitive exclusion of pathogen binding, 
modulation of the host’s immune system and production of inhibitory 
compounds (De Vuyst et al. 2004). Lactobacillus bacteria have been 
characterized as Gram-positive, non-sporeforming and non flagellated rods or 
cocci (Hammes and Vogel 1995), which have beneficial effects on the host by 
contributing to its intestinal microbial balance (Gomes and Malcata 1999).The 
distribution of lactobacilli is influenced by several environmental factors, 
including pH, oxygen availability, level of specific substrates, presence of 
secretions and bacterial interactions (Salminen et al. 1996). Some of the 
potential health benefits of probiotic lactobacilli are control of antibiotic colitis by 
acidity, microbial inhibition and prevention of pathogen adhesion or pathogen 
activation. In some intestinal disease, altered microflora, impaired gut barrier 
and different types of intestinal inflammation are present (Salminen et al. 1996), 
thereby effective application of lactobacilli is necessary not only for treatment 
171 
but also for prevention of such changes through the production of antimicrobial 
substances (Gomes and Malcata 1999). There are versatile possible 
mechanisms responsible for positive clinical responses. It has been reported 
that lactobacilli promote the immunologic and non-immunologic defense 
barriers in the gut. They produce inhibitory metabolites, such as organic acids 
(lactic, acetic and propionic acid) (Makras and De Vuyst 2006), oxygen 
catabolites, such as hydrogen peroxide (Falagas et al. 2007), di-acetyl (De 
Vuyst et al. 2004), carbon dioxide, proteinaceous compounds such as 
bacteriocins (Zacharof and Lovitt 2012), antifungal peptides/proteins, other 
metabolites, such as short-chain fatty acids (Carr et al. 2002), phenyl lactic acid, 
and hydroxy-phenyl lactic acid, deconjugated bile salts (Gibson and Wang 1994; 
Huttunen et al. 1995; Magnusson et al. 2003; De Vuyst et al. 2004).  
5.1.1 General antimicrobial properties 
Different studies have explained the role of lactobacilli in the prevention and 
treatment of gastrointestinal disorders and infectious diseases (Coconnier et al. 
2000), but little is known about lactobacilli underlying inhibitory mechanism 
toward adhesion/invasion action of pathogens. Two different hypotheses, which 
could explain these findings, are the production of antimicrobial substances and 
the competitive inhibition of entro-pathogen attachment to epithelial cells by 
lactobacilli (Santos et al. 2003). Ross et al. (2002) stated that the incorporation 
of bacteriocin-producing strains may have the disadvantage of the lack of 
compatibility with other starter cultures required for fermentation. 
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5.1.2 Antimicrobial substances produced by lactobacilli 
5.1.2.1 Organic acids 
Short-chain fatty acids, such as formic, acetic, propionic, butyric, and lactic 
acids, are produced during the anaerobic metabolism of carbohydrates and 
have an important role in decreasing pH (Gillor et al. 2008). It has been accepted 
that weak organic acids represent strong antibacterial activity (Ouwehand 1998; 
Alakomi et al. 2000).  
The effectiveness of the organic acids as antimicrobial agents is associated with 
the level of completely un-dissociated acid. Organic acids are more effective 
antimicrobial agents at lower pH because more undissociated acid is present 
when pH falls. The effectiveness of dissociated acids is lower because their 
hydro-phobicity is lower (Yang 2000). The undissociated acid, being lipophilic, 
can diffuse passively across the membrane (Kashket 1987). The un-dissociated 
acids collapse the electrochemical proton gradient or alter the cell membrane 
permeability, which leads to disruption of substrate transport systems 
(Earnshaw 1992).  
Organic acids, in particular acetic acid and lactic acid, have a strong inhibitory 
effect against Gram-negative bacteria (Makras and De Vuyst 2006). 
Lactobacillus species produce mainly lactic acid, resulting in reduced pH that 
may suppress pathogenic bacterial growth and proliferation (Spinler et al. 2008). 
The undissociated form of the organic acid enters the bacterial cell and 
dissociates inside the cytoplasm. Eventually, the decreasing of intracellular pH, 
accumulation of the ionized organic acid and collapsing in the electrochemical 
proton gradient have a bacteriostatic or bactericidal effect and result in the death 
of the pathogen (Kashket 1987; Russell and Diez-Gonzalez 1998). Lactic acid 
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is detected in low concentrations in the human colon, where it is produced as 
an intermediary product of carbohydrate fermentation (Topping and Clifton 
2001; Macfarlane and Macfarlane 2003; Duncan et al. 2004).  
Weak acids dissociate in the cytoplasm, resulting in the lowering of isoelectric 
pH and the accumulation of anions (Salmond et al. 1984). This anions 
accumulation can make an osmotic problem for the cell if it leads to an enhanced 
in turgor pressure of the cell (Roe et al. 1998). 
Some reports have suggested that the production of organic acids with 
concomitant lowering of the pH of the medium is the major factor in the activity 
of lactobacilli against Gram-negative bacteria (Ogawa et al. 2001; Fooks and 
Gibson 2002; Fayol-Messaoudi et al. 2005; De Keersmaecker et al. 2006) Acidic 
pH has been recognized as an important factor tending to limit the populations 
of certain gut pathogens (Diez-Gonzalez 2007). In the study of Makras et al. 
(2006) on antibacterial activity of probiotic lactobacilli towards Salmonella 
enterica serovar Typhimurium, all Lactobacillus tested followed a similar lactic 
acid production patterns. Moreover, Lb. johnsonii La1 produced succinic acid 
and phenyl lactic acid. Lactobacillus acidophilus IBB 801 produced high 
amounts of succinic acid in addition to phenyl lactic acid and hydroxy phenyl 
lactic acid. Organic acids, especially succinic, not only fulfill a barrier effect on 
pathogenic bacteria, but also play an important role in maintenance of the colon 
health (Cook and Sellin 1998). It has been indicated that inhibitory compounds 
such as aromatic and heterocyclic molecules e.g. mevalonolactone produced 
by Lb. plantarum E 76, are active against Gram-negative bacteria only at low 
pH values and in the presence of lactic acid (Niku-Paavola et al. 1999).  
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5.1.2.2 Bacteriocins 
Lactic acid bacteria (LAB) are a promising group of bacteriocin producing 
microorganisms due to their GRAS (Generally Recognised As Safe) status, 
which reveals their safe application in food (Nishie et al. 2012). Among the LAB, 
lactobacilli have gained particular attention, due to the production of bacteriocins 
(Zacharof and Lovitt 2012). Bacteriocins produced by lactobacilli are 
antibacterial proteinaceous compounds that exhibit antagonism mainly against 
closely related Gram-positive bacteria (De Vuyst and Vandamme 1994; Cotter 
et al. 2005). Bacteriocins are ribosomally synthesised, extracellularly released, 
low-molecular-mass peptides or proteins, which have a bactericidal or 
bacteriostatic influence on other bacteria, food-borne pathogen microorganisms 
and food spoilage bacteria (Klaenhammer 1988). The bacteriocin family 
includes a diversity of proteins in terms of size, mode of action, microbial target, 
release, and immunity mechanisms. They are sensitive to proteolytic enzymes 
such as proteinase K, pronase (Melancon and Grenier 2003). 
In a classification system, which is based primarily on the genetics and 
biochemistry of bacteriocins (Klaenhammer 1993), four classes of LAB 
bacteriocins have been described: Class I includes of modified bacteriocins, 
known as lantibiotics, such as nisin (Twomey et al. 2002); class II including heat 
stable, minimally modified bacteriocins, such as lactacin F (Eijsink et al. 2002; 
Drider et al. 2006); class III includes larger, heat-labile bacteriocins, such as 
helveticin J; and class IV encompasses complex bacteriocins carrying other 
elements, such as lipid or carbohydrate moieties (Heng et al. 2007).  
Most probiotic researches have focused on classes I and II (Gillor et al. 2008). 
Some of the bacteriocins namely; lactacin F, lactocin 705, lactoccin G and 
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plantaricin EF are the most important ones, which are produced by Lb. johnsonii, 
Lb. casei, Lactobacillus delbrueckii subsp. lactis and Lb. plantarum spp., 
respectively (Zacharof and Lovitt 2012).  
Some other lactobacilli used as starter cultures can produce many different 
bacteriocins. Lactobacillus helveticus produces helveticin J and lacticin LP27 
(Joerger and Klaenhammer 1986); Lb. casei produces caseicin 80 
(Rammelsberg et al. 1990); Lb. acidophilus produces lacticins B and F and 
acidocinJ1229 (Tahara and Kanatani 1996) and Lb. plantarum produces 
pediocin ACH (Ennahar et al. 1996). The cell target of these agents is the 
cytoplasmic membrane.  
It should be noted that determination of the cytotoxicity is a considerable factor 
in the characterisation of bacteriocins in order to recommend their application 
either as a food biopreservative or as an alternative to antibiotics in medical 
practice. 
5.1.2.3 Bacteriocin-like inhibitory substance  
In addition to bacteriocins, there are bacteriocin-like inhibitory substance (BLIS) 
with inhibitory activities against a wide range of Gram-positive and Gram-
negative bacteria (Batdorj et al. 2006; Cheikhyoussef et al. 2009). Bacteriocin 
like inhibitory substance is small cationic peptide, which are produced by gram-
positive bacteria (Chen and Hoover 2003). 
Bacteriocin-like peptides are different in molecular mass, antagonistic spectrum 
and heat resistance (He et al. 2006). Because molecular characterization of the 
compounds has not yet been done, they will be referred to as bacteriocin-like 
substances (Nemade and Musaddiq 2012). Bacteriocin like inhibitory substance 
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have molecular masses between 12 to 14 and 30 kDa (Melancon and Grenier 
2003), but bacteriocins molecular masses have been reported in the 30 to 50 
kDa range (Thompson et al. 1996; Van de Guchte et al. 2001). 
These peptide antibiotics are secondary metabolites, and insensitive to various 
proteolytic enzymes (Froyshov 1975). Some of the bacteriocin-like peptides are 
lichenin (Chang et al. 2001), bacillocin (Martirani et al. 2002) and coagulin 
(Hyronimus et al. 1998).  
In some studies, bacteriocin-like substances and other low molecular mass 
compounds with antifungal activity have been produced by Lb. pentosus and 
Lb. coryniformis (Magnusson et al. 2003). Other bacteriocin-like inhibitory 
substances with anti- H. pylori activity has been identified in probiotic Lb. 
johnsonii LA1 (Gotteland et al. 2008) and Lb. acidophilus LB (Coconnier et al. 
1998).  
Some theories have been proposed to explain the mechanism by which 
antimicrobial peptides kill bacteria. The antimicrobial activity of these peptides 
has been described as a carpet-like mechanism, where the antimicrobial 
peptides are proposed to bind to the surface of the membrane and cover it in a 
carpet-like manner and disturb its barrier function (Jensen et al. 1997; Papo et 
al. 2002).  
5.1.2.4 Other antimicrobial substances 
Common LAB metabolites including acetaldehyde, diacetyl, acetoin and 2, 3-
butanediol are active towards Gram-negative bacteria only at high 
concentrations (De Vuyst and Vandamme 1994). Some substances, such as 
phenyl lactic acid and hydroxy phenyl lactic acid, are produced by lactobacilli 
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(Valerio et al. 2004), and represent a wide antifungal spectrum in the 
concentration range of 100–400 μM (Lavermicocca et al. 2003). It is relevant to 
mention that phenyl lactic acid, in concentrations ranging from 20 to 80 mM, is 
also inhibitory towards Gram-positive bacteria, as well as against Gram-
negative bacteria (Dieuleveux et al. 1998). Lactobacillus casei, Lb. pentosus, 
Lb. coryniformis, Lb. sakei and Lb. curvatus have been reported to harbour 
antifungal activities. The production of antifungal proteinaceous substances by 
LAB isolated from Feta cheese has also been reported (Voulgari et al. 2010).  
Antifungal activities of LAB have been attributed to organic acids, cyclic peptides 
and bacteriocin-like substances (Lavermicocca et al. 2000; Magnusson et al. 
2003). High percentages of H2O2-producing lactobacilli from vaginal sources 
have been found by some researchers (Eschenbach et al. 1989; Song et al. 
1999). Peroxide-producing has been described as a strain-specific property 
(Annuk et al. 2003). On the other hand, H2O2 production has been associated 
with certain species like Lb. gasseri and Lb. crispatus (Song et al. 1999). 
Huttunen et al. (1995) studied production of antimicrobial substances by Lb. 
casei subsp. casei LC-10 and Lb. casei subsp. pseudoplantarum LB1931. In 
addition to lactic acid predominantly produced in the MRS broth, 2-pyrrolidone-
5-carboxylic acid (pyroglutamic acid) was formed and it was separated and 
found to contribute to antimicrobial activity of the noted lactobacilli. The present 
study aimed to assess the potential antagonistic activities of Lactobacillus spp. 
against pathogen organisms. The specific objectives were:  
a) Assessment of the isolates for production of inhibitory compounds in 
contact with three pathogen bacteria (spot test).  
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b) Determining the activity of metabolites obtained from tested Lactobacillus 
cultivated in broth medium. 
 
5.2 MATERIALS AND METHODS 
5.2.1 Media 
The following media were used: MRS, TSB and NA, all from Oxoid, UK were 
prepared as recommended by the manufacturer. 
5.2.2 Microorganisms 
The antimicrobial activities of six Lactobacillus spp., which were isolated from 
yogurt and other fermented milk products (Lb6 - Lb11), two commercial cultures 
of Lactobacillus spp. kindly provided by starter culture supplier, Chr. Hansen 
(Lb1 and Lb2) and three different type strains purchased from NCIMB (National 
Collection of Industrial Food and Marine Bacteria, UK) (Lb3, Lb4 and Lb5) were 
assessed (Table 3.1). 
The inhibitory properties of the isolates against the following three bacteria 
(indicator organisms), from Microbiology Research Unit (MRU) culture collection 
were investigated: 
 Salmonella enterica serovar Typhimurium DT124 
 Salmonella enterica serovar Enteritidis P125582  
 Escherichia coli NCIMB 555 
Further experiments were carried out by Lb. delbrueckii subsp. bulgaricus to 
assess any inhibition effects of tested bacteria against Gram-positive bacteria. 
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5.2.3 Screening lactobacilli isolates for antimicrobial activities 
5.2.3.1 Preparation of Lactobacillus spp. inoculum 
A suspension in MRD (final concentration of 107 CFU/ml) was made from 
overnight culture of isolates grown on MRS agar. For this purpose, after two 
consecutive subcultures of lactobacilli on MRS agar, a stock solution was 
prepared by suspending colonies in 1 ml of sterile MRD, then a few drops of this 
stock solution was added to 5 ml MRD until final concentration of cells reached 
to 0.5 MacFarland standard (107 CFU/ml) using a calibrated sensititre 
nephelometer (Trek, Dignostic Systems Ltd., East Grinstead, UK). This 
suspension was used as inoculum for further experiments, described in this 
chapter. 
5.2.3.2 Preparation of indicator organisms 
The active overnight culture of the indicator bacteria was prepared by growing 
each organism on NA. The harvested colonies were added to MRD solution and 
adjusted with 0.5 MacFarland standard to make a standard suspension (final 
concentration of ~107 CFU/ml) using a calibrated sensititre nephelometer (Trek, 
Diagnostic Systems Ltd., UK). 
5.2.3.3 Assessment of antimicrobial activity of isolates 
5.2.3.3.1 Conventional spot test 
The spot test recommended by Bernet et al. (1993) was used. An aliquot (2 µl) 
of active suspension of test bacteria was spotted on MRS agar, and plates were 
left for half an hour to dry at room temperature and then incubated at 37 °C for 
24 and 48 h under anaerobic condition. The grown colonies were overlaid with 
10 ml of soft TSB (containing 0.8% w/v agar) at 45 °C, which was seeded with 
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100 μl (final concentration of ca 107 CFU/ml) of the indicator organisms. The 
overlaid plates were incubated at 37 °C for another 24 h aerobically. 
5.2.3.3.2 Concurrent spot test 
For assessment of competition for nutrient between isolates and indicator 
bacteria, overlaying of isolates with indicator bacteria was carried out 
simultaneously. For this purpose, 2 µl of active microbial suspension was 
spotted on MRS plates, and then were immediately overlaid with 10 ml of soft 
TSB, which already was seeded with indicator bacteria and incubated for 24 and 
48 h at 37 °C. 
5.2.3.3.3 Buffered spot test 
In order to exclude the effect of acid on indicator organisms, a buffer was added 
to the medium to neutralize the produced acid in the medium. MRS containing 
2 g/l sodium bicarbonate was prepared for this purpose and spot test was 
carried out again using overlaying technique after 24 h incubation of isolates. 
5.2.3.3.4 Well diffusion assay 
The well diffusion method described by Toure et al. (2003) was used for 
examination of production of inhibitory substances in the culture medium.  
5.2.3.3.4.1 Well diffusion assay with un-buffered supernatant 
An overnight culture of isolates in MRS broth was centrifuged at 4 °C and 3000 
× g for 10 minutes and the supernatant was immediately used for well diffusion 
assay. In this method, 20 ml of TSB containing 0.8% w/v agar was inoculated 
with 200 μl of indicator bacteria at a final concentration of around 107 CFU/ml 
and poured into a sterile plate to solidify. Afterwards, three wells were excavated 
in the solidified agar using sterilized pipet tip and the wells were filled with 100 
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μl of filtered supernatant of the test organisms. All plates were kept 3-5 h in a 
fridge to allow diffusion of the supernatant (test organism) and then incubated 
at 37 °C for 24 h aerobically.   
It should be noted that inhibition activities by tested colonies or supernatant 
were considered to be represented by observation of a clear zone around wells. 
This was measured in mm. 
5.2.3.3.4.2 Well diffusion assay with concentrated, buffered/unbuffered 
supernatant 
An overnight culture of isolates in MRS broth was centrifuged at 4 °C and 3000 
× g for 10 minutes. The cell free supernatant was prepared by filtration of the 
supernatant through 0.2 µm syringe filter. 
The cell free supernatant with original pH of 4-4.4 was concentrated to 1/10 and 
1/20 of initial volumes by vaccum evaporation at 50 °C (Buchi, Switzerland). 
These concentrated supernatants were utilized in well diffusion assay. Also, in 
order to elucidate the mechanism of inhibition in the concentrated filtered 
supernatant the investigation was continued by neutralising the supernatant to 
pH 7 using 2 M NaOH. The aim was to exclude any inhibitory effect from organic 
acids. All plates were kept 3-5 h in a fridge and then incubated at 37 °C for 24 h 
aerobically.   
5.2.3.3.4.3 Sensitivity of produced inhibitory compounds to heat, 
proteolytic enzymes and catalase, where the inhibition was observed even 
after neutralisation 
The supernatant was tested for heat stability (100 °C for 5 min) using heating 
block (Techne, Stone, UK) and  treated with proteinase K, pronase E (both from 
Sigma), each at a final concentration of 0.1 mg/ml according to Karaoglu et al. 
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(2002). The samples with proteases were incubated at 30 °C for 1 h and residual 
activity was determined.  
In order to examine whether the inhibition is a result of H2O2 production by the 
isolate, 20 µl of catalase enzyme at a final concentration of 1 mg/ml was added 
into 180 µl of supernatant. One well having no catalase enzyme was used as 
the control. The presence or absence of an inhibition zone around wells was 
determined to be the effect of H2O2. 
 
5.3 RESULTS  
5.3.1 Spot test 
All 11 isolates were studied for their antimicrobial potential against three 
indicator bacteria using the spot test. In this test, all isolates were first spotted 
on the appropriate medium and then either straightaway (concurrent 
overlaying), or after 24 and 48 h, overlaid with soft TSA agar seeded with 
indicator microorganisms. The reason for doing so was to examine whether the 
potential inhibition was the result of competition of probiotics with indicator 
organisms for nutrients or space (concurrent over laying) or because of the 
production of inhibitory metabolites by probiotic organism. 
As Table 5.1 illustrates all isolates showed clear inhibition zone with overlaying 
after 24 and 48 h and, therefore, were able to inhibit all three used indicator 
bacteria. Interestingly, inhibition effect of all strains was considerably higher 
after 48 h of incubation. However, the spot test with concurrent overlaying did 
not result in inhibition zone for any of the tested isolates (results not shown). 
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7Table 5.1 Antibacterial activity of Lactobacillus isolates (Lb6-Lb11), commercial    
cultures (Lb1-Lb2) and type strains (Lb3-Lb5) against indicator bacteria using spot  
test. 
 
 
 
 
 
 
Microorganisms 
Indicator strains 
MRS agar 
 
 
Salmonella 
enterica serovar 
Typhimurium 
DT124 
 
 
Salmonella 
enterica serovar 
Enteritidis P125582  
 
 
 
Escherichia coli 
NCIMB 
555            
24h 
 
48h 24h 48h 24h 48h 
Lb1 
 
++ +++ ++ +++ ++ +++ 
Lb2 
 
+++ +++ ++ +++ ++ +++ 
Lb3 
 
++ +++ ++ +++ ++ ++ 
Lb4 
 
++ +++ ++ +++ ++ +++ 
Lb5 
 
++ +++ ++ +++ ++ +++ 
Lb6 
 
++ ++ ++ ++ + ++ 
Lb7 
 
++ +++ ++ ++ ++ ++ 
Lb8 
 
+++ +++ ++ +++ ++ +++ 
Lb9 
 
++ +++ ++ +++ ++ +++ 
Lb10 
 
+ +++ + ++ + +++ 
Lb11 
 
++ +++ ++ +++ ++ +++ 
The different scores represent different degrees of growth inhibition expressed in mm 
(-)           no inhibition 
(+)          zone of inhibition <10 mm 
(++)        zone of inhibition between 10-20 mm 
(+++)      zone of inhibition >20 mm 
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The antibacterial activity of all isolates against three indicator bacteria was 
further examined to elucidate the mechanism (s) involved.  
As Table 5.2 shows, when medium was buffered by 0.2% w/v sodium 
bicarbonate, antagonistic property of two strains (Lb3 and Lb10) disappeared 
after 24 h. After a longer incubation time (48 h), Lb3 showed some inhibitory 
effect, but no inhibition was seen for Lb10. All other tested strains displayed a 
clear inhibition zone, which were far less than that of the un-buffered medium.  
  
48Figure 5.1 Inhibition zone produced by Lactobacillus spp. against 
Salmonella enterica serovar Enteritidis using spot test 
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81Table 5.2 Antibacterial activity of Lactobacillus isolates (Lb6-Lb11), commercial 
cultures (Lb1-Lb2) and type strains (Lb3-Lb5) against indicator bacteria using the 
medium buffered with sodium bicarbonate in spot test 
 
 
 
 
 
 
 
 
Microorganisms 
Indicator strains 
 
 
Buffered MRS agar 
 
 
 
Salmonella 
enterica serovar 
Typhimurium 
DT124 
 
 
Salmonella 
 enterica serovar 
Enteritidis P125582  
 
 
Escherichia coli 
NCIMB 555 
24h 
 
48h 24h 48h 24h 48h 
Lb1 + 
 
++ + ++ + ++ 
Lb2 + 
 
++ + ++ + ++ 
Lb3 - 
 
+ - + - + 
Lb4 + 
 
+++ + ++ + ++ 
Lb5 + 
 
++ + + + + 
Lb6 + 
 
+ + + + + 
Lb7 + 
 
++ + ++ + ++ 
Lb8 + 
 
+++ + ++ + ++ 
Lb9 + 
 
++ + ++ + ++ 
Lb10 - 
 
- - - - - 
Lb11 + 
 
+++ + ++ + ++ 
The different scores represent different degrees of growth inhibition expressed in mm 
(-)           no inhibition 
(+)          zone of inhibition <10 mm 
(++)        zone of inhibition between 10-20 mm 
(+++)      zone of inhibition >20 mm 
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5.3.2 Well diffusion test 
Further studies of antimicrobial activity were accomplished by examining the 
mechanism (s) involved in antimicrobial activity. The isolates were screened by 
the well diffusion method for monitoring the likely production of antimicrobial 
compound(s) in broth media. In this method, when the filtered supernatants (cell 
free) of isolates were delivered into the wells, no detectable inhibition zone was 
seen for any of the isolates (Table 5.3).  
Since none of the cell free supernatants was able to show any antagonistic 
activity against indicator bacteria (neither un-buffered nor buffered cell free 
supernatant), it was thought that it could be because of low concentration of 
antibacterial compounds in the filtered supernatant. Therefore, the cell free 
supernatant was concentrated to1/10 and 1/20 of initial volumes.  
As can be seen in Table 5.3, unbuffered concentrated supernatant showed 
inhibition zone against indicator bacteria; however, the inhibition strength of the 
isolates were not consistent amongst tested isolates as they presented larger 
clear inhibition zone against S. enterica serovar Typhimurium DT124.  
 
 
 
187 
 
9Table 5.3 Antibacterial activity of cell free concentrated supernatant (1/10 and 1/20) 
against indicator bacteria using the well diffusion method 
 
 
 
Salmonella enterica 
serovar Typhimurium 
DT124 
Salmonella enterica 
serovar Enteritidis 
P125582 
 
Escherichia coli NCIMB 
555 
NC 1/10 1/20 
 
NC 1/10 1/20 NC 1/10 1/20 
U B U B B 
 
U B U B B U B U B B 
Lb1 - - +++ +P ++P 
 
- - ++ ++P ++P - - ++ - - 
Lb2 - - +++ +P +P 
 
- - ++ - - - - ++ +P +P 
Lb3 - - +++ ++P ++P 
 
- - ++ +P +P - - ++ +P +P 
Lb4 - - +++ +P +P 
 
- - +++ - - - - ++ +P +P 
Lb5 - - +++ +P ++P 
 
- - +++ - - - - ++ +P +P 
Lb6 - - +++ +P +P 
 
- - ++ - - - - ++ +P +P 
Lb7 - - ++ ++P ++P 
 
- - ++ - - - - + +P +P 
Lb8 - - +++ +P +P 
 
- - +++ - - - - +++ - +P 
Lb9 - - +++ +P ++P 
 
- - +++ - - - - ++ - - 
Lb10 - - +++ +P ++P 
 
- - ++ - - - - ++ - - 
Lb11 - - +++ +P +P 
 
- - ++ - - - - ++ - - 
The different scores represent different degrees of growth inhibition expressed in mm 
(-)        no inhibition 
(+)       zone of inhibition <10 mm 
(++)     zone of inhibition between 10-20 mm 
(+++)   zone of inhibition >20 mm 
NC      not concentrated (original) 
U         un-buffered 
B          buffered 
P          Partial 
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Also, when concentrated filtered supernatant (1/10 and 1/20) was buffered by 
neutralising to pH 7, opaque (not clear) inhibition zone was detected around the 
wells of all tested strains against S. enterica serovar Typhimurium DT124 (it was 
interpreted as partial inhibition). However, the antimicrobial effects of buffered 
concentrated filtered supernatant were reduced or disappeared against S. 
enterica serovar Enteritidis P125582 and E. coli NCIMB 555. 
The antagonistic activity exhibited by different Lactobacillus strains was further 
evaluated against a Gram positive bacterium, Lb. delbrueckii subsp. bulgaricus 
11778. When the neutralized supernatants of tested strains were concentrated 
to 1/20 of the original volume they all produced inhibition zones (Table 5.4).  
The inhibitory action of concentrated buffered supernatants of the tested strains 
did not disappear by heating at 100 °C for 5 min (except for Lb2, Lb4 and Lb8). 
49Figure 5.2 Inhibition zone produced by Lactobacillus spp. against 
Salmonella enterica serovar Typhimurium DT124 using well 
diffusion test 
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However, the treatment of concentrated buffered supernatants by pronase-E 
and proteinase-K at final concentration of 1 mg/ml resulted in complete 
elimination of their inhibitory potency except for Lb5, Lb6 and Lb10. 
 
10Table 5.4 Antibacterial activity of cell free concentrated supernatant (20 fold) 
against Lb. bulgaricus using the well diffusion method 
 
 
 
Lactobacillus delbrueckii subsp. bulgaricus 11778 
 20 fold(1/20) 
 
UB B BH Catalase BP BPN 
Lb1 ++ ++ ++ ++ - - 
Lb2 ++ +P - ++ - - 
Lb3 ++ ++ ++ +++ - - 
Lb4 ++ + - ++ - - 
Lb5 + + + ++ + + 
Lb6 ++ + + ++ +P +P 
Lb7 ++ + + ++ - - 
Lb8 ++ + - ++ - - 
Lb9 + +P +P ++ - - 
Lb10 ++ ++ + ++ ++ ++ 
Lb11 ++ + + ++ - - 
The different scores represent different degrees of growth inhibition expressed in mm 
(-)        no inhibition 
(+)       zone of inhibition <10 mm 
(++)     zone of inhibition between 10-20 mm 
UB       un-buffered 
B         buffered 
BH      heated-buffered 
BP      Buffered + Protease 
BPN    Buffered + Proteinase 
 
 
 
5.4 Discussion 
Several studies have undertaken about the potential of lactobacilli to produce 
antimicrobial compounds, but still the antimicrobial effects of lactobacilli have 
not been characterized to a great extent and the antagonistic property of 
lactobacilli has not been described in as much detail. 
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Therefore, this study was conducted to assess Lactobacillus isolates 
capabilities for producing antimicrobial compounds. 
Antimicrobial production is a strain-dependent property (Annuk et al. 2003). As 
mentioned earlier the production of organic acids and lowering of the pH of the 
medium is the main factor in the activity of lactobacilli against Gram-negative 
bacteria (Ogawa et al. 2001; Fooks and Gibson 2002; Fayol-Messaoudi et al. 
2005; De Keersmaecker et al. 2006). 
Niku-Paavola et al. (1999) categorised these biological compounds into two 
groups: (a) non proteinaceous low molecular mass compounds (<1000 Dalton), 
and (b) proteinaceous compounds with high molecular mass (>1000 Dalton). In 
this study, apart from organic acids, all tested strains appeared to produce 
unknown antimicrobial compounds against indicator bacteria. The antibacterial 
compounds produced by tested strains against Lb. delbrueckii subsp. 
bulgaricus, were heat-stable proteinaceous, and lost their activities in presence 
of proteinase K and pronase E (except Lb5, Lb6 and Lb10). This indicates that 
the nature of antimicrobial substances produced by tested strains vary and 
depends on the bacteria that compete with Lactobacillus spp. 
In this study, all tested Lactobacillus spp. showed a good degree of antimicrobial 
activity against three different indicator organisms using the spot test. Such 
activity was more noticeable after 48 h of incubation, which may indicate that 
higher concentration of metabolites, were accumulated through the time.  
Neutralisation of MRS with sodium bicarbonate, in spot test, diminished 
antimicrobial activity of all tested isolates, where inhibition zone was observed 
around the isolates but to a much lesser degree compared to contol (MRS with 
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original pH). It indicates that production of organic acids might be considered as 
the main inhibition substances.  
Neutralisation of MRS agar in the spot test provides a localised and ongoing 
neutralisation. In other words, the acids produced by Lactobacillus isolates are 
neutralised as they are produced and, as a result, no reduction in pH occurs. 
Zhang et al. (2011) stated that the nature of antimicrobial substances are 
dependent on the production of organic acids, in particular the lactic acid, while 
bacteriocins are not involved in the antimicrobial activity of the lactobacilli. Also, 
they concluded that Lb. johnsonii F0421 was unable to produce antibacterial 
substances other than organic acids, but it has a great potential as a 
gastrointestinal probiotic. 
Apart from lactic acid, some of the Lactobacillus strains have different organic 
acid production patterns. Lactobacillus johnsonii La1 and Lb. acidophilus IBB 
801 can produce succinic acid, phenyl lactic acid, and hydroxy phenyl lactic acid 
(Makras et al. 2006). 
In some studies it has been hypothesized that bacteriocin is not produced by 
Lactobacillus spp. In a study conducted by Huttunen et al. (1995), Lb. casei 
subsp. casei LC-10 and Lb. casei subsp. pseudoplantarum LB1931 did not 
produce bacteriocin. In addition of lactic acid, which is predominantly produced 
by these strains, 2-pyrrolidone-5-carboxylic acid (pyroglutamic acid) was formed 
and contributed to the antimicrobial activity against Bacillus subtilis 1205, B. 
subtilis MCM-I, E. cloacae 1575 and Pseudomonas putida 1560-2. 
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As previously mentioned, production of short-chain fatty acids has been 
considered to be the main factor allowing LAB to dominate mucosal 
ecosystems, but other reports suggest that H2O2 production by Lactobacillus 
spp. may be more relevant than acid production (Aslim and Kilic 2006; 
Kaewsrichan et al. 2006). However, addition of catalase to the supernatant in 
our research did confirm lack of H2O2 production and therefore resulted in the 
inhibition effect of Lactobacillus strains via the hydrogen peroxide mechanism. 
Other compounds may also contribute towards antimicrobial activity. It has been 
indicated that aromatic and hetero-cyclic molecules, including mevalonolactone, 
benzoic acid, methyl hydantoin produced by Lb. plantarum E 76, are active 
against Gram-negative bacteria only at low pH values and in the presence of 
lactic acid (Niku-Paavola et al. 1999).  
This study found that unconcentrated culture supernatants of all tested strains 
did not exhibit inhibitory or suppressive activity against indicator bacteria when 
tested by the well diffusion method. The inability to detect suppression by well 
diffusion does not necessarily imply the absence of suppressive activity, but 
might be due to a lower concentration of such antimicrobial compounds. 
Confirming this hypothesis the antibacterial activity of tested strains was 
amplified (noticeable only) after concentrating their filtered supernatant.  
According to Toure et al. (2003) study, the failure of unconcentrated supernatant 
to inhibit the same target strain as in the spot test might be due to absence of 
cell-to-cell interaction between test and indicator bacteria. The presence of 
Lactobaillus spp. along with indicator bacteria in the same medium might induce 
the production of antimicrobial compounds. 
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In this research, production of organic acid besides other unknown substances 
was detected to suppress the growth of indicator bacteria, as when media in 
spot test or supernatant in well diffusion was buffered by NaOH, this property 
was reduced or even disappeared in some of tested strains. 
Formic, acetic, propionic, butyric, and lactic acids are the main short-chain fatty 
acids which decrease the pH (Gillor et al. 2008). Among these organic acids the 
suppressive effect on pathogenic bacterial growth due to the reduced pH is 
mainly related to the lactic acid (Spinler et al. 2008). Lactic acid acts as a 
permeabilizer of the outer membrane of Gram-negative pathogens, allowing 
other antimicrobial compounds to penetrate the bacteria and thus may trigger 
the antibacterial activity of other inhibitory substances (Alakomi et al. 2000). The 
suppressive effects of unbuffered concentrated supernatant disappeared when 
they were buffered in this study. It is believed that the activity of some 
bacteriocin-like inhibitory substances (BLIS) is pH dependent and that some 
BLIS could maintain their activities at very low pH (e.g. 2-6), but not at pH higher 
than 8 (Zouhir et al. 2011). This could explain why the buffered supernatant lost 
their antimicrobial activity. 
Makras et al. (2006) distinguished between the influence of lactic acid and other 
inhibitory compounds produced through investigation of production kinetics of 
antibacterial activity and applying the appropriate acid and pH control samples. 
They concluded that the antimicrobial activity of Lb. acidophilus IBB 801, 
Lactobacillus amylovorus DCE 471, Lb. casei subsp. casei Shirota and Lb. 
rhamnosus GG was solely due to the production of lactic acid, while the 
antibacterial activity of Lb. johnsonii La1 and Lb. plantarum ACA-DC 287 was 
due to the production of lactic acid and unknown inhibitory substances.  
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5.5 CONCLUSION  
Our research reported various unknown inhibitory substances and variable 
mechanisms by which Lactobacillus strains can inhibit both Gram-positive and 
Gram-negative bacteria. It is more likely that the inhibition of indicator organisms 
by tested strains is the result of the combined effect of organic acids and 
bacteriocin. However, no further characterisation of these compounds was 
carried out and such presumption needs further investigation. The use of 
Lactobacillus strains capable of challenging with pathogenic bacteria, provide a 
useful alternative for inhibiting intestinal pathogens and also improving the 
intestinal flora ecosystem, especially with the current increase in antibiotic 
resistance among pathogens. Further characterisation of the inhibitory 
substances produced by isolated strains and their effects on intestinal flora is 
necessary in future studies. 
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CHAPTER SIX: IN VITRO ASSESSMENT OF 
LACTOBACILLUS SPP. FOR FUNCTIONAL 
PROPERTIES: PRODUCTION OF CONJUGATED 
LINOLEIC ACID
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6.1 INTRODUCTION 
Conjugated linoleic acid (CLA) contains a heterogeneous group of positional 
and geometric isomers of linoleic acid (LA) (C18:2). Conjugated linoleic acid is 
considered as an intermediate product, which is formed by bacteria. Therefore, 
ruminant meat and also dairy products contain a mixture of CLA isomers. 
Various isomers of CLA have different structure and present more than one 
biochemical mechanism in their specific effects (Sieber et al. 2004). The 
biological activities of CLA mainly are attributed mainly to the presence of cis9- 
trans11 CLA (known as rumenic acid) and trans10- cis12 CLA. Among all 
different CLA isomers which have been identified in natural foods, 
predominantly in ruminant meat and dairy products, 75%–90% is accounted to 
cis9- trans11 CLA (Kelley et al. 2007). 
The positive benefits of CLA have been weIldocumented. Some important 
health-promoting properties, such as antiatherosclerotic, anticarcinogenic, 
antiadipogenic, immunoenhancing, antioxidative, hypotensive, and anti-
inflammatory effects, are attributed to CLA (Nagao and Yanagita 2005; 
Bhattacharya et al. 2006; Kelley et al. 2007; Benjamin and Spener 2009). 
6.1.1 Structure of CLA 
Conjugated linoleic acid structure contains 18 carbon chains, which are 
connected to a carboxyl group at the end, and conjugated double bonds present 
along this chain (Figure 6.1). Double bonds in CLA isomers are adjacent to each 
other (i.e. –C=C-C=C–). Due to several possible locations for double bonds (C7 
and C9; C8 and C10; C9 and C11; C10 and C12; C11 and C13 or C12 and C14) 
and also cis or trans configuration, which depends on whether they are located 
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on the same side or the opposite sides of the double bond, respectively, a wide 
variety of CLA isomers could be generated (Jang et al. 2005).  Twenty eight 
possible positional and geometrical isomers of CLA were reported by Liu et al. 
(2011). However, it does not necessarily mean that all CLA isomers occur in 
significant amount. 
 
 
 
6.1.2 Sources of CLA 
6.1.2.1 Ruminant 
Compared to non-ruminant animals, ruminant’s products (meat and milk) 
contain higher levels of CLA, and such a difference is solely the result of LA 
biohydrogenation in the rumen (Coakley et al. 2003). The main dietary sources 
of CLA for human consumption are ruminant fats and dairy products. Butyrivibrio 
fibrisolvens plays an important role in the conversion by biohydrogenization of 
LA to CLA, which naturally takes place in rumen such as cows. It is interesting 
50Figure 6.1 Structures of linoleic acid (typical n-6 polyunsaturated fatty acid) (1), 
cis9- trans11 octadecadienoic acid (in fact an n-7 fatty acid) (2) and trans10-cis12 
octadecadienoic acid (3) (Source: Benjamin and Spener 2009). 
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to know that the concentration of CLA in some dairy products are even more 
than the fat and meat of ruminants (Table 6.1). 
 
11Table 6.1 The mean positional /geometric isomer composition (% of total isomers) 
and the CLA content of milk, butter, cheese, and beef fat (Source: Khanal, 2004). 
CLA isomer Milk Butter Cheese Beef 
cis, trans- isomers     
7,9 5.5 6.7 3.6 7.0 
8,10 1.5 0.3 1.0 2.6 
9,11 72.6        76.5        83.5 72.0 
10,12 0.4 1.1 - 2.6 
11,13 7.0 0.4 4.7 1.1 
12,14 0.7 0.8 0.4 0.7 
Total cis, trans  87.7        85.8        93.2 86.0 
 
trans, trans 
isomers 
    
6,8 - - 0.1 0.7 
7,9 2.4 - 0.6 1.5 
8,10 0.4 - 0.3 0.7 
9,11 2.0 - 1.5 3.7 
10,12 0.6 - 0.5 1.9 
11,13 4.2 - 2.3 1.9 
12,14 2.8 - 0.9 1.9 
13,15 - - 0.1 - 
Total trans, trans 12.3 9.4 6.3 12.3 
 
cis, cis isomers  
    
8,10 - - 0.1 - 
9,11 - - 0.3 - 
10,12 - - 0.3 - 
11,13 - - 0.3 - 
Total cis, cis  - 4.8 0.7 - 
 
Total CLA (% of fat) 
 
- 
 
0.5 
 
0.93 
 
0.27 
 
It has been stated that CLA content in milk depends on cattle feed pattern (fresh 
pasture versus regular corn diet), the presence of poly unsaturated fatty acids 
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(PUFA) in their diet, breed of cow and also season. As a result for example, the 
CLA content of milk is considerably higher in May, June and July (Sieber et al. 
2004; Nieuwenhove et al. 2007). 
CLA formation in ruminants (meat and milk) occurs by transformation of LA by 
anaerobic ruminal bacteria and also by conversion of vaccenic acid in the 
mammary gland.  
Butyrivibrio fibrisolvens, a strict anaerobic bacterium, found in human faeces 
and in rumen fluid of sheep (Sieber et al. 2004), is able to hydrogenate the PUFA 
in consumed food. It has been reported that the biohydrogenation of LA to 
stearic or oleic acids in rumen includes several steps (Kepler et al. 1966). At the 
first step of bioconversion, in presence of LA isomerise enzyme, cis9-trans11 
CLA are formed. In the next step, by the partial hydrogenation of cis9-trans11 
CLA, trans-vaccenic acid (trans11 C18:1) is produced and finally this substrate 
is reduced to stearic acid at the last step (Figure 6.2). Conjugated linoleic acid 
may also be produced from the vaccenic acid (trans11 -C18:1) by the action of 
Δ9-desaturase in the mammary gland (Parodi 1994).  
The toxicity of CLA to rumen bacteria is less than LA, and the toxicity of 
saturated fatty acids is much less than polyunsaturated fatty acids; therefore, 
biohydrogenation is a detoxification activity to reduce the harmful effect of free 
fatty acids (Jenkins and Courtney 2003). 
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6.1.2.2 Non-ruminant 
A variety of animal and plant derived foods contain CLA. According to the nature 
of product, the amount and distribution of CLA isomers may vary.  
Meat from non-ruminal animals such as pigs contains low quantities CLA which 
might originate from their feed that contain CLA (Fritsche et al. 1999). 
Conjugated linoleic acid was reported in turkey meat which contains 2.5 mg/g 
fat. This amount of CLA is significant compared with other non-ruminant animal 
meat (Jang et al. 2005). The content of CLA in egg yolk is minimal. Some plant 
oils such as olive, sunflower and canola contain small amount of CLA. 
Vegetable oils and partially hydrogenated oils such as shortenings and 
margarines are considered as main sources of trans10- cis12 CLA (Sieber et al. 
2004). 
51Figure 6.2 Metabolic pathways involved in the biosynthesis of rumenic acid in 
ruminants (Source: Chardigny et al. 2005). 
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6.1.2.3 Chemical isomerisation 
Chemical isomerisation is a commercial technique for production of cis9- 
trans11 and trans10- cis12 CLA from LA, but they are not pure and are 
contaminated with different other isomers and toxic materials. Therefore, such 
synthesized CLAs are not reliable and recommendable (Pariza et al. 2001). 
6.1.3 CLA in dairy products 
Conjugated linoleic acids are extensively found in numerous foods, mainly in 
dairy products and meat from ruminants.  
Shantha et al. (1995) reported 5.25 mg CLA/g fat in yogurt with 0.05% fat 
compared to 4.4 mg CLA/g fat in the skim milk before fermentation. However, 
others reported no significant difference between CLA content of milk and its 
fermented products (Boylston and Beitz 2002). 
Lactic acid bacteria (LAB) and propionibacteria are the main starter cultures 
used for producing Emmental cheese. Some strains of propionibacteria show 
good potential for formation of CLA from free LA. Therefore, an increased level 
of CLA is expected in this Swiss cheese (Sieber et al. 2004). As a consequence 
of lipolytic strain activities during cheese ripening, LA is released continuously 
and could then be converted to CLA. 
6.1.4 Health benefits 
Several animal models and cell culture studies reported that a daily CLA 
consumption delivers positive effects on health. Some of their potential 
beneficial effects are discussed below.   
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6.1.4.1 Anti-obesity 
Animal studies showed that CLA improve feed efficiency and induce greater 
growth rate. Conjugated linoleic acid changes body composition, reduces whole 
body fat and significantly increases body protein and ash (Khanal 2004). 
Conjugated linoleic acid might also increase lipolysis and energy expenditure 
and decrease lipogenesis (Salas-Salvado et al. 2006). Trans10- cis12 CLA is 
responsible for lipid metabolism (Sieber et al. 2004). 
6.1.4.2 Anti carcinogenesis 
Conjugated linoleic acid may suppress cancer by inhibiting the growth and 
spread of tumours. It has been claimed that the action of CLA to inhibit the 
tumours is fast. However, anticarcinogenic activities of CLA are quite complex. 
It is also reported that cell transformation through signal transduction might be 
inhibited by CLA (Benjamin and Spener 2009). Conjugated linoleic acid also 
presents antioxidant properties and quenches free radicals. The mixture of both 
isomers (cis9- trans11 and trans10- cis12) is more effective than either isomer 
alone. The cis9- trans11 CLA isomer has the most biological activities, and 
presents an anticarcinogenic effect (Sieber et al. 2004). 
6.1.4.3 Anti atherosclerosis 
Atherosclerosis is known as hardening of the arteries. When fat and cholesterol 
precipitate in the artery walls, hard structures called plaques are formed and 
might block the arteries. 
Conjugated linoleic acid, as dietary fatty acid has presented some anti-
atherogenic activities in animal models of atherosclerosis. Conjugated linoleic 
acid is capable of diminishing the level of atherogenic low density lipoprotein 
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cholesterol (LDL) in plasma and also increase the level of anti atherogenic high 
density lipoprotein cholesterol (HDL) (Weldon et al. 2004).  
6.1.4.4 Bone formation 
Ostheosynthesis also is affected by different isomers of CLA. Animal studies 
show that CLA increases calcium absorption from diet and reduces the rate of 
bone resorption (Kelly and Cashman 2004). Also CLA has been suggested as 
a preventive supplement for rheumatoid arthritis (Hur and Park 2007). Platt et 
al. (2007) reported that number and size of mineralized bone nodules were 
increased by cis9- trans11 CLA; however, trans10- cis12 did not show such 
effect and it is an evidence of isomer-specific effects of CLA on health benefits. 
6.1.5 Safety of CLA 
Although many positive health benefits of CLA have been stated, there are 
some negative impacts of concern. Some negative results were obtained in 
some animal studies. There were indications of increased liver and spleen 
weight and as well as insulin resistance (Clement et al. 2002; Syvertsen et al. 
2007). One should also bear in mind that different animal or human studies use 
different CLA (mixed or individual isomer), and due to isomer-specific effects of 
CLA isomers, results from such studies might considerably vary and sometimes 
report conflicting and less convincing for health benefits of the components 
(Benjamin and Spener 2009).  
The adverse effects of CLA, such as insulin resistance and non-alcoholic fatty 
liver disease were attributed to the shortage of n-3 PUFA in the diet, and by 
inclusion of n-3 PUFA (such as α- linolenic acid), the reported adverse effects 
would be avoided (Kelley et al. 2009). Also it was concluded that most of the 
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reported adverse effects are related to the short-term studies in humans, and in 
long term adverse effect rate was decreased (Gaullier et al. 2005). 
6.1.6 CLA intake 
Conjugated linoleic acid level is estimated at 0.1% (w/v) of the total fatty acid 
content in the human body (Zlatanos et al. 2008), but CLA level in foodstuffs 
does not seem to be sufficient for any significant therapeutic effect (Chung et al. 
2008). Conjugated linoleic acid intake can be improved by manipulations of food 
products. Fortification of the ruminant diet with vegetable oils is an important 
practice for increasing of CLA level (Sieber et al. 2004). 
Desirable consumption levels of CLA on human health is not well documented, 
However, based on different studies, It has been suggested that for obtaining 
positive biological effects, CLA should be taken about 2-3 g per day for 6 to 12 
months (Sieber et al. 2004; Whigham et al. 2007), and CLA in form of 
triacylglycerol is the best form for consumption, as cis9- trans11 and trans10- 
cis12 are absorbed similarly into chylomicrons (Fernie et al. 2004). However, a 
mixture of n-3, n-6 (CLA) and n-9 fatty acids in human diet can be suggested to 
ameliorate any possible adverse effect of CLA consumption (Kelley et al. 2009).   
6.1.7 Bioconversion of LA by bacteria 
Apart from rumen-derived bacteria, certain bacterial strains used in fermented 
dairy foods are able to biosynthesise the CLA isomers (Sieber et al. 2004). 
Therefore, these bacteria could offer an opportunity for manufacturing enriched 
CLA products.  It is noticeable that environmental parameters affect the 
production of CLA by these strains (Jang et al. 2005).  
 
 
 
205 
 
The present study aimed to assess the capabilities of the isolates for converting 
LA to free CLA. The specific objectives were:  
a) In vitro assessment of the isolates for the conversion of different 
concentration of LA to CLA. 
b) In vitro assessment of the isolates forfor the conversion of LA to CLA at 
different incubation time (24 and 48 h). 
 
6.2 MATERIALS AND METHODS 
6.2.1 Microorganism and culture conditions 
In this study, a total of 11 lactobacilli were screened, including six isolates from 
yogurt and other fermented milk products, 2 commercial cultures of Lb. 
acidophilus (La5) and Lb. casei (C431) kindly provided by Chr. Hansen as well 
as three different type strain lactobacilli purchased from the National Collection 
of Industrial, Food and Marine Bacteria (NCIMB, UK) (Lb. casei subsp. casei, 
Lb. paracasei subsp. paracasei and Lb. acidophilus) (Table 3.1). The cultures 
were prepared and kept on beads as described earlier (section 2.2.4). 
6.2.2 Inoculum preparation 
Three consecutive subcultures (anaerobically at 37 °C for 24 h on MRS agar) 
were carried out on all bacterial cells kept at - 20 °C on beads in cryovials before 
use. The active inoculum’s concentration was adjusted to ~107-108 CFU/g by 
comparing the turbidity of the bacterial suspension in Maximum Recovery 
Diluent (MRD) with 0.5 MacFarland standard using sensititre nephelometer 
(Trek, Diagnostic Systems Ltd., East Grinstead, UK). 
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6.2.3 The extraction of CLA  
Quantification of CLA formation was performed according to the method of 
Alonso et al. (2003) with some modifications. The extraction of CLA involved the 
following main steps: 
Lipid standards for fatty acid analysis (LA and CLA) were obtained from Sigma-
Aldrich (Poole, UK). All other chemicals used in this study were of analytical 
grade and purchased from Sigma unless otherwise stated. 
6.2.3.1 Preparation of stock solution of LA 
A stock solution of LA (30 mg/ml) was prepared by suspending 30 mg LA/ml in 
2% v/v Tween 80 (polyoxyethylene sorbitan monooleate) solution. Tween 80 
was needed to dissolve LA in the medium. The resulting solution was filter 
sterilized through a 0.45 µm syringe filter (Nalgene, Fisher Scientific, 
Loghborough, UK) and stored in the dark at – 20 °C until use. 
6.2.3.2 Measuring microbial production of CLA 
In order to assess in vitro production of CLA by the isolates, the reaction medium 
was prepared. The stock solution of LA was added to MRS broth to a final 
concentration of 0.2 and 0.5 mg LA/ml. 
One percent inoculum (v/v) of each strain was added to 10 ml reaction medium, 
and incubated anaerobically at 37 °C for 24 and 48 h. The CLA content in the 
cultures was expressed as percentage of the added LA, using the following 
equation: 
 % CLA = CLA ⁄ (CLA + LA) ×100. 
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6.2.3.2.1 pH value  
The pH of the reaction medium was measured with a pH meter instrument 
(Whatman PHA 2000), which was calibrated using pH buffer at pH 4·0 and 7·0 
according to the operating manual. 
6.2.3.2.2 Viable count 
The viable count of the reaction medium was determined by plating serial 
dilutions of the bacterial suspensions on MRS agar (Oxoid) followed by 
incubation under anaerobic conditions at 37 °C. 
6.2.3.3 Lipid extraction from bacterial supernatant fluids 
Samples (500 µl) were taken after 24 and 48 h incubation and centrifuged at 4 
°C at 7000 x g for 10 min. The supernatant was mixed with 15 ml 
hexhane/isopropanol (HIP) (3:2 v/v) (Fisher Scientific, Loughborough, UK) in a 
universal bottle and 0.01% v/v butylated hydroxytoluene (BHT) (Fisher 
Scientific, UK) was added to the solvent to prevent potential oxidation. All 
samples were flushed for about 1 min with nitrogen and stored overnight at 4 
°C. 
6.2.3.3.1 Partitioning 
The HIP mixture (15.5 ml) was fully evaporated under nitrogen flush for 1 h and 
3 ml of chloroform/methanol (2:1 v/v) (Fisher Scientific, UK), BHT (0.01% v/v) 
and 1 ml of distilled water was added to each tube. The tubes were vortexed 
and the mixture centrifuged at 2500 x g for 5 min. After centrifugation, there was 
a clear separation of the organic phase (bottom layer) from the aqueous phase 
(top layer). The lipid enriched organic phase was collected and transferred to 
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new tubes, and the solvent was fully evaporated under nitrogen flush as 
described above.  
6.2.3.3.2 Extraction of methyl ester 
Four ml of 15% (v/v) acetyl chloride in methanol was added to tubes containing 
dried organic phase. The tubes were flushed with nitrogen for few second, 
sealed and left in the oven at 70 oC for 3 h. Afterwards, 4 ml of 5% w/v NaCl and 
2 ml of petroleum ether (Fisher Scientific, UK) were added to each tube. The 
tubes were shaken for few seconds. The upper petroleum ether layer was 
transferred into a new tube containing 2 ml of 2% (w/v) potassium bicarbonate. 
Another 2 ml of petroleum ether was added to each of the original tubes and the 
tubes were shaken again and the upper petroleum ether was transferred to the 
tube containing 2% (w/v) potassium bicarbonate. The tubes were then vortexed 
and the upper layer was transferred to a new tube containing 100-200 mg of 
dried granular sodium sulphate. This solution containing fatty acid methyl esters 
(FAME) in petroleum ether was transferred to a 3 ml glass vial. The petroleum 
ether was removed under nitrogen and the samples were dissolved in 1 ml 
heptane (Fisher Scientific, Loughborough, UK) and BHT (0.01% v/v). The 
samples were flushed under nitrogen and stored at -20 oC until use. 
6.2.3.3.3 Gas chromatography 
Fatty acid methyl ester (FAME) was analysed by a capillary gas liquid 
chromatograph (HRGC Mega 2 Series, Fison’s Instruments, Italy). Injection (1 
µl) was performed automatically with an inlet temperature of 250 °C and a split 
ratio of 100:1. Hydrogen was used as a carrier through a BPX-70 capillary 
column (60 m, 320 µm). The oven operated at an initial temperature of 140 °C 
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for 1 min, with 4 ramps to attain 180, 184 and 240 °C at a rate of 1, 2, 0.5 and 
30 °C/min respectively. Detection was carried out by flame ionization at 270 °C. 
The relevant peaks were identified by comparison of retention times with 
authentic standards and calculation of equivalent chain length values. The peak 
areas were quantified by a computer chromatography data system (Agilent EZ 
Chrom Elite chromatography Data System version 3.2, Scientific Software, 
Pleasanton, CA). 
6.2.4 Statistical analysis 
Results are the mean±standard deviation. Data were analysed using the 
univariate analysis of variance was performed using SPSS 21 software 
(Chicago, IL: SPSS Inc) to determine the statistical significance of differences. 
Data were considered significantly different when p < 0.05. 
 
6.3 RESULTS 
Eleven Lactobacillus isolates were studied for their ability to convert free LA to 
CLA. These bacteria were selected from different origin (dairy products, 
commercial cultures and type strains).  
6.3.1 Effect of the incubation time and LA concentration on the growth of 
tested isolates 
The effect of free LA on cell counts of the tested bacteria was determined by 
enumeration of viable cells after 24 and 48 h of incubation. As shown in Figure 
6.3, the growth of all isolates was not affected by the presence of 0.2 mg LA/ml.  
However, the growth of some of the isolates was rather inhibited in the presence 
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of 0.5 mg LA/ml and, in most isolates the reduction was not considerable after 
24 h (Figure 6.4). 
Enumeration after 48 h in MRS+0.2 mg LA/ml showed higher counts compared 
to the enumeration after 24 h. Also in MRS+0.5 mg LA/ml, except few isolates 
(Lb3, Lb7, Lb8), all others presented higher number after 48 h (p < 0.05). 
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52Figure 6.3 Number of Lactobacillus spp. in MRS broth with LA (0.2 mg/ml) after 24 
and 48 h anaerobic incubation at 37 °C (n=3) 
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53Figure 6.4 Number of Lactobacillus spp. in MRS broth with LA (0.5 mg/ml) after 24 
and 48 h anaerobic incubation at 37 °C (n=3) 
 
6.3.2 Effect of incubation time and LA concentration on pH changes in 
growth media 
When pH changes were measured during cultivation, all isolates showed a 
similar pH profile after 24 and 48 h incubation. However, the inhibitory effect of 
high level LA (0.5 mg/ml) on the growth of isolates was demonstrated by their 
higher pH compared to 0.2 mg/ml LA (p < 0.05). The pH of the medium gradually 
decreased as the cells grew, reaching values of 3.71- 4.37 in MRS broth 
containing 0.2 mg LA/ml after 24 and also 3.52 – 4.01 after 48 h of incubation. 
Additionally, the final pH for MRS broth treated with 0.5 mg LA/ml varied from 
3.77- 4.78 after 24h and 3.51- 4.38 at the end of the incubation time (Figure 6.5 
and 6.6). 
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55Figure 6.6 Effect of LA concentration (0.5 mg/ml) on the pH of MRS broth 
inoculated with the tested Lactobacillus spp. and anaerobically incubated for 24 and 
48 h at 37 ºC (n=3) 
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54Figure 6.5 Effect of LA concentration (0.2 mg/ml) on the pH of MRS broth 
inoculated with the tested Lactobacillus spp. and anaerobically incubated for 24 and 
48 h at 37 ºC (n=3) 
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6.3.3 Screening Lactobacillus spp. for CLA production 
Screening six strains of isolated Lactobacillus, two commercial cultures (La5 
and C431) and three type strains (Lb. acidophilus, Lb. casei subsp. casei and 
Lb. paracasei subsp. paracasei) for CLA production in treated MRS with 0.2 and 
0.5 mg/ml free LA was undertaken after anaerobic incubation at 37 oC for 24 
and 48 h (Figure 6.7 and 6.8). It was found that all 11 tested isolates were 
capable of synthesising CLA in the supernatant with varying conversion 
percentage.  
Figure 6.7 shows the percentage of CLA in MRS+ 0.2 mg/ml LA after 24 and 48 
h. After 24 h of incubation isolate Lb11 showed the highest CLA production 
(33.43%), followed by Lb10 (28.88%) and Lb6 (25.35%); Lb1 presented the 
lowest conversion (12.06%). After 48 h, the highest conversion was obtained 
with Lb8 (40.89%), Lb2 (36.22%) and Lb10 (33.69%) and the lowest conversion 
rate was still observed with Lb1 (12.7%). 
According to Figure 6.8, the highest and the lowest converted LA in MRS+0.5 
mg LA/ml after 24 h incubation, was recorded for isolates Lb11 (24.95%) and 
Lb5 (6.41%), respectively. In MRS+0.5 mg LA/ml; however, after 48 h 
incubation, Lb10 (%35.64) showed the highest rate of conversion and Lb5 
exhibited as the lowest conversion (%10.09).  
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Data are means ± SD of three replications 
 
 
 Data are means ± SD of three replications 
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56Figure 6.7 Conversion rate (%) of LA to CLA by tested Lactobacillus spp. in MRS 
broth with added 0.2 mg LA/ml, after 24 and 48 h incubation 
57Figure 6.8 Conversion rate (%) of LA to CLA by tested Lactobacillus spp. in broth 
with added 0.5 mg LA/ml, after 24 and 48 h incubation 
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The highest level of CLA production was observed after 24 h of incubation in 
the broth media supplemented with LA (0.2 and 0.5 mg LA/ml) and 
approximately similar pattern of formation of CLA were obtained with all cultures 
included in this study.  
For all tested isolates, the total amount of CLA in the broth containing LA did not 
considerably rise with further 24 h increases of the incubation time (p < 0.05). 
6.3.4 GC analysis of CLA isomers produced by Lactobacillus spp. 
The percentage of two major isomers of CLA, cis9- trans11 and trans10- cis12, 
was determined for all tested isolates. By comparing the retention times of the 
products produced in this study with standards, it was concluded that cis9-
trans11 CLA was the major CLA isomer, which was formed by the fermentation 
process (Figure 6.9). 
 
 
 
58Figure 6.9 Example of a GC chromatogram of the fatty acid composition of the 
fermented MRS supplemented with LA.  
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Table 6.2 shows the production of the individual isomers cis9-trans11 and 
trans10-cis12 by all Lactobacillus studied, in MRS broth supplemented with 0.2 
and 0.5 mg LA/ml LA after 24 and 48 h incubation. The amount of cis9-trans11 
varied from 64.56 to 92.53 % of the total CLA isomer products in MRS+0.2 mg 
LA/ml, and from 68.11-95.71% in MRS+0.5 mg LA/ml (calculated based on the 
results presented in Table 6.2). 
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 12Table 6.2 Mean percentages of CLA isomers produced by tested Lactobacillus spp. in MRS broth + 0.2 and 0.5 mg LA/ml after 24 and 48 h 
incubation anaerobically at 37 °C 
Data are means ± SD of three replications 
 MRS +0.2  
mg LA/ml  
   MRS + 0.5  
mg LA/ml  
   
 Cis9-trans11 
(24h) 
trans10-cis12 
(24h) 
Cis9-trans11 
(48h) 
trans10-cis12 
 (48h) 
    Cis9-trans11  
(24h) 
trans10-cis12           
(24h) 
Cis9-trans11 
(48h) 
trans10-cis12 
(48h) 
Lb1 9.9±3.67  
 
2.15±0.49 
 
11.61±2.87 
 
1.09±0.45 
 
11.75±3.07 
 
0.96±0.27 11.69±3.05 0.63±0.31 
Lb2 20.27±9.0 2.77±0.89 25.71±4.99 10.5±3.45 14.56±3.96 6.01±2.55 20.00±3.52 9.06±3.73 
Lb3 9.13±1.89 3.22±2.23 8.74±4.36 4.79±0.94 7.17±1.59 3.35±1.24 8.763±2.67 2.75±0.78 
Lb4 13.99±0.82 1.99±0.79 16.04±0.59 1.31±1.09 15.89±0.42 4.52±2.00 14.44±0.67 2.46±1.48 
Lb5 11.21±1.49 2.36±0.82 16.17±2.92 3.51±1.80 5.54±1.41 0.86±0.28 9.02±0.72 1.60±0.94 
Lb6 22.63±2.88 2.72±0.57 21.35±8.33 4.70±3.90 17.39±2.36 2.37±0.95 16.92±4.45 2.61±2.37 
Lb7 15.45±0.69 2.69±0.92 17.24±4.79 7.86±2.38 17.69±5.48 1.22±0.77 16.10±1.00 2.51±1.61 
Lb8 17.17±4.13 3.82±1.21 36.07±2.45 4.81±1.98 21.22±1.01 1.53±0.88 18.14±3.38 1.34±0.66 
Lb9 17.81±1.95 4.15±0.93 20.58±3.19 2.99±1.51 23.60±4.34 1.361±0.78 23.99±3.72 1.11±0.50 
Lb10 24.80±2.48 4.07±1.76 31.17±2.76 2.51±2.99 22.91±1.80 1.28±1.25 33.00±11.49 2.64±1.92 
Lb11 30.03±7.53 3.40±2.09 23.55±4.88 2.54±1.71 23.51±4.32 1.44±1.16 22.53±4.37 1.00±0.71 
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6.4 DISCUSSION 
Many investigations have been undertaken on the formation of CLA by LAB 
(Jiang et al. 1998; Ogawa et al. 2001; Kim et al. 2002; Alonso et al. 2003; 
Coakley et al. 2003; Lee et al. 2009). It has been reported that several 
parameters, such as pH, media and phase of growth might influence the CLA 
production (Sieber et al. 2004); therefore, very dissimilar results might be 
obtained in various studies.  
Lactobacillus acidophilus La5 is a widely used commercial culture with well-
established probiotic properties. It has been reported that Lb. acidophilus La5 is 
able to form CLA when used for the fermentation of dairy products (Kim and Liu 
2002; Akalin et al. 2007; Ekinci et al. 2008), but Bzducha and Obiedzinski (2007) 
did not find any CLA accumulation in the ripening of cheeses. 
Hernandez-Mendoza et al. (2008) obtained a higher production of CLA (0.08 
mg/ml) by Lb. reuteri in MRS broth containing high substrate concentrations (20 
mg/ml) free LA, which was incubated aerobically at 10 ˚C for 30 h. However, it 
should be noted that the initial level of LA added in their study was much higher 
as compared to this present study, which were 0.2 and 0.5 mg LA/ml. In addition, 
the purity of LA in their study is not known and also their experiments were 
carried out at low temperature (10 °C), which might be an advantage. Alonso et 
al. (2003) reported those two strains of Lb. acidophilus and also two of Lb. casei 
could produce CLA in MRS broth supplemented with LA (0, 0.05, 0.1, 0.2 and 
0.5 mg/ml). They reported that all tested strains were able to form free CLA in 
all concentrations. Maximum production of CLA (80.14 to 131.63 µg/ml) was 
recorded at 24 h of incubation in medium containing 0.02% LA. 
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In the current study, all tested strains were able to produce CLA from free LA, 
which might be due to the presence of LA hydrogenase enzyme. These bacteria 
efficiently converted LA to CLA in MRS broth, but the percentage of CLA 
conversion was variable among them. 
The CLA formed by the tested strains was extracted from extracellular phase 
and of the different CLA isomers, cis9-trans11 18:2 was found to represent 64–
95% of total CLA formed and this is similar to the proportion indicated by other 
research (Jiang et al. 1998; Kelley et al. 2007).  
According to Ogawa et al. (2001), produced CLA is accumulated into Lb. 
acidophilus cells. They claimed it is considered as an advantageous to the 
consumer. However, it should be mentioned that cell associated CLA might not 
be available, as probiotic bacteria are not digested in the human gut. The use 
of Lactobacillus spp. which able to produce free CLA in the fermentation process 
may offer health benefits, because free CLA in fermented milks is more 
absorbable than CLA incorporated into the cells of the starter culture (Alonso et 
al. 2003).  Therefore, it would be more valuable that cells export CLA to the 
environment, i.e. the GIT. In this research, bacterial cells were separated from 
broth by centrifugation and cell free supernatant was assayed only. Therefore, 
this may not include any cell associated CLA. It is more important for the 
products that their CLA be available when the products are digested. 
The antibacterial effect of free LA has been reported by different research. In 
this research, also growth of many of the screened stains was rather lower upon 
inclusion of 0.5 mg/ml linoleic acid into the growth media. It should be stated 
that toxic effects of free fatty acids for bacteria depends on its concentration and, 
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in this study, we reported that the tested isolates could grow better in the 
presence of 0.2 mg LA/ml than 0.5 mg LA/ml. It appeared that addition of greater 
than 0.2 mg/ml LA exerted an inhibitory effect on CLA production because less 
was produced in the presence of 0.5 mg/ml LA. This indicates that conversion 
of free LA to CLA might be part of a detoxification process. Alonso et al. (2003) 
also reported that free LA has a negative effect on the growth and metabolism 
of tested isolates. 
As mentioned earlier, the formation of CLA is usually affected by the media 
composition. Macouzet et al. (2009) reported that MRS broth is not a suitable 
medium for conversion of LA to CLA. According to their research Lb. acidophilus 
was not able to produce CLA in MRS broth. They stated that Lb. acidophilus 
strains produce higher CLA in a milk-based medium. Coakley et al. (2003) 
reported no CLA formation in a MRS medium with 0.55 mg LA/mL by different 
strains of lactobacilli, lactococci and pediococci. In addition, several researches 
demonstrated that milk compounds, such as proteins, are able to neutralize the 
harmful effects of free fatty acids on the bacterial growth (Boyaval et al. 1995; 
Kim and Liu 2002). Chung et al. (2008) stated that proteins in the growth media 
may have facilitated the production of CLA by enhancing the interaction of 
substrate with the bacteria. These findings point out that skim milk might be a 
better and perhaps more realistic medium for production of CLA. It is more likely 
that casein and whey protein are able to neutralize the toxic effect of LA in milk. 
However, the results observed in this study indicated that the tested isolates 
actively convert free LA to CLA in MRS broth, which might be due to the 
presence of Tween-80 in the medium, that plays an important role in helping 
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Lactobacillus spp. to recover from the inhibitory effects of LA and became able 
to produce CLA (Jiang et al. 1998). 
The mechanism of CLA production by these microorganisms might be due to 
the presence of LA hydrogenase enzyme, which needs to be studied more. The 
results obtained in the current research present remarkable perspectives for 
producing fermented dairy products enriched with CLA. 
 
6.5 CONCLUSION 
In conclusion, tested strains were able to produce variable amounts of CLA in 
the presence of free LA. The largest percentage of CLA was produced during 
the first 24 h of incubation. Cis9-trans11 CLA was the main isomer detected, 
which constituted 64–95% of total CLA produced. 
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CHAPTER SEVEN: 
RESISTANCE/SUSCEPTIBILITY OF 
LACTOBACILLUS SPP. TO THE ANTIBIOTICS 
AND DETERMINATION OF THE RESISTANCE 
GENES 
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7.1 INTRODUCTION 
Lactobacillus strains have long history of use in food and extensively been used 
as probiotics (Shah 2007). Bringing probiotic products containing lactobacilli to 
the market involves a step-wise process that requires to be carefully controlled 
in order to obtain a safe product (Saarela et al. 2000). Amongst other criteria, it 
is recommended to screen the potential probiotics for their antibiotic resistance 
spectrum. Although antibiotics have been developed for the treatment of several 
infectious diseases, these may have various adverse results, such as antibiotic-
associated diarrhoea (Riley 1998; Luchansky 1999). Widespread prescription of 
antibiotics is often associated with the disruption of the protective flora in the 
GIT (Forestier et al. 2001). Alterations in the microflora by antibiotic therapy also 
encourage the emergence of resistant strains (Lee et al. 2003). 
It has been reported that probiotic lactobacilli may have the potential to serve 
as a reservoir/host for antibiotic resistance genes with the risk of transferring the 
genes to pathogenic and non-pathogenic bacteria (Teuber et al. 1999; 
Danielsen and Wind 2003; Kastner 2006; Ammor et al. 2007). 
Before launching a probiotic product into the market, it is important to consider 
that any single probiotic strain do not contain transferable antibiotic resistance 
genes. 
7.1.1 Antibiotic categories 
Antibiotics can be categorised based on their functions and also their specific 
targets. A summary of groups of antibiotics based on their mechanism of action 
is shown in Table 7.1.  
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13Table 7.1 Antibiotics and their mechanisms of action (target) 
Mechanism of 
inhibition 
Antibiotic 
Cell wall 
directed 
β-lactam antibiotics, vancomycin 
Protein 
synthesis 
Aminoglycosides (such as streptomycin, 
kanamycin, gentamycin, amikacin), 
tetracycline, chloramphenicol, lincomycin 
and macrolides (such as erythromycin). 
Nucleic acid 
synthesis 
Quinolones, such as nalidixic acid and 
ciprofloxacin 
Antimetabolite Sulfonamides 
 
Antibiotics, such as β-lactam antibiotics and vancomycin, act as inhibitors of cell 
wall synthesis. Production of a β-lactamase, such as penicillinase or 
cephalosporinase, is the principal resistance mechanismamong clinically 
important anaerobes including lactobacilli (Cooksey 1991). 
Cell wall impermeability is also one of the main mechanisms of resistance to 
antibiotic (Condon 1983). Vancomycin may be able to inhibit cell wall synthesis. 
Vancomycin comes into contact with the peptidoglycan precursors on the cell 
wall side of the cytoplasmic membrane, and it binds to the D-alanine/D-alanine 
terminus of the pentapeptide and inhibits the polymerization of peptidoglycan 
precursors (Gueimonde et al. 2013). 
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Homofermentative lactobacilli group are susceptible to vancomycin (EFSA, 
2008), but there are some Lactobacillus species such as Lb. plantarum, Lb. 
casei subsp. Casei, Lb. salivarius, Lactobacillus leishmannii and Lb. acidophilus 
(excluding obligate heterofermentative species) that carry intrinsic resistance 
towards vancomycin, which can be associated to the presence of D-alanine/D-
alanine ligase-related enzymes (Elisha and Courvalin 1995). It is thought that 
the reduced susceptibility of lactobacilli to vancomycin occurs because of 
membrane impermeability (Elkins and Mullis 2004). 
Aminoglycosides (streptomycin, kanamycin, gentamycin and amikacin) and 
tetracycline are able to bind the 30S ribosomal subunit and act as inhibitors of 
protein synthesis. The aminoglycosides irreversibly bind to the 30S ribosome 
and freeze the 30S initiation complex and no further initiation can occur. 
Chloramphenicol, lincomycin and macrolides, such as erythromycin bind to the 
50S ribosome and inhibit peptidyl transferase activity. 
Antibiotics, which inhibit the nucleic acid synthesis are enoxacin, pefloxacin, 
norfloxacin, nalidixic acid, sulphamethoxazole, trimethoprim, co-trimoxazole 
and metronidazole (Coppola et al. 2005). Some resistance mechanisms are 
associated with enzymatic actions. Resistance of lactobacilli to metronidazole 
might be related to the absence of hydrogenase activity (Church et al. 1996). 
Antimetabolites antibiotics, such as sulfonamides, mainly inhibit folic acid 
synthesis. They bind to dihydrofolate reductase and inhibit formation of 
tetrahydrofolic acid. 
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7.1.2 The mechanisms of antibiotic resistance in lactobacilli 
Resistance mechanisms of the lactobacilli to antimicrobial agents are different. 
Physiological resistance is expressed when bacteria are in a particular 
physiological condition like when they produce biofilm and the bacteria adopt a 
biofilm lifestyle. In such conditions, it is hard to eradicate bacteria by antibiotics. 
The reason for this resistance is not clear. It might be due to slow penetration 
of antibiotics through the biofilm, which surrounds the bacteria. Other reason for 
this resistance might be that bacteria in biofilm condition are in a stationary 
phase and their growth and death are in balanced state (Normark and Normark 
2002).  Bacteria in the stationary phase tend to be more resistant. Some of other 
reasons for defensive functions and phenotypic resistance to antimicrobial 
agents are: 
 decreased uptake of the antibiotic by microorganisms 
  increased export of the antibiotic,  
 introduction of a new antibiotic resistant target,  
 inactivation of the antibiotic target,  
 hydrolysis and/or modification of the antibiotic (Normark and 
Normark 2002). 
7.1.3 Resistance genes in lactobacilli 
The intrinsic resistance of lactobacilli to several antibiotics can be partially due 
to genes that encode multidrug resistance efflux pumps, which expel different 
kinds of antibiotics and chemicals such as biocides, organic solvents, dyes, 
detergents and metabolic products (Munoz et al. 2014). In a study on Lb. sakei 
Rits 9, strain isolated from Italian Sola cheese, transposon-associated tet(M) 
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gene and plasmid-carried tet(L) gene, which mediate two resistance 
mechanisms to tetracycline have been described (Ammor et al. 2008). Toomey 
et al. (2010) have shown that Lb. paracasei, Lb. reuteri and Lb. curvatus were 
resistant to erythromycin containing erm(B) and msrA/B genes. Also in their 
study, Lb. plantarum was resistant to tetracycline because it contains a 
resistance gene such as tet(M). 
Huys et al. (2008) indicated that Lb. paracasei and Lb. casei were uniformly 
susceptible to ampicillin and clindamycin but exhibited natural resistance to 
gentamicin and streptomycin. Kastner et al. (2006) showed that Lb. reuteri SD 
2112 harbour tetracycline resistance gene tet(W) and the lincosamide 
resistance gene lnu(A). Rosander et al. (2008) identified two plasmids carrying 
tet(W) tetracycline and lnu(A) lincosamide resistance genes in Lb. reuteri 
ATCC55730 . 
In a study by Mayrhofer et al. (2010) Lb. johnsonii, which was phenotypically 
susceptible to clindamycin and erythromycin seemed to harbour the erm (B) 
gene. The tet(W) gene has been reported in strains of Lb. crispatus, Lb. 
johnsonii, Lb. paracasei and Lb. reuteri (Egervarn et al. 2009). Chloramphenicol 
resistance cat gene has been found in Lb. plantarum (Ahn et al. 1992) and Lb. 
reuteri (Lin et al. 1996). 
7.1.4 Transferability of resistance genes 
Antibiotic resistance among Lactobacillus strains may be desirable (Charteris et 
al. 1998), but continuous attention should be paid to the selection of 
Lactobacillus strains free of transferable antibiotic resistance (Temmerman et 
al. 2003). 
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The dissemination of antibiotic resistance determinants in microbial 
communities are vertical or horizontal. Vertical dissemination is through the 
clonal spread of a special resistant strain, while horizontal gene transfer is 
through conjugation, transformation and transduction (Davison, 1999). The 
three types of resistance to a given antibiotic can be intrinsic, acquired and 
mutational (Ashraf and Shah 2011).  
a) Intrinsic (inherent/innate/natural) resistance: 
Intrinsic resistance to a bacterial species or genus is not horizontally 
transferable, and poses no risk in non-pathogenic bacteria. Inherent resistance 
to vancomycin for Lb. paracasei, Lb. salivarius and Lb. plantarum has been 
confirmed in Italian probiotic products (Blandino et al. 2008). In the study of 
Toomey et al. (2010) intrinsic streptomycin resistance has been observed in 
Lactobacillus strains isolated from Irish pork and beef abattoirs. It has been 
noted that in different lactobacilli natural resistance to vancomycin is not 
transmissible (Klein et al. 1998; Bernardeau et al. 2008). 
b) Acquired resistance: 
Some bacteria strains or species, which were usually susceptible to some 
antibiotics may acquire antibiotic resistance elements that might further be 
horizontally spread among other bacteria (Mathur and Singh 2005). 
It has been shown that antibiotic resistance of Lb. acidophilus, Lb. crispatus, Lb. 
gasseri and Lb. plantarum may be acquired in the intestinal tract during transit 
(Cataloluk and Gogebaken 2004). Acquired resistance to tetracycline is well 
known in Lb. acidophilus strains (Delgado et al. 2005; Cauwerts et al. 2006; 
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Klare et al. 2007). In acquired resistance, horizontal transfer increases the 
evolution of antibiotic resistance in microbial communities. It is happened by 
moving resistance genes across species borders via conjugative plasmids, 
integrons, transposons, insertional elements, lytic and temperate 
bacteriophages (Davies 1994). Among different mechanisms, conjugation is the 
main way of antibiotic resistance gene transfer (Salyers 1995), because 
conjugation allows DNA to move across genus and species lines, whilst 
transformation and transduction are restricted to within the same species 
(Mathur and Singh, 2005).  
There are plasmids, which encode resistance to tetracycline, erythromycin, 
chloramphenicol in Lb. fermentum (Fons et al. 1997), Lb. plantarum (Danielsen 
2002) and Lb. reuteri (Lin et al. 1996).  
In vitro and in vivo studies in mice have revealed the transfer of vancomycin 
resistance (gene vanA) from enterococci to a commercial Lb. acidophilus strain 
(Mater et al. 2008). Such evidence may suggest that intestinal bacteria, such as 
lactobacilli, can acquire resistance especially by horizontal transfer of resistance 
genes from other intestinal species (Liu et al. 2009). Thus, one of the safety 
traits of lactobacilli, which should be evaluated, is their capability of acquiring 
and disseminating resistance determinants. 
c) Mutation: 
Mutations may cause genetic changes in multiple regions of the genome; they 
play a minor role in the development of resistance (Howden et al. 2006). It needs 
to be stated that intrinsic resistance and the resistance caused by mutation of 
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chromosomal genes have a low risk of horizontal transfer, and such strains 
should be acceptable to use in food (Ashraf and Shah 2011). 
The aim of this part of the research was to study the antibiotic resistance profiles 
of isolated lactobacilli. The objectives included: 
a) To determine the antibiotic resistance profile of the isolates, type strains 
and commercial lactobacilli. 
b) To detect possible antibiotic resistance genes in these isolates, type 
strains and commercial lactobacilli. 
c) To screen of the isolates, type strains and commercial cultures ability to 
transfer resistance genes to other bacteria. 
 
7.2 MATERIALS AND METHODS 
7.2.1 Microorganisms 
A) Strains tested for antibiotic resistance 
The bacteria tested in this experiment were shown in Table 3.1. 
B) Positive control organisms for the gene transfer study (Table 7.2) which 
werekindly provided by the Technical University of Denmark, (National Food 
Institute, Antimicrobial Resistance Centre, Denmark). 
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14Table 7.2 The organisms used as positive controls for the detection of antibiotic 
resistance genes 
Bacteria 
 
Gene related 
Staphylococus rissem 7522486-1 aph(3’’)-I 
Entrococus faecalis aadE 
Salmonella Typhimurium aadA 
Staphylococus aureus RN422 erm(C) 
Enterococus Faecalis JH2-2 erm(B) 
Staphylococus aureus Tn554 erm(A) 
Staphylococus aureus PSTS 9-like tet(L) 
Staphylococus aureus PT181-like tet(K) 
Staphylococus intermedius 2567 tet(M) 
Escherichia coli tet(Q) 
Listeria monocytogenes BM4210/PIP811 tet(S) 
Escherichia coli K2 ant(2’’)-I 
Enterococus  faecalis JH2-1-5 aph(3’’)-III 
Escherichia coli tet(W) 
Entrococus faecium BM4147 Van A 
Entrococus faecalis V583 Van B 
Entrococus faecalis SF 350 la aac(6’)aph(2") 
Salmonella Typhimurium DS611 cmlA 
Salmonella Weltevreden TA 428/97 Cat1 
No positive control Van X, tet O, Cat, Str A, Str B, 
aac(3")IV  
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7.2.2 Determination of minimum inhibitory concentration (MIC)  
Minimum inhibitory concentration (MIC) is defined as the lowest concentration 
of antibiotic giving a complete inhibition of visible growth in comparison to an 
antibiotic-free control well. MIC for 25 antibiotics was determined using a 
sensititre plate of 96 wells containing variable amounts of antibiotics (Trek, 
Diagnostic Systems Ltd., East Grinstead, UK). After two consecutive 
subcultures of each organism (table 3.1), a single colony on MRS (CM0361, 
Oxoid, UK) plate was suspended in 1 ml of sterile MRD (this was used as stock 
solution for preparing the final inocula). The working inoculum suspension was 
prepared by diluting the stock inoculum in 5 ml MRD in a glass boiling tube using 
a calibrated sensititre nephelometer (Trek, Diagnostic Systems Ltd., UK) to 
measure the turbidity. The final concentration of cells per tube was adjusted to 
0.5 MacFarland standard (107-108 CFU/ml). The liquid medium used was MRS 
broth (CM0359, Oxoid, UK). The working inoculum suspension was then diluted 
100-fold in fresh MRS broth and 50µl of inoculated MRS broth was dispensed 
in each well. Incubation was carried out at 37 °C for 48 h in an anaerobic cabinet 
(Don Whitley, Skipton, UK) in an atmosphere of 80% N2, 10% H2 and 10% CO2. 
The antibiotic 96 well plates were observed with a magnifier mirror after the 
incubation period and visible growth (precipitated cells at the bottom of wells) or 
no visible growth was reported. For determination of degree of 
resistance/susceptibility a breakpoint for each antibiotic was established based 
on published literature (Table 7.3). 
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15Table 7.3 The concentration of each antibiotic tested and the suggested  
breakpoints 
Antibiotics Range of 
concentration 
studied (µg/ml) 
Proposed 
breakpoints 
(µg/ml) 
Reference 
Amikacin 0.5-64 >16 EUCAST 
Amoxicillin/clavulanic acid 1/0.5-32/16 >2 Ouoba et al. 
(2008b) 
Ampicillin 1-32 >1 EFSA 
Cefoxitin 0.5-32 >32 Moubareck 
et al. 2005 
Ceftiofur 0.12-8 8 Ouoba et al. 
(2008b) 
Ceftriaxone 0.25-64 >4 Karlowsky 
and Jones 
(2003) 
Ciprofloxacin 0.015-4 4 Ouoba et al. 
(2008b) 
Chloramphenicol 2-32 >4 EFSA 
Daptomycin 0.25-16 ≥8 King and 
Phillips 
(2001) 
Erythromycin 0.25-8 >1 EFSA 
Gentamycin 0.25-1024 >16 EFSA 
Kanamycin 8-1024 >256 Ouoba et al. 
(2008b) 
Lincomycin 1-8 ≥1 UKPAR 
Linezolid 0.5-8 ≥8 Ouoba et al. 
(2008b) 
Nalidixic acid 0.5-32 32 Ouoba et al. 
(2008b) 
Nitrofurantoin 2-64 ≥128 Otero et al. 
2007 
Penicillin 0.25-16 4 Ouoba et al. 
(2008b) 
Quinupristin/dalfopristin 0.5-32 >4 EFSA 
Streptomycin 512-2048 >64 EFSA 
Sulfisoxazole 16-256 256 CLSI 
Tetracycline 4-32 >4 EFSA 
Tigecycline 0.015-0.5 ≥8 Nord et al. 
(2006) 
Trimethoprim/sulfamethoxazole 0.12/2.38-4/76 >32/512 Ouoba et 
al.(2008b) 
Tylosin tartrate 0.25-32 ≥32 Ruzauskas 
et al. (2010) 
Vancomycin 0.25-8 >2 EFSA 
 
EUCAST: European Committee on Antimicrobial Susceptibility Testing 
EFSA: European food safety authority 
CLSI: Clinical and Laboratory Standards Institute 
UKPAR: United Kingdom Public Assessment Report 
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The resulting MIC of each isolate for individual antibiotics were compared with 
that of proposed breakpoints and the isolate was considered resistant to any 
particular antibiotic if the MIC was greater than the breakpoint. If any tested 
organisms show resistance to any antibiotic, it might indicate intrinsic resistance. 
However, if for any individual antibiotic the tested strains react differently, then 
there is a possibility of acquired resistance. For such cases, further investigation 
was carried out to examine the presence of selected genes. 
7.2.3 Detection of the resistance genes 
A further investigation was carried out to study the presence or absence of some 
selected genes in the isolates that showed resistance to some antibiotics. The 
genetic background of antibiotic resistance genes was studied by PCR using 
specific primers for antibiotic resistance genes. For an antibiotic to which a 
tested isolate showed resistance, PCR was carried out for most frequent genes. 
The following antibiotic genes were screened. 
 Tetracycline: tet(M), tet(L), tet(S), tet(Q), tet(K), tet(O), tet(w) 
 Kanamycin: aph(3’’) -I, ant(2’’) -I, aph(3’’) -III 
 Streptomycin: strA, strB, aadA, aadE 
 Erythromycin: erm(A), erm(B), erm(C) 
 Gentamycin: aac(6′), aph(2″), ant(2”)-I, aac(3″)IV,  
 Vancomycin: van(A), van(B), van(X) 
 Chloramphenicol: Cat, Cat1, CmlA 
DNA extraction in all isolates was carried out as described in section 2.2.7.1. 
The PCR reaction mix (49µl) used for tetracycline, kanamycin, vancomycin, 
gentamycin and erythromycin contained the following reagents and for each 
investigated gene the corresponding set of its primers were applied (Table 7.4). 
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High purity water 41.4 µl, 10×PCR buffer (with 15 mM MgCl2) 5 µl, dNTP (1.25 
mM) 0.5 µl, Primer 1 (21 pmol/µl) 0.5 µl, Primer 2 (21 pmol/µl) 0.5 µl, Taq DNA 
Polymerase (5 U/µl) 0.1 µl, DNA extract 2 µl and volume in total was 50 µl. 
The PCR reagents for investigation of two corresponding genes (str A and str B) 
for streptomycin and also chloramphenicol, were as follows, 
High purity water 39.4 µl, 10×PCR buffer (with 15 mM MgCl2) 5 µl, dNTP (1.25 
mM) 0.5 µl, MgCl2 (25 mM) 2 µl, Primer 1 (21 pmol/µl) 0.5 µl, Primer 2 (21 
pmol/µl) 0.5 µl, Taq DNA Polymerase (5 U/µl) 0.1 µl, DNA extract 2 µl and 
volume in total was 50 µl. 
The PCR reagents for investigation of the resistance gene aadA for 
streptomycin were as follows, 
High purity water 40.9 µl, 10×PCR buffer (with 15 mM MgCl2) 5 µl, dNTP (1.25 
mM) 0.5 µl, MgCl2 (25 mM) 0.5 µl, Primer 1 (21 pmol/µl) 0.5 µl, Primer 2 (21 
pmol/µl) 0.5 µl, Taq DNA Polymerase (5 U/µl) 0.1 µl,  DNA extract 2 µl and 
volume in total was 50 µl. 
The PCR reagents for investigation of resistance gene aadE for streptomycin 
were as follows: 
High purity water 38.4 µl, 10×PCR buffer (with 15 mM MgCl2) 5 µl, dNTP (1.25 
mM) 0.5 µl, MgCl2 (25 mM) 3 µl, Primer 1 (21 pmol/µl) 0.5 µl, Primer 2 (21 
pmol/µl) 0.5 µl, Taq DNA Polymerase (5 U/µl) 0.1 µl, DNA extract 2 µl and 
volume in total was 50 µl. 
All PCR amplifications were performed in a thermocycler (GeneAmp PCR 2700 
system) using the following temperature program: 
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Initial denaturation temperature was 94 °C for 3 min, 25 or 35 cycles of 94 °C 
for 1 min, 45-68 °C according to annealing temperature for the individual primers 
(Table 7.4) and 72 °C for 1 min and a final extension step at 72 °C for 10 min. A 
volume of 10 µl of PCR products were separated by electrophoresis on 1.5% 
w/v agarose gel and visualised by ethidium bromide staining (see section 
2.2.7.3 for more details). 
16Table 7.4 The studied genes and their specific primers and annealing temperatures 
Resistance 
genes 
Primers Annealing 
 temperature(°C) 
tet(M) 5’-GTT AAA TAG TGT TCT TGG AG-3’ 
5‘-CTA AGA TAT GGC TCT AAC AA-3‘ 
45°C 
tet(L) 5’-GTT GCG CGC TAT ATT CCA AA-3’ 
5’-TTA AGC AAA CTC ATT CCA GC-3’ 
54°C 
tet(S) 5’-TGG AAC GCC AGA GAG GTA TT-3’ 
5’-ACA TAG ACA AGC CGT TGA CC-3’ 
55°C 
tet(Q) 5’-ATG TTC AAT ATC GGT ATC AAT GA-3’ 
5’-GCG GAT ATC ACC TTG CTT C-3’ 
55°C 
tet(K) 5’-TTA GGT GAA GGG TTA GGT CC-3’ 
5’-GCA AAC TCA TTC CAG AAG CA-3’ 
55°C 
tet(O) 5’-GAT GGC ATA CAG GCA CAG AC-3’ 
5’-CAA TAT CAC CAG AGC AGG CT-3’ 
55°C 
aph(3’’)-I 5’-AAC GTC TTG CTC GAG GCC GCG-3’ 
5’-GGC AAG ATC CTG GTA TCG GTC TGC G-
3’ 
68°C 
ant(2’’)-I 5’-GGG CGC GTC ATG GAG GAG TT-3’ 
5’-TAT CGC GAC CTG AAA GCG GC-3’ 
67°C 
aph(3’’)-III 5’-GCC GAT GTG GAT TGC GAA AA-3’ 
5’-GCT TGA TCC CCA GTA AGT CA-3’ 
52°C 
strA 5’-CTT GGT GAT AAC GGC AAT TC-3’ 
5’-CCAATCGCAGATAGAAGGC-3’ 
55°C 
strB 5’-ATC GTC AAG GGA TTG AAA CC-3’ 
5’-GGA TCG TAG AAC ATA TTG GC-3’ 
56°C 
aadA 5’-ATC CTT CGG CGC GAT TTT G-3’ 
5’-GCA GCG CAA TGA CAT TCT TG-3’ 
56°C 
aadE 5’-ATG GAA TTA TTC CCA CCT GA-3’ 
5’-TCA AAA CCC CTA TTA AAG CC-3’ 
50°C 
erm(A) 5’-AAG CGG TAA AAC CCC TCT GAG-3’ 
5’-TCA AAG CCT GTC GGA ATT GG-3’ 
55°C 
erm(B) 5’-CAT TTA ACG ACG AAA CTG GC-3’ 
5’-GGA ACA TCT GTG GTA TGG CG-3’ 
52°C 
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Resistance 
genes 
Primers Annealing 
 temperature(°C) 
erm(C) 5’-CAA ACC CGT ATT CCA CGA TT-3’ 
5’-ATC TTT GAA ATC GGC TCA GG-3’ 
48°C 
tet(w) 5’-GCCATCTTGGTGATCTCC-3’ 
5’-TGGTCCCCTAATACATCGTT-3’ 
55°C 
aac(6′)aph(2″) 
 
 
5′-CCA AGA GCA ATA AGG GCA TA-3′  
5′-CAC TAT CAT AAC CAC TAC CG-3′ 
48°C 
aac(3″)II 
 
5′-TGA AAC GCT GAC GGA GCC TC-3′  
5′-GTC GAA CAG GTA GCA CTG AG-3′ 
55°C 
aac(3″)IV 5′-GTG TGC TGC TGG TCC ACA GC-3′  
5′-AGT TGA CCC AGG GCT GTC GC-3′ 
63°C 
Van(A) 5′-AAC AAC TTA CGC GGC ACT-3′  
5′-AAA GTG CGA AAA ACC TTG -3′ 
55°C 
Van(B) 5′-GAT ATT CAA AGC TCC GCA GC-3′  
5′-TGA TGG ATG CGG AAG ATA CC-3′ 
55°C 
Van(X) 5′-TGCGATTTTGCGCTTCATTG -3′  
5′-ACTTGGGATAATTTCACCGG -3′ 
55°C 
cmlA 5′-TACTCGGATCCATGCTGGCC -3′  
5′-TCCTCGAAGAGCGCCATTGG -3′ 
65°C 
Cat 5′-GGATATGAAATTTATCCCTC -3′  
5′- CAATCATACCCTATGAAT-3′ 
47°C 
Cat1 5′-CGCCTGATGAATGCTCATCCG -3′  
5′- CCTGCCACTCATCGCAGTAC -3′ 
60°C 
 
 
7.3 RESULTS 
Eleven strains of Lactobacillus species were selected from a variety of sources 
to study their antibiotic resistance profile by determination of MIC. Their genetic 
background of antibiotic resistance genes was also studied by PCR reactions. 
7.3.1 Susceptibiliy to antibiotics 
Table 7.5 shows the results for MIC for the tested isolates.  
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17Table 7.5  Minimum Inhibitory Concentrations (μg/ml) of tested lactobacilli with their susceptibility status (resistance/sensitive) 
according to recommended breakpoints (Table 7.3) 
 
                     Strains 
Anibiotic 
 
Lb1 
 
Lb2 
 
Lb3 
 
Lb4 
 
Lb5 
 
Lb6 
 
Lb7 
 
Lb8 
 
Lb9 
 
Lb10 
 
Lb11 
Amikacin >64 
R 
64 
R 
64 
R 
>64 
R 
64 
R 
64 
R 
>64 
R 
>64 
R 
>64 
R 
>64 
R 
>64 
R 
Amoxicillin/ 
Clavulanic acid 
<1/0.5 
S 
<1/0.5 
S 
<1/0.5 
S 
<1/0.5 
S 
2/1 
S 
<1/0.5 
S 
<1/0.5 
S 
<1/0.5 
S 
<1/0.5 
S 
<1/0.5 
S 
<1/0.5 
S 
Ampicillin <1 
S 
<1 
S 
<1 
S 
<1 
S 
<1 
S 
<1 
S 
<1 
S 
<1 
S 
<1 
S 
<1 
S 
<1 
S 
Cefoxitin 32 
S 
32 
S 
32 
S 
>32 
R 
>32 
R 
8 
S 
>32 
R 
16 
S 
16 
S 
16 
S 
>32 
R 
Ceftiofur 
 
1 
S 
0.25 
S 
0.25 
S 
1 
S 
1 
S 
0.25 
S 
0.25 
S 
1 
S 
0.25 
S 
0.25 
S 
1 
S 
Ceftriaxone 8 
R 
2 
S 
2 
S 
16 
R 
16 
R 
2 
S 
1 
S 
2 
S 
2 
S 
4 
R 
8 
R 
Ciprofloxacin 4 
R 
>4 
R 
>4 
R 
>4 
R 
>4 
R 
>4 
R 
>4 
R 
>4 
R 
>4 
R 
>4 
R 
>4 
R 
Chloramphenicol 8 
R 
 8 
R 
 8 
R 
8 
R 
8 
R 
<2 
S 
8 
R 
8 
R 
8 
R 
8 
R 
8 
R 
Daptomycin >16 
 
R 
>16 
 
R 
>16 
 
R 
>16 
 
R 
>16 
 
R 
>16 
 
R 
>16 
 
R 
>16 
 
R 
>16 
 
R 
>16 
 
R 
0.5 
 
S 
Erythromycin 2 
 
R 
0.5 
 
S 
0.5 
 
S 
2 
 
R 
<0.25 
 
S 
<0.25 
 
S 
1 
 
S 
 
1 
 
S 
1 
 
S 
1 
 
S 
<0.25 
 
S 
 
 
 
239 
 
Table 7.5 continued   
 
          Strains 
 
 
Antibiotic 
 
 
 
Lb1 
 
 
 
 
 
Lb2 
 
 
 
 
 
Lb3 
 
 
 
 
 
Lb4 
 
 
 
 
 
Lb5 
 
 
 
 
 
Lb6 
 
 
 
 
 
Lb7 
 
 
 
 
 
Lb8 
 
 
 
 
 
Lb9 
 
 
 
 
 
Lb10 
 
 
 
 
 
Lb11 
 
 
 
Gentamycin >16 
 
R 
>16 
 
R 
>16 
 
R 
>16 
 
R 
8 
 
S 
8 
 
S 
>16 
 
R 
>16 
 
R 
>16 
 
R 
>16 
 
R 
>16 
 
R 
Kanamycin 512 
 
R 
64 
 
S 
1024 
 
R 
512 
 
R 
64 
 
S 
<128 
 
S 
256 
 
S 
1024 
 
R 
512 
 
R 
256 
 
S 
512 
 
R 
Lincomycin 8 
 
R 
>8 
 
R 
>8 
 
R 
<1 
 
S 
<1 
 
S 
8 
 
R 
<1 
 
S 
>8 
 
R 
>8 
 
R 
>8 
 
R 
<1 
 
S 
Linezolid 
 
4 
 
S 
<0.5 
 
S 
2 
 
S 
4 
 
S 
<0.5 
 
S 
1 
 
S 
4 
 
S 
2 
 
S 
4 
 
S 
2 
 
S 
<0.5 
 
S 
Nalidixic acid >32 
 
R 
>32 
 
R 
>32 
 
R 
>32 
 
R 
>32 
 
R 
>32 
 
R 
>32 
 
R 
>32 
 
R 
>32 
 
R 
>32 
 
R 
>32 
 
R 
Nitrofurantoin 16 
 
S 
>64 
 
S 
16 
 
S 
16 
 
S 
64 
 
S 
<2 
 
S 
16 
 
S 
4 
 
S 
16 
 
S 
8 
 
S 
<2 
 
S 
 
Penicillin 
<.025 
 
S 
<.025 
 
S 
<.025 
 
S 
<.025 
 
S 
<.025 
 
S 
<.025 
 
S 
<.025 
 
S 
<.025 
 
S 
<.025 
 
S 
<.025 
 
S 
<.025 
 
S 
Quinupristin/ 
Dalfopristin 
1 
 
S 
1 
 
S 
2 
 
S 
<0.5 
 
S 
<0.5 
 
S 
4 
 
S 
<0.5 
 
S 
2 
 
S 
2 
 
S 
<0.5 
 
S 
<0.5 
 
S 
 
Streptomycin 
>64 
 
R 
<32 
 
S 
<32 
 
S 
>64 
 
R 
>64 
 
R 
<32 
 
S 
>64 
 
R 
>64 
 
R 
<32 
 
S 
<32 
 
S 
>64 
 
R 
 
Sulfisoxazole 
>256 
 
R 
>256 
 
R 
>256 
 
R 
>256 
 
R 
>256 
 
R 
>256 
 
R 
>256 
 
R 
>256 
 
R 
>256 
 
R 
>256 
 
R 
>256 
 
R 
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 Table 7.5 continued 
 
          Strains 
 
 
Antibiotic 
 
 
 
Lb1 
 
 
 
 
 
Lb2 
 
 
 
 
 
Lb3 
 
 
 
 
 
Lb4 
 
 
 
 
 
Lb5 
 
 
 
 
 
Lb6 
 
 
 
 
 
Lb7 
 
 
 
 
 
Lb8 
 
 
 
 
 
Lb9 
 
 
 
 
 
Lb10 
 
 
 
 
 
Lb11 
 
 
 
Tigecycline  
0.12 
 
S 
 
0.12 
 
S 
 
0.12 
 
S 
 
0.12 
 
S 
 
<0.015 
 
S 
 
0.12 
 
S 
 
0.12 
 
S 
 
0.25 
 
S 
 
0.12 
 
S 
 
0.12 
 
S 
 
<0.015 
 
S 
Trimethoprim/ 
Sulfamethoxazole 
 
>4/76 
 
S 
 
>4/76 
 
S 
 
>4/76 
 
S 
 
>4/76 
 
S 
 
>4/76 
 
S 
 
>4/76 
 
S 
 
>4/76 
 
S 
 
>4/76 
 
S 
 
>4/76 
 
S 
 
>4/76 
 
S 
 
>4/76 
 
S 
Tylosin tartrate  
8 
 
S 
 
>32 
 
R 
 
0.5 
 
S 
 
4 
 
S 
 
1 
 
S 
 
0.5 
 
S 
 
1 
 
S 
 
1 
 
S 
 
0.5 
 
S 
 
0.5 
 
S 
 
<0.25 
 
S 
Tetracycline  
4 
 
S 
 
2 
 
S 
 
<1 
 
S 
 
>32 
 
R 
 
<1 
 
S 
 
<1 
 
S 
 
4 
 
S 
 
2 
 
S 
 
<1 
 
S 
 
2 
 
S 
 
<1 
 
S 
Vancomycin  
>32 
 
R 
 
1 
 
S 
 
1 
 
S 
 
>32 
 
R 
 
>32 
 
R 
 
1 
 
S 
 
>32 
 
R 
 
4 
 
R 
 
1 
 
S 
 
2 
 
S 
 
>32 
 
R 
 
(R) Resistant  (S) Sensitive 
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The β-lactam antibiotics appeared to be the most effective antibiotics and all 
tested bacteria showed susceptibility to them, which inhibit the cell wall 
synthesis. Penicillin was the most active and had a MIC value below 0.25 μg/ml 
for the all tested bacteria. According to the breakpoints, the isolates were 
considered susceptible to penicillin. The MIC value determined for ampicillin 
also was below 1 μg/ml. Also some of the tested bacteria (Lb2, Lb3, Lb6, Lb9 
and Lb10) showed susceptibility to vancomycin. Their MIC for vancomycin was 
1μg/ml. Vancomycin acts on the cell wall synthesis. However, the rest of the 
tested isolates showed resistance to vancomycin and the MIC was detected 
above 32 μg/ml. 
With the exception of Lb2, Lb5, Lb6, Lb7 and Lb10, all others were resistant to 
kanamycin where the MIC value ranged from 512 to <1024 μg/ml. Also for 
streptomycin, Lb2, Lb3, Lb6, Lb9 and Lb10 were susceptible to streptomycin 
(MIC <32 μg/ml), but other isolates exhibited resistance toward the antibiotic 
(MIC value was >64 μg/ml). 
All isolates except Lb6, showed resistance toward chloramphenicol and only 
Lb4 showed resistance to tetracycline. However, the reaction of the isolates 
toward other 50S ribosomal subunit directed antibiotics, such as erythromycin 
was variable. Nine out of 11 isolates were susceptible to erythromycin, but Lb1 
and Lb4 showed reduced susceptibility (MIC 2μg/ml). 
All strains tested in this study showed low susceptibility to nalidixic acid and 
ciprofloxacin. The MIC for nalidixic acid and ciprofloxacin were >32 and >4 μg/ml, 
respectively. 
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There was no resistance to a combination of trimethoprim and sulfamethoxazole 
and all strains showed susceptibility with MIC value ranging from 4 to 76 μg/ml. 
7.3.2 Detection and characterization of possible resistance genes 
Based on the results obtained for bacterial resistance to antibiotics (Table 7.5), 
seven out of 25 tested antibiotics were selected to be assessed for resistance 
determinants. As seen in Table 7.5, 12 antibiotic affected the tested strains 
differently (some inhibitory and some not). It was, therefore, decided to screen 
the resistant isolates for the presence of common genes related to seven of 
these antibiotics based on our access and availability of these genes. 
The DNA of selected isolates (Table 7.5) was subjected to genetic screening for 
a selection of different resistance genes using PCR (section 7.2.3) with primers 
specific for the respective antibiotic resistance genes. 
For all resistance genes screened, no positive amplicon was observed for all 
tested strains. It should be pointed out that positive control was used for 
accuracy of the experiment, and in all related experiments, they produced a 
clear positive amplicon.  
As a representative, Figure 7.1 shows the result of five isolates (Lb2, Lb4, Lb5, 
Lb8 and Lb9) for six popular genes including tetracycline, tet(L), (M), (W), (K), 
(Q) and tet(S) where there is no clear amplicon for any of the tested isolates 
except for the positive control.  
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59Figure 7.1 Representative gel image of tested isolates for presence of selected 
tetracyclin genes; tet(L), tet(M), tet(W), tet(K), tet(Q) and tet(S) by PCR 
 
 
7.4 Discussion 
Special attention has been paid to prevalence of antibiotic resistance in 
lactobacilli, and due to growing interest in probiotic bacteria, the number of 
studies on this issue has recently increased (Ashraf and Shah 2011). The 
Scientific Committee for Animal Nutrition (SCAN) has concluded that some 
probiotic products pose a risk to human/animal health, because they include 
bacterial strains having transferable resistance genes (European Commission, 
2001). The presence of the genes, which are not considered intrinsic, is slightly 
1000 bp 
 
750 bp 
1000 bp 
 
750 bp 
Lb2  Lb4  Lb5  Lb8 Lb9 +ve1+ve2 
Tet M 
Lb2  Lb4  Lb5  Lb8 Lb9 +ve1+ve2 Lb2  Lb4  Lb5  Lb8 Lb9 +ve1 
Lb2  Lb4  Lb5  Lb8 Lb9 +ve1+ve2 Lb2  Lb4  Lb5  Lb8 Lb9 +ve1+ve2 Lb2  Lb4  Lb5  Lb8 Lb9 +ve1+ve2 
Tet L Tet W 
Tet K Tet Q Tet S 
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alarming because they may be found in commercial starter/probiotic lactobacilli, 
which are consumed at higher dosages (Teuber et al. 1999). 
In this research, the reaction of 11 tested strains was studied against 25 different 
antibiotics. Results obtained demonstrated that all tested isolates might be 
intrinsically resistant to amikacin, ciprofloxacin, daptomycin, nalidixic acid, 
sulfisoxazole. Resistance of Lb. acidophilus strains to nalidixic acid was 
reported by Gupta and Mittal (1995).  
 This study showed that they are sensitive to ampicillin, penicillin, ceftiofur, 
linezolid, nitrofurantoin, tigecycline, trimethoprim/sulfamethoxazole, 
quinupristinm/dalfopristin and amoxicillin/clavulanic acid. Huys et al. (2008) 
indicated that Lb. paracasei and Lb. casei were uniformly susceptible to 
ampicillin, but exhibited natural resistance to gentamicin and streptomycin. 
Lactobacilli has been reported to be intrinsically resistant to streptomycin and 
kanamycin, gentamicin, fluoroquinolones and vancomycin (Elisha and 
Courvalin 1995; Danielsen and Wind, 2003; Liu et al. 2009). Intrinsic resistance 
to aminoglycosides, such as streptomycin and kanamycin, has been indicated 
as a general feature of lactobacilli (Danielsen and Wind 2003).However, this 
piece of research reported that resistance to cefoxitin, ceftriaxone, 
chloramphenicol, erythromycin, gentamycin, kanamycin, lincomycin, 
streptomycin, tylosintartarate, tetracycline and vancomycin were rather variable 
among tested strains and they react differently, therefore it may be considered 
as acquired resistance. Based on the method used, none of the tested bacteria 
in this research presented positive PCR for the resistance genes investigated. 
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Therefore, they may be considered safe regarding their potential to transfer 
resistance genes. 
Vancomycin resistance is considered a major concern because it is widely 
effective against clinical infection (Zhou et al. 2005). The literature shows 
contradictory reports concerning the susceptibility of lactobacilli to vancomycin. 
It should be stated that these studies were carried out using different methods; 
accordingly, the contradictions might be because of variations in methodologies 
(Zhou et al. 2005).Therefore, it is necessary to standardize the applied methods. 
As mentioned earlier, vancomycin inhibits the synthesis of cell walls in 
susceptible microrganisms. They bind to D-alanine/D-alanine in peptidoglycan. 
Liu et al. (2009) ascribed the intrinsic resistance of Lb. plantarum LP1 and LP2 
to vancomycin to this fact that peptidoglycan precursors of Lb. plantarum 
composed of D-lactate rather than D-alanine. Another study has also stated that 
the resistance could be due to the presence of D-alanine/D-lactate as the 
normal peptide in the peptidoglycan (Florez et al. 2005). In our research, 
resistance to vancomycin was observed, but the screened resistance gene 
(van(A), van(B), van(X) was not found for this antibiotic. 
Klein et al. (2000) indicated that Lb. rhamnosus GG (ATCC 53103) is resistant 
to vancomycin, but do not possess the van(A), van(B)or van(C) genes. 
According to their results the safety of this strain was established for use as 
probiotic regarding its vancomycin resistance. 
The tet genes are the most abundant antibiotic resistance determinants, which 
were described for resistance to tetracycline resistance and coding for 
ribosomal protective proteins (Gueimonde et al. 2010).The tet(W) gene has 
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been reported in strains of  Lb. johnsonii, Lb. paracasei and Lb. reuteri (Egervarn 
et al. 2009). Huys et al. (2008) found that Lb. paracasei strains from cheese 
showed acquired resistance to tetracycline, which were related to tet(M) or tet(W) 
genes. They also reported resistance to erythromycin, which was associated 
with erm(B) gene. However, no resistance gene neither for tetracycline nor for 
erythromycin was seen in this study. 
Ouoba et al. (2008b) reported the aph (3´)-III gene conferring kanamycin 
resistance in Lb. casei and Lb. paracasei strains of human origin, but in the 
current research no gene associated with kanamycin resistance was found. 
Resistance to certain antibiotics is not an unusual feature of starter and probiotic 
cultures. Many of these resistances are due to complex intrinsic features such 
as cell wall structure or metabolic properties. This is perhaps the reason why 
the resistances detected in this study could not be traced back to specific genes 
by PCR. The absence of the investigated genes in this study is not surprising 
since the study was on isolates from commercial probiotic cultures, which are 
consumed at high dosages and may have undergone tests to assure the 
absence of transferable resistance genes before their use. 
 
7.5 CONCLUSION 
In conclusion, tested isolates presented intrinsically resistant to amikacin, 
ciprofloxacin, daptomycin, nalidixic acid, sulfisoxazole. They showed 
susceptibiliuty to ampicillin, penicillin, ceftiofur, linezolid, nitrofurantoin, 
tigecycline, trimethoprim/sulfamethoxazole, quinupristinm/dalfopristin and 
amoxicillin/clavulanic acid. However, their resistance to cefoxitin, ceftriaxone, 
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chloramphenicol, erythromycin, gentamycin, kanamycin, lincomycin, 
streptomycin, tylosin tartarate, tetracycline and vancomycin were rather variable 
and it might be considered as acquired resistance. 
The presence of associated resistance genes was investigated in tested isolates 
which based on the method used in this research, no resistance gene was 
discovered. Therefore, they can be considered safe regarding their potential to 
transfer resistance genes. 
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CHAPTER EIGHT: GENERAL DISCUSSION, 
CONCLUSION AND FUTURE WORK 
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8.1 General framework of the study 
This research primarily studied the variety and viability of probiotic lactobacilli in 
fermented milk marketed in the UK and Europe throughout their shelf-life and 
also identified the isolated probiotic Lactobacillus spp. with molecular 
techniques. In addition, other major objectives of this research were in vitro 
studies of the possible physiological and functional properties of the isolates, 
such as resistance to simulated gastric secretions in stomach and bile salts, 
antibiotic resistance and detection of any gene associated with antibiotic 
resistance, biofilm formation, antimicrobial activity and production of CLA.  
 
8.2 Scope of research 
In order to achieve the overall aim, this study was carried out in two steps: 
In the first step, the presence of probiotic lactobacilli in 36 probiotic fermented 
dairy products from the UK/Europe market at the time of purchase and at the 
end of shelf-life was assessed. The isolated lactobacilli were further studied to 
identify them by means of genotypic methods at subspecies/strain level by 
sequencing of 16S rRNA and rpoA genes, and also discriminatory examination 
using rep-PCR. 
To achieve the first aim of this study, isolation and identification of lactobacilli 
from fermented milks, it was considered essential to use a suitable medium for 
isolation of lactobacilli (chapter 2). Evaluation of three selective media (MRS-
Clindamycin, MRS-Sorbitol and MRS-IM Maltose) for the selective enumeration 
of Lactobacillus spp. demonstrated that MRS-Clindamycin and MRS-Sorbitol 
were effective for enumeration of Lactobacillus spp. in fermented dairy products. 
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However, MRS-Clindamycin was chosen for its selectivity as well as good 
recovery of lactobacilli and simplicity of preparation.  
Lankaputhra and Shah (1995) reported that MRS-clindamycin has the potential 
to differentiate Lb. acidophilus in mixed probiotic cultures in yogurt. In their study, 
0.5 ppm clindamycin was added to MRS medium and incubated anaerobically 
at 37 °C for 2–3 days. Van de Casteele et al. (2006) used MRS-clindamycin for 
enumeration of commercial probiotic culture. According to their suggestion, 
MRS-clindamycin was considered as the preferred medium for the selective 
enumeration of commercial Lb. acidophilus strains La-145 and Lafti L10 in the 
presence of yogurt and starter. MRS-clindamycin-ciprofloxacin agar has been 
used by ISO (2006) for enumeration of Lb. acidophilus in milk products in the 
presence of other LAB and bifidobacteria. 
The clindamycin and ciprofloxacin both can inhibit the growth of the Lb. 
delbrueckii subsp. bulgaricus, Lb. delbrueckii subsp. lactis, S. thermophilus, Lb. 
casei subsp. casei, Lb. paracasei subsp. paracasei, Lb. rhamnosus, Lb. reuteri, 
bifidobacteria, lactococci and Leuconostoc species. Moreover, it has been 
stated that this method is not applicable when the number of Lb. acidophilus is 
less than 104 CFU/g and the numbers of Lb. rhamnosus, Lb. reuteri and Lb. 
paracasei subsp. paracasei are greater than106 CFU/g. It is necessary to note 
that Lb. acidophilus is closely related to Lb. johnsonii, Lb. gasseri and Lb. 
crispatus. This method cannot distinguish between them and, therefore, only 
presumptive Lb. acidophilus is mentioned (ISO, 2006). 
The results of lactobacillus counting in 36 samples of probiotic dairy products 
revealed that 31 out of 36 fermented milks contained more than 106 CFU/g at 
the time of purchase. By the end of shelf-life, and depending on the tested 
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product, the number of Lactobacillus spp. reduced between 0.00 and 2.62 log10 
unit. There are various studies regarding the decrease/increase population of 
the probiotic lactobacilli in dairy products (Cruz et al. 2009b). In some studies, 
the viability of probiotics dramatically decreased about three log10 cycles or 
more during the storage (Phillips et al. 2006). In some other studies, the viable 
counts of probiotic bacteria increased one log cycles or more throughout the 
storage period of dairy products (Kasımoglu et al. 2004; Bergamini et al. 2005; 
Buriti et al. 2005). The most of isolated lactobacilli, in this research, were 
demonstrated to be technologically viable, and 61.1% of tested samples 
contained greater than 106 CFU/g viable Lactobacillus spp. at the end of shelf 
life, which is the suggested minimum level required for functional and 
therapeutic benefits.  
A correct identification of the employed probiotic strains is certainly of 
fundamental importance. In this research, genotypic techniques made it 
possible to achieve a reliable identification. Rep-PCR was used as a valuable 
technique for rapid and accurate differentiation of probiotic strains in 
combination with other genotypic analysis to identify and discriminate bacteria 
contained in commercial dairy products. Using rep-PCR, this study revealed that 
Lactobacillus spp. in fermented milks in the UK covers a diverse range of 
species. Eighty five Lactobacillus spp. were isolated from a total of 36 fermented 
milk samples and were identified mainly as Lb. acidophilus, Lb. casei and Lb. 
paracasei using genotypic analysis. The presence of these organisms in 
fermented milks, as an adjunct culture, is in agreement with results of other 
studies. Pyar and Peh (2014) isolated probiotic Lactobacillus species from 
commercial yogurt and they were identified as Lactobacillus acidophilus. 
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Coeuret et al. (2004) studied the different probiotic food in Europe market for 
claimed probiotic lactobacilli stated on their labels. They could identify isolated 
bacteria as Lb. casei defensis, Lb. acidophilus, Lb. casei Shirota and Lb. casei 
subsp. rhamnosus. 
 It has been believed that reduction in the number of probiotic lactobacilli in 
fermented products might be avoided or limited by choosing of appropriate 
carrier, technological care during processing and the use of higher initial 
inoculum levels. 
The majority of tested products were inadequately labelled (in terms of number 
and type of probiotic species) and a few did not correspond with the real identity 
of the incorporated strains. Further research stated on mislabelling of the 
probiotic products. Microbial investigation of probiotic products have indicated 
that the number and identity of recovered species do not always correspond to 
those declared on the labels of products (Hamilton-Miller and Shah 2002; 
Temmerman et al. 2003). However, this study also signifies that the current 
situation still needs to be improved. 
 
8.3 Assessment of probiotic characteristics of Lactobacillus spp. isolates 
Out of 20 identified isolates of probiotic Lactobacillus, six were selected to be 
screened for physiological and functional properties. These isolates along with 
two commercial cultures of Lactobacillus spp. from Chr. Hansen (La5 and C431), 
and also three different type strains from National Collection of Industrial Food 
and Marine Bacteria (NCIMB) (Lb. casei subsp. casei, Lb. paracasei subsp. 
paracasei and Lb. acidophilus) were used throughout this part of the study.  
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8.3.1 Resistance to gastrointestinal tract conditions 
In chapter three, further characterisation of Lactobacillus spp. isolates based on 
their ability to tolerate conditions in the GIT was carried out. Such observations 
(which need to be supported by in vivo studies) could therefore guide us to: 
• Decide on the minimum required intake of probiotics, considering the rate 
of survival/reduction of the isolates in the stomach and/or intestinal tract 
• Decide on the need for protection methods (e.g. embedding in food 
matrices, microencapsulation) for those isolates that show efficient functionality, 
but some degree of sensitivity to the upper digestive tract condition. 
The strains studied showed very poor survival at pH 2, but some degree of 
protective effects were seen in presence of pepsin at pH 2. No significant 
reduction in the viable counts of tested Lactobacillus spp. was observed at pH 
values of 3 and 4 in presence of pepsin. 
This study confirmed that capability to survive in acidic condition is a 
characteristic feature of Lactobacillus spp., which is entirely depend on pH 
values and time. It has been reported that Lb. acidophilus La5 reduced only 1 
log10 cycle after 2 h of exposure to pH 2, but were entirely destroyed after 1 h at 
pH 1 (Favaro and Grosso  2002). Pan et al. (2009) evaluated the resistance of 
Lb. acidophilus NIT to pH 2–4 and, at pH 2, the counts of lactobacilli had 
decreased to an undetectable level after 2 h; however, within 1 h treatment, the 
survival rate was >20%. The lactobacilli survival at pH 3 was higher than at pH 
2. After 3 h interaction, the viable rate of Lb. acidophilus NIT was about 10%. 
When the test pH was enhanced to pH 4, a high survival was notable. They 
observed that with increasing the incubation time, the count of viable lactobacilli 
was decreased. 
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Tested isolates in this research showed extreme sensitivity to acidic condition 
at pH 2, and the protective effect of pepsin in pH 2 was not as noticeable as pH 
3 and 4. 
Supporting evidence for protective effects of pepsin on Lactobacillus spp. in low 
pH has been accumulating in recent years (Schillinger et al. 2005; Madureira et 
al. 2005). According to the results of Schillinger et al. (2005), the reduction of 
Lb. acidophilus strains isolated from probiotic yogurts varied from 0.1 to 2.5 log10 
cycles during 90 min exposing to a simulated gastric buffer containing pepsin at 
pH 2.0, while Lb. paracasei and Lb. rhamnosus indicated a complete loss of 
viability within 30 min of experiment. Such protective effect might be due to 
decreased hyper-polarisation of the cells during exposure to low pH, and it might 
be linked to the H+-ATPase activity of the cells (Matsumotoa et al. 2004; Matto 
et al. 2006). This was not studied and is considered worthy of examination in 
future. 
In contrast to acid resistance, all tested strains in this study presented good 
resistance to different percentage of bile salts, and were able to retain their 
viability. It might be due to deconjugation of bile salts, by the isolates as a result 
of the presence of bile salt hydrolase (BSH). Hypothetically, this increases the 
demand on cholesterol for the synthesis of bile salts and, thus, leads to lower 
blood serum cholesterol levels (De Smet et al. 1994; Taranto et al. 2000). 
However, it should be taken into consideration that the presence of BSH activity 
in probiotic bacteria is controversial. Marteau et al. (1995) reported that the 
absence or limited dehydroxilation of bile salt is a priority for probiotic bacteria 
and stated that excessive BSH activity might be detrimental and undesirable. 
Tanaka et al. (2000a) stated that extensive bile salts deconjugation leads to 
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steatorrhoea (excessive discharge of fat in the faeces). However, the 
survivability of tested bacteria in presence of different concentration of bile salts 
was examined in this research, and BSH activities need to be more investigated 
in future. 
In this study, in spite of good tolerance of tested strains to bile salts, most of 
them died in a sequential model after exposing to gastric condition followed by 
exposure to bile salts (without pancreatin). But, viable numbers was retained 
when duodenal juice was complemented by pancreatin. It seems that all tested 
strains not only are intrinsically resistant to pancreatin, but also pancreatin 
facilitated to recover the strains from harsh conditions in duodenum, and it is a 
remarkable result in this research which need to be studied further. 
8.3.2 Biofilm formation 
Another trial undertaken in this study enabled measurement of biofilm formation 
by Lactobacillus spp. The importance of this study originates from the fact that 
few such studies have been carried out for Lactobacillus spp. Such 
characteristic might be considered valuable to Lactobacillus spp. since it helps 
them to support the colonisation in different ecosystems. After covering of 
epithelial receptors by Lactobacillus spp. biofilm, undesirable microorganisms 
will not be able to colonise. 
It is reported that many parameters influence biofilm formation and composition 
of growth media might be one of them (Djordjevic et al. 2002). Various growth 
media with normal and altered compositions were applied and, the capability of 
tested isolates for growing in these media either in planktonic or biofilm form, 
were assessed (Chapter 4). It was revealed that potential of tested strains for 
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biofilm formation in different growth media is completely strain dependent, as all 
tested isolates were not able to produce considerable biofilm in the tested media. 
It is not easy to interpret which isolate is the most biofilm producer, as it varies 
among tested isolates in different tested media and at different incubation times. 
The evaluation of biofilm formation by tested strains concluded that they 
produced more biofilm in nutrient rich medium. In general, there was no direct 
relationship between the extent of biofilm formation and planktonic growth in 
tested media. Nutrient limitation in diluted media and also replacing of glucose 
by inulin, caused inadequate or no growth. But, growth limitation was not 
enough to induce biofilm formation. 
Lebeer et al. (2007) have reported that Lb. rhamnosus GG can form biofilms on 
abiotic surfaces in contrast to the strains of the Lb. casei. Biofilm formation by 
Lb. rhamnosus GG was prevented at an initial pH of 4.0 in contrast to neutral 
pH. Also, the addition of 0.2% bile to the medium increased biofilm formation, 
but in presence of 1.5% bile, this effect was much less. Contradictory to the 
observation of Lebeer et al. (2007), this study showed that the effect of bile salts 
does not appear to be dependent to its concentration, since the effect was 
similar when two different concentration of bile (0.3% and 1.5%) was added to 
the medium.  
Hood and Zottola (1997) studied biofilm production by five different bacterial 
species. They reported that the growth medium, which induced the formation of 
the maximum amounts of biofilm, varied for each tested bacteria. They also 
reported that Salmonella enterica serovar Typhimurium produced more biofilm 
in nutrient limited medium than Listeria monocytogenes which produced more 
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biofilm in nutrient rich media. Nevertheless, the composition of the used medium 
did not show the same extent of influence on all tested isolats. Based on these 
results, it is concluded that the tested strains have the ability to form a well-
structured biofilm. 
8.3.3 Antimicrobial properties 
This research reported that culture supernatants (un-concentrated) of all tested 
isolates did not show suppressive activity against indicator bacteria. Failure of 
well diffusion method to detect any inhibition activity does not necessarily imply 
the absence of suppression activity, but might be due to a low concentration of 
antimicrobial compounds. Confirming this hypothesis the antibacterial activity of 
tested strains was recovered by concentrating their filtered supernatant. 
Concentration of supernatants by vacuum evaporation increased the amount of 
antibacterial compounds in the supernatant which then showed an inhibition 
zone of more than 10 mm diameter. However, when concentrated supernatants 
were neutralized, then antimicrobial activities disappeared or reduced. In this 
research, production of organic acid besides other unknown substances was 
detected to suppress the growth of indicator bacteria. There is, however, a 
possibility of antimicrobial compound production other than organic acids by 
these organisms. Regardless of organic acids and bacteriocins, there are some 
investigations about bacteriocin-like inhibitory substance (BLIS) produced by 
some lactobacilli with inhibitory activities against a wide range of Gram-positive 
and Gram-negative bacteria (Cheikhyoussef et al. 2009; Batdorj et al. 2006). 
Zhang et al. (2011) assessed the antimicrobial substances of 4 lactobacilli 
strains (Lb. paracasei subp. paracasei M5-L, Lb. rhamnosus J10-L, Lb. casei 
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subsp. casei Q8-L and Lb. rhamnosus GG, against Shigella sonnei, E. coli and 
S. Typhimurium. Organic acids, in particular lactic acid, were identified as the 
main antimicrobial substances because such activity disappeared when the pH 
was buffered, and also proteinase K did not affect the extent of the inhibition 
zones, which indicated that bacteriocins were not involved in the antimicrobial 
activity. 
8.3.4 Production of secondary metabolite (CLA) 
Using bacterial strains for bioconversion of LA to produce dietary CLA, is 
attracting more attention (Nieuwenhove et al. 2007; Sieber et al. 2004). The use 
of Lactobacillus spp., which are able to produce free CLA in fermentation 
process, may offer health benefits. The potential of Lactobacillus spp. strains in 
production of CLA in presence of 500 µg LA/ml in MRS broth was studied 
(Chapter 6). The results obtained in this research showed that tested isolates 
efficiently converted free LA to CLA in MRS broth, which might be due to 
presence of Tween-80 in MRS, and plays an important role in the recovery of 
inhibitory effects of LA on the growth of bacteria and hence, the production of 
CLA (Jiang et al. 1998).  
Alonso et al. (2003) tested 4 strains of Lb. acidophilus and Lb. casei subsp. 
casei for their ability to produce CLA in MRS broth containing different 
concentrations of LA. All strains were able to produce CLA. Maximum 
production of CLA was observed after 24 h of incubation in MRS broth 
containing 0.02% of LA. 
The percentage of CLA conversion was variable among the isolates in our 
research. The CLA produced by the tested isolates was recovered from 
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extracellular phase. It was reported that cis9-trans11 18:2 represent 64–95% of 
total CLA formed and this is similar to the proportion indicated by other 
researches (Jiang et al. 1998; Kelley et al. 2007).  
However, based on existing knowledge, intrinsic characteristic of tested bacteria 
and also experimental conditions could have essential effect on performance of 
bacteria for CLA production. The mechanism of CLA production by these 
bacteria might be due to LA hydrogenase enzyme, which needs to be studied 
further. 
8.3.5 Antibiotic resistance 
Qualified Presumption of Safety (QPS) is an approach for assessment of 
selected microorganisms referred to European Food Safety Authority (EFSA 
2007). Experience has shown that a tool is required to set priorities in the risk 
assessment of food/feed associated microorganisms referred to EFSA and 
formal assessment of safety. Some of the microbial species used in food and 
feed production have a long history of safe use, while others may represent risks 
for consumers. 
This study reported that all tested strains were intrinsically resistant to amikacin, 
ciprofloxacin, daptomycin, nalidixic acid, sulfisoxazole. Also it was shown that 
they are susceptible to amoxicillin/clavulanic acid, ampicillin, ceftiofur, linezolid, 
nitrofurantoin, penicillin, quinupristinm/dalfopristin, tigecycline and 
trimethoprim/sulfamethoxazole. However, resistance to cefoxitin, ceftriaxone, 
chloramphenicol, erythromycin, gentamycin, kanamycin, lincomycin, 
streptomycin, tylosintartarate, tetracycline and vancomycin were relatively 
variable among tested isolates. 
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Susceptibility of Lactobacillus species to chloramphenicol has been reported in 
many studies (Baumgartner et al. 1998; Charteris et al. 1998; Katla et al. 2001; 
Arici et al. 2004) but, in some studies, a resistance to this antibiotic has been 
seen (Lin et al. 1996; Chang et al. 2001). However, resistance to 
chloramphenicol was varying among tested strains in this study.  
Temmerman et al. (2003) observed the relatively high percentage of kanamycin 
and vancomycin resistance among a large collection of lactobacilli. In their study, 
the studied lactobacilli (187 isolates) comprised strains resistant to kanamycin 
(79% of the isolates), vancomycin (65%), tetracycline (26%), penicillinG (23%), 
erythromycin (16%) and chloramphenicol (11%). They reported that the majority 
of the Lactobacillus spp. are intrinsically resistant to glycopeptides. This study 
screened the presence of the transferable glycopeptide resistant genes vanA, 
vanB and vanX, but no amplicons were obtained, and it confirmed that 
resistance of lactobacilli to glycopeptides is intrinsic. These findings are also in 
line with the results of Ouoba et al. (2008b). 
For safety reasons, probiotic bacteria should not carry transferable antibiotic 
resistance. Therefore, some possible genes which were assumed to be 
associated with acquired antibiotic resistance were studied in Chapter 7.  
According to the results, none of the tested strains in current study presented 
positive PCR for the resistance genes investigated. Consequently, they can be 
considered safe regarding their potential to transfer resistance genes. The 
absence of the transferable resistance genes in this research is not unexpected, 
because they were isolated from commercially probiotic products where the 
commercial cultures are used at high dosages and which may have undergone 
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several assessments to guarantee the absence of transferable resistance genes 
before their use. Also, resistance to certain antibiotics is not considered as an 
abnormal characteristic of probiotic cultures. The complex intrinsic 
characteristics such as cell wall structure or metabolic properties are considered 
the reasons for many of these resistances. It could be argued, however, that the 
resistances detected in this study could not be traced back to specific genes by 
PCR. 
Outcomes of this research indicated that as part of the commercialisation 
procedure for probiotic strains, such important safety measures need to be 
carried out. However, such data by no means are inclusive and, as a 
controversial topic, needs further investigations. 
 
8.4 Strengths and limitations of this study 
Characterisation of probiotic microflora is needed for the legal requirements to 
sustain associated claims in functional dairy foods (Sanders 2008). The 
manufacturers of probiotic products always need to assure consumers for 
viability of probiotic microorganisms in functional products and also whether 
they provide any benefits for them. Recently, European Food Safety Authority 
(EFSA) has rejected numerous health claims for probiotics, and banned on the 
descriptive usage of the term ‘probiotic’ as it implies health benefit. The reason 
for this has been the insufficient reports of evidence available to trace back such 
health claims (Katan 2012; Salminen and van Loveren 2012; Binnendijk and 
Rijkers 2013). 
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This research was considered necessary because of the gaps in knowledge 
about the exact mechanisms by which probiotics can exert their health benefits. 
However, there are very few studies on diversity of lactobacilli to demonstrate 
their probiotic beneficial properties, specifically after exposure with low pH 
condition in commercial fermented products. 
Even though probiotic products, such as fermented milks are generally regarded 
as safe and stable, this research emphasises the necessity for continuing 
studying and publication by researchers which may persuade manufacturers to 
improve the quality of their products. This research has attempted to understand 
what could happen to probiotic bacteria which are not protected. The behaviour 
of probiotic bacteria protected by food matrix or other secured form, such as 
microencapsulation, might be different and, depending on the desired function 
of strain, test conditions should be adapted. This study revealed a considerable 
diversity in probiotic properties among the different isolates of lactobacilli. From 
the results of this study, it could be suggested that tested isolates are justified 
in their use as a probiotic in most of occasions, while these strains would need 
to be protected from very harsh condition (i.e. pH 2) in order to increase the 
likelihood of obtaining benefit from their probiotic properties. 
Our findings are good indication of the improvement that has been made over 
the years in selecting and applying more resilient strains of lactobacilli in 
fermented dairy products. Also, based on the results of this research, there is a 
greater chance for achieving higher numbers of probiotic when these products 
consumed earlier than their expiry date. 
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Although Lactobacillus spp. has many technological advantages, such as 
resistance to harsh conditions in the products and even in the GIT, their 
superiority is not necessarily extended to functional properties. The observed 
differences in some of the functional properties of the isolates could be a result 
of diverse environmental stresses that the isolates might have been subjected 
to during preparation. 
The difficulties involved in the analysis of probiotic in vivo have led to the 
development of in vitro models for the selection of potentially adherent strains. 
But in vitro studies and animal experimental analyses only give indications to 
possible health relevant effects. It has been found that due to the complexity of 
the immune system and the numerous interactions with the indigenous gut 
microbiota and administered probiotic bacteria, interpretation of obtained data 
is often difficult. 
Indeed, in vivo studies are necessary to confirm the potential influences prior to 
introducing the probiotic species to clinical intervention studies (Collado et al. 
2007). Besides, individual strains should be tested for each attributes because 
characteristics ascribed to a probiotic are strain-specific (Verdenelli et al. 2009). 
 
8.5 Suggestions for future works 
• Continued search for finding more diverse range of Lactobacillus 
species/strains with other beneficial properties for use in fermented dairy 
products and also an expansion to other probiotic groups, such as 
Bifidobacterium spp., Lactococcus spp., etc. 
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• Further research on labelling of the probiotic products and suggestions 
for improvement of current situation. 
• Improving the quality of in vitro studies on resistance to gastric fluid, using 
actual human gastric fluid, such as secretions which could be obtained from 
patients undergoing routine gastric drainage in order to give an even more 
realistic representation of how gastrointestinal stress could affect functional 
properties. 
• Research on possible protective mechanisms of pepsin and pancreatin 
on probiotic bacteria during exposure to low pH. 
• Further investigations and more evidences as potential warning that risk 
of transfer of antibiotic resistance genes, might be associated with commercial 
probiotic foods.  
• Research on gene associated with biofilm formation and its expression 
after being exposed to conditions similar to GIT, such as low pH, presence of 
bile salts and mucus. 
• Further investigations on interactions of lactobacilli with indigenous 
organisms of the human. 
• Further studies in food systems, such as milk, to maximize the 
enrichment with CLA and to enhance the health functionality of the product 
• Further investigations on the effect of different environmental and 
physiological stresses on probiotic and functional properties of commercial 
strains.  
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APPENDIX 
Media and composition 
DeMan, Rogosa and Sharp broth and agar (MRS, CM0359 
and CM0361, Oxoid Ltd) 
g/l 
‘Lab-Lemco’ Powder 8 
Yeast extract 4 
Pepton 10 
Glucose 2 
Tween 80 1 
Di-potassium phosphate 2 
Ammonium citrate 2 
Sodium acetate 5 
Magnesium sulphate 0.2 
Manganese sulphate 0.05 
Agar 10 
 
Phosphate Buffered Saline g/l 
Sodium chloride 8 
Potassium chloride 0.2 
Di-sodium hydrogen phosphate 1.15 
Potasium dihydrogen phosphate 0.2 
 
Nutrient agar g/l 
‘Lab-Lemco’ Powder 1 
Yeast extract 2 
Pepton 5 
Sodium chloride 5 
Agar 15 
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Maximum Recovery Diluent (MRD, CM0733, Oxoid 
Ltd) 
g/l 
Pepton 1 
Sodium chloride 8.5 
 
Tryptone Soya Agar (TSA, CM131, Oxoid Ltd) g/l 
Pancreatic digest of casein 15 
Papaic digest of soybean  5 
Sodium chloride 5 
Agar 15 
 
Tryptone Soya Broth (TSB, CM129, Oxoid Ltd) g/l 
Pancreatic digest of casein 17 
Papaic digest of soybean  3 
Sodium chloride 5 
Di-basic potassium phosphate 2.5 
Glucose 2.5 
 
 
In general, media and solutions were sterilised at 121 °C for 25 min according 
to manufacturer’s instructions except otherwise stated. Where required, filter 
sterilisation was performed using sterile membrane filter (0.2 µm, 7187, 
Whatman Filters, Maidstone, UK) or with sterile syringe-driven membrane filters 
(0.2, 190-2545, Nalgene, Fisher Scientific, Loghborough, UK).  
 
QIAquick® PCR Purification Kit 
Notes before starting 
 This protocol is for the purification of up to 10 μg PCR products (100bp 
to 10 kb in size). 
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 Add ethanol (96–100%) to Buffer PE before use (see bottle label for 
volume). 
 All centrifugation steps are carried out at 17,900 x g (13,000 rpm) in a 
conventional table-top microcentrifuge at room temperature. 
 Add 1:250 volume pH indicator I to Buffer PB. The yellow color of Buffer 
PB with pH indicator I indicates a pH of ≤7.5. The adsorption of DNA to 
the membrane is only efficient at pH ≤7.5. If the purified PCR product is 
to be used in sensitive microarray applications, it may be beneficial to 
use Buffer PB without the addition of pH indicator I. Do not add pH 
indicator I to buffer aliquots. 
 Symbols: ● centrifuge processing; ▲vacuum processing. 
 
1. Add 5 volumes Buffer PB to 1 volume of the PCR reaction and mix. If the 
color of the mixture is orange or violet, add 10 μl 3 M sodium acetate, pH 
5.0, and mix. The color of the mixture will turn yellow. 
2. Place a QIAquick column in ● a provided 2 ml collection tube or into ▲ a 
vacuum manifold. For details on how to set up a vacuum manifold, refer 
to the QIAquick Spin Handbook. 
3. To bind DNA, apply the sample to the QIAquick column and ● centrifuge 
for 30–60 s or ▲ apply vacuum to the manifold until all the samples have 
passed through the column. ● Discard flow-through and place the 
QIAquick column back in the same tube.  
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4. To wash, add 750 μl Buffer PE to the QIAquick column ● centrifuge for 
30–60 s or ▲ apply vacuum. ● Discard flow-through and place the 
QIAquick column back in the same tube. 
5. Centrifuge the QIAquick column once more in the provided 2 ml collection 
tube for 1 min to remove residual wash buffer. 
6. Place each QIAquick column in a clean 1.5 ml microcentrifuge tube. 
7. To elute DNA, add 50 μl Buffer EB (10 mM Tris·Cl, pH 8.5) or water (pH 
7.0– 8.5) to the center of the QIAquick membrane and centrifuge the 
column for 1 min. For increased DNA concentration, add 30 μl elution 
buffer to the center of the QIAquick membrane, let the column stand for 
1 min, and then centrifuge. 
8. If the purified DNA is to be analyzed on a gel, add 1 volume of Loading 
Dye to 5 volumes of purified DNA. Mix the solution by pipetting up and 
down before loading the gel. 
 
